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Definition of Key Terms 
Chronic disease (CD): complex long-term, progressive diseases that develop in response genetic, 
environmental, physiological or behavioural risk factors (Larsen & Lubkin, 2009). 
Multimorbidity (MM): the presence of two or more chronic medical conditions (Wallace et al., 
2015).  
Cardiovascular disease (CVD):  a group of disorders of the heart and blood vessels and include 
coronary heart disease, cerebrovascular disease, rheumatic heart disease and other conditions 
(World Health Organization, 2020c).  
Chronic obstructive pulmonary disease (COPD): a progressive disease of the lungs characterized 
by airflow limitation that is not fully reversible (World Health Organization, 2019b).   
Type 2 Diabetes (T2D): a chronic metabolic disease, characterized by disruption of glucose 
homeostasis, resulting from defects in insulin secretion, insulin action, or both (American Diabetes 
Association, 2005; DeFronzo, 2004).  
Cancer: is a generic term applied to a large group of diseases characterised by the growth of 
abnormal cells beyond their usual boundaries (World Health Organization, 2019b).  
Physical Activity (PA): any bodily movement produced by the contraction of skeletal muscle that 




Light intensity physical activity (LIPA): activities <3.0 METs or that do not cause a noticeable 
change in breathing rate and can be sustained for prolonged periods (Haskell et al., 2007; Norton 
et al., 2010).  
Moderate to vigorous physical activity (MVPA): activities >3.0 METs or that cause an increase in 
heart rate and breathing rate (Haskell et al., 2007; Norton et al., 2010).  
Exercise: a sub-category of PA that is planned, structured, repetitive and is completed with the 
purpose of improving or maintaining one or more components of physical fitness (Caspersen et al., 
1985). 
Cardiorespiratory fitness (CRF): an integrated measure of the ability of the cardiovascular, 
respiratory and muscular systems to supply and utilise oxygen during sustained physical work.   
Community-based exercise rehabilitation (CBER): exercise rehabilitation that is delivered in local 
fitness centres, gyms and community centres.   
Sedentary behaviour: a range of human endeavours that result in an energy expenditure of no 
more than 1.5 times resting energy expenditure and typically includes time spent sitting or lying 








Skelly, Fiona. Community-Based Exercise Rehabilitation in a Diverse Chronic Disease Population 
The effectiveness of physical activity (PA) for reducing the morbidity and mortality in individuals 
with chronic disease (CD) has been widely established. CD populations participate in lower levels 
of PA than their healthy counterparts. Currently research has focused on individual disease cohorts 
and limited evidence exists investigating levels of PA and SB in a mixed CD population. Study I used 
a cross-sectional study design to evaluate total daily PA and SB in men and women (62.98 ± 10.99 
yr and 50.6% men) with a variety of CDs and examined the association between these behaviours 
and selected health indices. Participants spent 9.5 h.day-1, 4.1 h.day-1, 1.4 h.day-1, and 0.3 h.day-1 
sedentary, standing, in light intensity PA (LIPA) and moderate to vigorous intensity PA (MVPA), 
respectively and on average took 6713 steps per day. The majority of SB was accumulated in bouts 
lasting ≥ 30 min. A higher daily step count was associated with more favourable measures of body 
composition, aerobic fitness and self-rated health. Increased daily sedentary time was associated 
with less favourable lower body strength. These findings highlighted that individuals with CD, 
regardless of specific condition, are a target cohort for intervention. Community-based exercise 
rehabilitation (CBER) programs have the potential to improve health outcomes in CD groups by 
increasing PA levels and reducing sedentary behaviour (SB). Historically such programs have 
involved single CDs.  Given the similar programme design and the growing prevalence of 
multimorbidity (MM), an integrated model may be more suitable.  MedEx Wellness is a novel CBER 
service in Ireland, which offers a shared programme to a range of CDs. In study II a quasi-
experimental design was used to investigate the effects of a CBER program on levels of PA, SB and 
selected health indices, in men and women with a variety of CDs. There were significant 
improvements in LIPA, patterns of SB, physical function, body composition and psychological 
health following participation in a CBER program. A higher attendance to the CBER program was 
associated with improvements in measures of LIPA, MVPA, step count, time in sedentary bouts > 
60 min, physical function, body composition and psychological health and psychosocial 
determinants of PA. These findings demonstrate that CBER is an effective approach to increasing 
PA and improving health related outcomes for individuals with CD, however statistically significant 
findings often mask the range of inter-individual variability that exists within response to CBER. In 
study III factors associated with an effective response to participation in a CBER, in terms of a 
measurable change, in men and women with a variety of CDs were explored. For measures of LIPA, 
strength, body composition and psychological health, a lower baseline (BL) value increased the 
likelihood of achieving a measurable change. A higher cardiorespiratory fitness (CRF) level at BL, 
increased the likelihood of achieving a measurable change. Individuals with cancer were more 
likely to improve measures lower body strength. Individuals with metabolic disease and respiratory 
disease were less likely to improve measures of LIPA and psychological health, respectively. 
Individuals with CD participate in low levels of PA and accumulate high levels of SB. A shared CBER 
program is an effective approach to inducing change in PA, SB, physical function and psychological 
health in a CD cohort. Identifying factors associated with a non-response to CBER could optimise 







Chronic disease (CD) is an umbrella term that describe long-term progressive illnesses 
including cardiovascular disease (CVD), cancer, type 2 diabetes mellitus (T2DM) and chronic 
obstructive lung disease (COPD) (World Health Organization, 2013).  Globally, CD is the leading 
cause of mortality accounting for > 70% of annual deaths (Roth et al., 2018; World Health 
Organization, 2018b) and > 60% of all adult  (≥ 18 yr) deaths in Ireland in 2018 (Department of 
Health, 2019).  CD represents the major driver of health care utilization and it is estimated that the 
management of CD accounts for 70% - 90% of healthcare budgets in Europe and the United States 
(US) (Cronin et al., 2017; National Center for Chronic Disease Prevention and Health Promotion, 
2020).   
Multimorbidity (MM) refers to the coexistence of two or more long-term medical 
conditions or diseases and is associated with a higher risk of premature death, hospital admission, 
reduced functional capacity and quality of life (QoL), compared to a single CD (SCD) (Bayliss et al., 
2004; Fortin et al., 2005; Smith & O’Dowd, 2007; Wallace et al., 2015).  Currently, > 90% of older 
adults in Ireland a living with at least one CD and 70% with MM (Hernández et al., 2019). 
Maximizing disease outcomes requires a combination of medical management, primarily 




changes, reducing SB and increasing physical activity (PA).  PA is defined as any bodily movement 
produced by the contraction of skeletal muscle that increases energy expenditure above basal level 
(Caspersen et al., 1985).  Exercise is a subcategory of PA that involves planned, structured, and 
repetitive body movements undertaken to improve and/or maintain physical fitness or health.  
PA can be classified by the intensity of the activity, which in absolute terms is measured 
by the rate of energy expenditure, usually described in metabolic equivalents (METs).  Moderate 
to vigorous intensity PA (MVPA), is identified as any activity that requires 3-6 METs  (World Health 
Organization, 2020a).  It is currently recommended that individuals with CD should accumulate  at 
least 150 min per week of moderate to vigorous PA (MVPA) (US Department of Health and Human 
Services, 2018b).  However, only a small proportion of individuals with CD meet the recommended 
PA guidelines (Bernard et al., 2018; Fox et al., 2015; Loprinzi et al., 2013; Morrato et al., 2007; 
Serrano-Sanchez et al., 2014).  This may be due in part to the fact that many individuals living with 
CD have a low functional capacity, limiting their ability to participate in MVPA (Brown & Flood, 
2013; Kujala et al., 2019; Welmer et al., 2013).  
The health enhancing benefits of increasing light intensity PA (LIPA), which refers to 
activities performed at >1.5 METs to < 3 METs (Chastin et al., 2019) are now emerging.  In a meta-
analysis by Chastin et al., (2019) evidence for beneficial acute and long-term cardiometabolic 
responses associated with LIPA are demonstrated. Furthermore, an association between LIPA and 
a reduced risk of mortality was found. Additional research has reported favourable associations 
between LIPA and body composition, blood lipids and glucose, systemic inflammation, depression, 




Gando et al., 2014; Healy et al., 2007; Loprinzi & Pariser, 2013; Park & Larson, 2014).  A threshold 
for the amount of LIPA required to onset health benefits has yet to be established, however 
increasing LIPA by 2 min every hour was associated with a lower risk of mortality in individuals with 
chronic kidney disease (Beddhu et al., 2015). Recent evidence reports that reallocating 30 min of 
sleep, sedentary time or standing with LIPA is associated with significant decreases in BMI, body 
fat and fat mass in older adults (Powell et al, 2020). For some individuals with MM, LIPA or MVPA 
is potentially the most effective treatment option to positively impact all components of the illness 
(Barker et al., 2018) and the term ‘polypill’ has been used to describe the pleotropic effects of PA, 
which has been shown to include physical functioning, clinical and psychological enhancements in 
health (Pareja-Galeano et al., 2015). 
Sedentary behaviour (SB) refers to any waking behaviour characterized by an energy 
expenditure ≤ 1.5 METs while in a seated, reclined or lying posture (Tremblay et al., 2017). The 
specific postural component of SB (sitting activities), differentiates SB from physical inactivity. 
Physical inactivity refers to PA levels which are below the recommended guidelines. SB is 
associated with an increased risk of all-cause and CVD mortality, which appear to be independent 
of PA (Patterson et al., 2018; Rezende et al., 2014). Prolonged SB has been associated with 
detrimental effects on glycaemic control, lipid levels and body composition (Brocklebank et al., 
2015; Powell et al., 2018; Wirth et al., 2017). The relative risks associated with prolonged sitting 
become more pronounced in individuals who are also insufficiently active (Biswas et al., 2015; 
Bouchard et al., 2015; Ekelund et al., 2016).  Moreover, among CD populations, the number and 
length of sedentary periods along with frequency of interruptions with standing or LIPA are 




cardiovascular health in CD populations (Bankoski et al., 2011; Biswas et al., 2015).  Interestingly, 
the negative effects of too much sitting may not exist on the same continuum as the health-
enhancing benefits achieved through PA (Dempsey & Thyfault, 2018; Knaeps et al., 2018). Distinct 
genomic regions are linked to PA and SB and SB has detrimental cardiovascular and metabolic 
effects which are independent of PA (Hamilton et al., 2008). From a public health perspective, 
MVPA by itself may be insufficient to eliminate the negative health effects of SB and findings a 
health balance between sitting, standing and PA throughout the day may encompass a more 
integral public health recommendation for individuals with CD (Van der Ploeg et al., 2017).  
Although several biological risk factors are shared across CD groups including 
hypertension, insulin resistance, hyperglycemia, dyslipidemia and chronic inflammation, all of 
which are positively impacted by PA and reduced SB (Koene et al., 2016; Nesto, 2019; Warburton 
et al., 2006; World Health Organization, 2005b), PA studies to date have largely focused on SCD 
cohorts, and comparison across disease groups are limited. Community-based exercise 
rehabilitation (CBER) programs are exercise rehabilitation services that take place in a local fitness 
centre, gym or community centre and have the potential to increase daily PA levels and improve 
health outcomes in CD cohorts (Moreton et al., 2018; Varas et al., 2018, Gallé et al., 2019; Marsden 
et al., 2016; Pang et al., 2005; Santa Mina et al., 2017)  Although CBER programs have historically 
accommodated specific disease cohorts (Anderson et al., 2016; Dunlay et al., 2014; Houchen-
Wolloff et al., 2018; McCarthy et al., 2015; Puhan et al., 2016; Shepherd & While, 2012) they often 
incorporate similar structures and primarily comprise of a combination of aerobic and resistance 
training (Bourke et al., 2016; Heiwe & Jacobson, 2011; Heran et al., 2011; Lane et al., 2014; 




individuals with MM have been shown as effective therapeutic strategies (Barker et al., 2018; 
Ewanchuk et al., 2018; Zgibor et al., 2017).  Given the commonality in program design and delivery, 
an integrated approach to CBER may offer a more resource efficient strategy for reducing SB and 
increasing PA. The effectiveness of a shared exercise rehabilitation program for CD and MM has 
yet to be established.  
Wide-ranging responses exists within participant cohorts in response to pharmacologic 
treatments or lifestyle interventions and indeed, it is not uncommon for some participants to 
experience an adverse response to an intervention or treatment (Garrod et al., 2006; Gayda et al., 
2008; Stoilkova-Hartmann et al., 2015).  Reporting mean changes in health indices as a 
representative of the entire group usually has little clinical importance for individual patients 
(Jaeschke et al., 1989) and can often may mask adverse responses. In contrast, determining 
clinically meaningful changes in indices of health are of much greater importance in the 
management of CD (Cook, 2008). Research identifying factors associated with meaningful 
biological and behavioural responses could assist in program design and delivery.   
The CD population is currently primarily segregated in terms of both research and 
healthcare. Research capturing PA levels and SB has focused on SCD populations and comparisons 
are limited as a result of different methodologies used to capture these outcomes. Moreover, 
individuals with MM are often excluded from SCD cohort studies. An integrated model of CBER has 
the potential to highly effective for improving PA and health related outcomes in the CD 
population, while also reducing a substantial burden on healthcare services. The evidence base for 





















I. Determine the levels of PA and SB in a mixed CD cohort and to investigate the associations of 
PA and SB with selected indices of health 
II. Evaluate the effects of CBER on PA levels, SB and selected indices of health in a mixed CD cohort 
III. Investigate factors associated with a favourable response to CBER in a mixed CD cohort 
Hypotheses 
I. Total daily PA will be low, SB will be high and will be accumulated in prolonged bouts in men 
and women with CD and MM and higher PA and lower SB will be associated with more 
favourable measures of physical, clinical and psychological health 
II. Participation in a CBER program will result in significant improvements in PA, SB, physical, 
clinical and psychological health 
III. Inter-individual variability in physical (activity behaviours and physical functioning), clinical or 










Chronic Disease  
CD, also known as a non-communicable diseases, are complex long-term, progressive 
diseases (Larsen & Lubkin, 2009) that develop in response to genetic, environmental, physiological 
or behavioural risk factors.  There are a wide range of medical conditions which are captured under 
the umbrella term CD, with CVD, cancer, T2DM and chronic lung conditions being most prevalent 
(World Health Organization, 2013).  CD require ongoing medical treatment, which can limit 
activities of daily living (ADL).  Lifestyle behaviours such as smoking, poor nutrition, excessive 
weight, physical inactivity and alcohol consumption are the primary, preventable determinants of 
CD (Ezzati & Riboli, 2013).  
Mortality Associated with Chronic Disease 
More people worldwide die as a result of a CD than any other cause of mortality. In 2017, 
CDs were responsible for > 73% of global deaths (figure 2.1) (Roth et al., 2018).  According to the 
World Health Organisation (WHO) (World Health Organization, 2018b), CD are responsible for 75% 
of premature adult deaths, i.e., death occurring between the ages of 30-69 yr.  CDs develop at a 
younger age in low and middle income countries (World Health Organization, 2005a) resulting in a 




With the number of people over the age of 65 yr increasing in the developed and 
developing world, the proportion of the population living with a CD is growing.  Approximately half 
of all Americans and one-third of adults in EU member states are living with at least one CD 
(Raghupathi & Raghupathi, 2018, OECD/European Observatory on Health Systems and Policies, 
2019b).  The primary causes of death in European Union (EU) countries are circulatory disease, 
cancers and respiratory diseases (OECD/European Union, 2018).   
In Ireland, around 50% of men and women aged 65 yr and over, reported to have at least 
one CD (OECD/European Observatory on Health Systems and Policies, 2019a). In 2018, CD 
accounted for 61.4% of all deaths in the population between the ages of 0 – 64 yr and 64.7% of all 
deaths in adults aged 65 yr in Ireland with CVD, cancer and respiratory diseases the most common 






Figure 2.1 Global causes of death in 2017 
Adapted from Ritchie (2018) 
Prevalence of Chronic Disease 
The prevalence of CD in the UK is expected to increase by more than 50% between 2015 
and 2035 (Kingston et al., 2018). Specifically, by 2035 the number of people diagnosed with cancer, 
diabetes and coronary artery disease (CAD) is expected to increase by 179%, 118% and 22% 
respectively.  Likewise, the number of older adults in the US living with a CD is expected to double 
and reach close to 71 million by 2030 (Centers for Disease Control and Prevention, 2011).  A 40% 
increase in the number of adults in Ireland living with a CD is expected in the next decade 



































































Economic Burden of Chronic Disease  
The cost of CD encompasses direct costs (e.g., medical care, including ambulances 
services, inpatient or outpatient care, rehabilitation and medication), indirect costs (e.g., loss of 
human resources caused by morbidity, reduced working population) and intangible costs (e.g., the 
impact on mental health, bereavement, and suffering, which can result in low productivity).  
Examining healthcare expenditure alone illustrates the magnitude of the burden of CD.  It is 
estimated that 90% of the US $3.5 trillion annual health care expenditure and 70%-80% of 
healthcare budgets in the EU are spent caring for individuals with CD (National Center for Chronic 
Disease Prevention and Health Promotion, 2020, Cronin et al., 2017).  In Ireland, approximately 
90% of the total healthcare budget is spent treating CD (Smyth, 2017). The management of CD is 
Ireland has been described as inadequate and the present system is unsustainable.  Public 
outpatient services in Ireland are overwhelmed and constantly operating off waiting lists (Irish 
College of General Practitioners, 2018).  Unless urgently addressed, it is expected that CD will have 
profound social and economic consequences (Riley et al., 2016).  
Patient Burden of Chronic Disease 
Living with a CD is associated with considerable burden.  All CDs have the potential to limit 
the quality of life (QoL) of the people who live with them (Harris & Wallace, 2012).  Functional 
capacity can be impacted which in turn effects independence (Nihtilä et al., 2008). CD impacts the 
general wellbeing of individuals across a variety of components including functional capacity and 




Functional capacity and functional independence 
Functional capacity can be defined as an individual’s ability to independently carry out ADL 
(Liang & Jette, 1981) and a single CD (SCD) is a significant predictor of functional status decline 
(Stuck et al., 1999).  Furthermore, loss of mobility over a 4 yr follow-up period in adults ≥ 65 yr is 
highly predicted by the presence of CD (Guralnik et al., 1993).  Approximately 80% of older adults 
with a CD are unable to perform some ADL unaided.  (Júnior et al., 2017). Among community-
dwelling women with CD, three-quarters indicated that the illness had a significant impact on daily 
life, including reducing activity participation, necessitating modifications to their usual routine and 
affecting future plans (Restorick Roberts et al., 2017). A decrease in independence can significantly 
impact QoL. The presence of a CD appears to accelerate the normal decline in functional capacity 
associated with ageing.  This is of concern considering that a decline in functional capacity is a 
major cause of disability and increases ADL dependency (Hou et al., 2018).   
Quality of life and psychological health 
Treatment priorities for CD populations have shifted over the decades as increased 
survivorship and non-fatal health outcomes, including HRQoL and psychological health, are now a 
major factor for consideration in healthcare.  Health-related quality of life (HRQoL) is based on an 
individual’s level of satisfaction with their current level of functioning in terms of physical, social 
and psychological health (Stenman et al., 2010).  The CD population have a lower HRQoL than 
healthy age and gender matched counterparts (Alonso et al., 2004).  An increased life expectancy 




living with a reduced HRQoL (Siegel et al., 2012; Wilmot et al., 2015). Across a range of CDs,  Lam 
and Launder, (2000) reported adverse effects on HRQoL in a number of physical, social and 
psychological health components including physical fitness, emotional health, limitations in daily 
activities, limitations in social activities and overall health.  
Rates of depression and decreased life satisfaction are increased in individuals with CD 
(Hébert, 1997; Mhaoláin et al., 2012).  Chapman et al., (2005) reported elevated rates of depressive 
disorders across a range of CDs including asthma, arthritis, CVD, cancer and diabetes.  Among 
T2DM, the presence of depression and anxiety is significantly higher than in healthy age-matched 
controls (Rajput et al., 2016) and is related to risk of mortality in this population (Naicker et al., 
2017).  A high proportion individuals with COPD report having a persistent low mood and lack of 
interest (Kotrotsiou et al., 2017).  Furthermore, individuals with depressive symptoms following a 
myocardial infarction are less likely to adhere to lifestyle and behavioural therapies, which 
potentially will increase their risk of additional cardiac events (Ziegelstein et al., 2000).   
Multimorbidity  
MM, defined as the presence of two or more chronic medical conditions has been shown 
to have a significant impact on QoL, functional capacity, risk of depression,  and health care 
utilization (Wallace et al., 2015, Marengoni et al., 2011).  Furthermore, the presence of MM is 
associated with increased likelihood of hospital admissions, length of stay and readmission, 




al., 2011; Salive, 2013). Studies in both the UK and US have found the patients with MM contribute 
largely to healthcare expenditure (Safran et al., 2005; Sum et al., 2018).   
MM affects a substantial percentage of the population and the burden is expected to 
grow, owing to the aging population (Laires & Perelman, 2019). More than half of the UK 
population (54%) over the age of 65 yr were reported to have ≥ 2 CDs in 2015 and this is expected 
to increase to 67% by 2035 (Kingston et al., 2018).  In a representative sample of the Irish 
population > 50 yr, it was estimated that 66.2% of individuals have MM, with 11% having > 4 
chronic conditions (Glynn et al., 2011). Currently, > 70% of older adults in Ireland are classified as 
having MM (Hernández et al., 2019).  
Risk Factors associated with Chronic Disease  
A number of non-modifiable and modifiable risk factors are shared across many CDs.  Non-
modifiable risk factors include age, gender, race and family history.  Modifiable risk factors include 
depression, impaired glucose tolerance, hyperinsulinemia, dyslipidemia, hypertension, obesity, 
unhealthy diet, smoking, physical inactivity and excessive alcohol (World Health Organization, 
2020b).  At least 80% of CAD, 90% of T2DM and 30% of cancers could be avoided with lifestyle 
modifications (Waxman, 2004).  SB is also a lifestyle behaviour that is associated with the 
development of CD  (Owen et al., 2014).  In the US > 95% of the adult population have at least one 
modifiable risk factor, > 70% have two or more and > 45% have three or more (Adams et al., 2019).  




overweight and obese respectively (Healthy Ireland, 2019). In addition, 69% do not get the 
recommended levels of daily physical activity (PA) (World Health Organization, 2018c).   
Physical Activity, Inactivity and Sedentary Behaviour  
 PA is defined as any bodily movement produced by the contraction of skeletal 
muscle that increases energy expenditure above basal level (Caspersen et al., 1985) and includes 
occupational, household (e.g. caregiving, household cleaning, gardening), transport (e.g. walking 
or cycling to work) and leisure time activities  (Booth et al., 2011). Exercise is a sub-category of PA 
that is planned, structured, repetitive and is completed with the purpose of improving or 
maintaining one or more components of physical fitness (Caspersen et al., 1985). The current 
minimum recommended amount of PA is 150 min of moderate PA, 75 min of vigorous PA or an 
equivalent combination totalling ≥600 MET-min per week (US Department of Health and Human 
Services, 2018a). Subsequentially, physical inactivity refers to PA levels which are below the 
recommended guidelines and hence, less than those required for optimal health and prevention 
of premature death (Booth et al., 2011).  
A continuum depiction based on intensity is frequently used where physical activity lies 
at the lower end. Research investigating the underlying mechanisms of physical inactivity as a risk 
factor and PA as a primary prevention tool have challenged the continuum theory of these two 
behaviours.  The effects of inactivity are not simply a mirror image of the effects of activity.  One 
example is their differing effects on vascular function.  Inactivity results in immediate (within days) 




(Thijssen et al., 2010).  The primary mechanisms involved with exercise training in enhancing 
vasodilator activity is outwards remodelling, which requires 4-6 weeks.  Comparing the response 
to bed rest and exercise training also highlights the non-parallel association between activity and 
inactivity.  Alibegovic et al., (2010) found that 9 days of bed rest induced insulin resistance in 20 
healthy males and altered the expression of more than 4,500 genes and a subsequent 4 weeks of 
exercise training only partially recovered these adaptations.  
The term physical inactivity can be defined in different ways.  It can refer to individuals 
who are insufficiently active to meet the recommended levels of PA (Thivel et al., 2018).  Given the 
established dose-response relation between PA and health, defining physical inactivity in a similar 
manner suggest a continuum theory.  Physical inactivity, defined in terms of non-active behaviours 
characterized by a lack of motion, distinguishes the unique nature of inactivity. This behaviour is 
now more commonly described as sedentary behaviour (SB).   
SB can include a range of human endeavours that result in an energy expenditure of no 
more than 1.5 times resting energy expenditure and typically includes time spent sitting or lying 
during waking hours (Matthews et al., 2008).  SB refers to too much sitting rather than too little 
PA and is thought to be a distinct set of behaviours. A physically inactive person is someone who 
does not meet the recommended levels of PA.  However this does not characterize them as 






Physical inactivity has been identified as a primary risk factor for the development of CD 
(Booth et al., 2017; González et al., 2017). Indeed the risk of CD development associated with 
physical inactivity is similar to the risk associated with obesity or smoking (Lee et al., 2012b). 
Globally, physical inactivity is accountable for 6-10% of CD (Lee et al., 2012b), and 30% of the 
burden of ischemic heart disease, 27% of T2DM, and 21-25% of breast cancer and colon cancer 
(World Health Organization, 2009).  Booth et al., (2011) concluded that physical inactivity is one of 
the most important causes of most CDs and have identified 35 conditions highly associated with 
physical inactivity (Figure 2.2)  
 
Figure 2.2. Chronic diseases associated with physical inactivity 
(Booth et al., 2011) 
Technological advances in modern society have greatly contributed to the growing 




are estimated to have dropped approximately 50-70% (Booth et al., 2011).  A third of adults 
globally are physically inactive (Hallal et al., 2012).  Almost 70% of the adult population in Ireland 
are insufficiently active (World Health Organization, 2018c).  It is estimated that reducing physical 
inactivity by 10% - 25% would avert 533,000 to 1.3 million global deaths annually (Lee et al., 2012).  
Physical Activity 
Participation in PA can be classified in terms of absolute and relative intensity. The 
absolute intensity of an activity is measured by the rate of energy expenditure associated with that 
activity, usually described in metabolic equivalents of task (METs)  (Miles, 2007). A limitation 
associated with the measurement of PA intensity on an absolute scale is that a particular activity 
might require quite different physical effort between individuals with varying fitness levels (Lee et 
al., 2003). For example, walking at 3 to 4 mph (brisk walking), on an absolute scale, is classified as 
moderate intensity or requiring 4 METs, regardless of whether it is performed by a young man or 
elderly women. PA can be also be expressed in relative terms, where the intensity of an activity is 
classified by measuring the energy requirement in a particular individual compared to their level 
of fitness (Howley, 2001). The relative intensity of an aerobic activity can be described in terms of 
percentage of maximal oxygen uptake (VO2max), oxygen uptake reserve, heart rate reserve or 
maximal heart rate. Likewise, intensity can be classified relative to an individual’s subjective 





 Categories along this continuum can be described as follows: 
Light: activities < 3.0 METs or that do not cause a noticeable change in breathing rate and 
can be sustained for prolonged periods.  
Moderate: activities 3.0 – 5.9 METs or that cause an increase in heart rate and breathing 
rate but where one can still hold a conversation. This intensity can generally be sustained 
for 30-60 minutes.  
Vigorous: activities ≥ 6.0 METs or in which a conversation could not be maintained and 
activity can usually be sustained for up to 20 minutes.  
(Haskell et al., 2007; Norton et al., 2010) 
Light intensity physical activities (LIPA) can include, but are not limited to, activities that 
involve casual walking, stretching, light weight bearing activities and can be performed as part of 
ADL or as leisure time pursuits.  Observational evidence reporting that LIPA can confer health 
benefits is accumulating. Cross-sectional and longitudinal research reports that LIPA is positively 
associated cardiometabolic health, lipid metabolism, glucose metabolism, bone mineral density 
and functional capacity and inversely associated with adiposity, T2DM, metabolic syndrome, C-
reactive protein, levels of depression (Fuezeki et al., 2017a) and all-cause mortality (Beddhu et al., 
2015; Loprinzi, 2017). Increasing LIPA by 2 min every hour was associated with a lower risk of 
mortality in individuals with chronic kidney disease (hazard ratio (HR), 0.59; 95% CI, 0.35 to 0.98) 




interpretation beyond an association.  LIPA is associated with a reduced risk of hospitalization (HR 
0.79, 95% CI 0.67 to 0.93), lower waist circumference and blood glucose levels in individuals with 
COPD (Donaire-Gonzalez et al., 2015; Park & Larson, 2014); cholesterol (odds ratio (OR) 0.99; 95% 
CI 0.99 to 0.99), waist circumference (OR 0.98; 95% CI 0.97 to 0.99) and risk of visual impairments 
(OR 0.62; 95% CI 0.42 to 0.92) in individuals with T2DM (Loprinzi et al., 2014; Loprinzi & Pariser, 
2013); and high density lipoprotein cholesterol (HDL-C) (ß=1.23; 95% CI 0.46 to 2.05) and total 
cholesterol (ß=2.72; 95% CI 0.53 to 4.90) in individuals with MM (Li et al., 2019).  In a recent study 
which employed a composite data analysis approach, that accounted for device-measured sleep, 
sedentary time, standing time, LIPA and MVPA, greater LIPA was strongly associated with 
favourable measures of adiposity in older adults (Powell et al., 2020). The results demonstrated 
that reallocating 30 min of sleep, sedentary time or standing with LIPA was associated with marked 
improvements in BMI (0.63, 0.96 and 1.08 kg/m2, respectively), body fat (1.58, 1.61 and 1.73%, 
respectively) and fat mass (1.92, 2.12 and 2.26 kg, respectively). The current evidence promoting 
the benefits of LIPA remains predominantly observational and interventional studies are 
warranted to further investigate the health enhancing potential of LIPA.      
The benefits associated with participation in MVPA have been extensively investigated. In 
1995, the American College of Sports Medicine issued the first public health recommendations on 
PA, stating that every adult should accumulate 30 min or more of moderate intensity PA on most 
days of the week to promote and maintain health (Pate et al., 1995). The current minimum 
recommended amount of PA is 150 min of moderate PA, 75 min of vigorous PA or an equivalent 




MVPA must be a minimum of 10 min in duration to be health enhancing (Physical Activity 
Guidelines Advisory Committee, 2008). However, subsequent research has established that a bout 
of MVPA of any duration can contribute to meeting the recommended target (US Department of 
Health and Human Services, 2018a).    
A meta-analysis of 44 studies found a 20-30% reduced risk of all-cause mortality among 
those meeting the MVPA guidelines (Lee and Skerrett 2001).  Based on the analysis of the pooled 
results from 6 population-based studies, Arem et al., (2015) reported that individuals meeting the 
PA guidelines had a 20% reduced risk of mortality compared to those reporting no leisure time 
MVPA.  The risk was further reduced to 31%, 37% and 39% from those achieving 1-2 times, 2-3 
times and 3-5 times the recommended minimum, respectively.  
An abundance of research has demonstrated the protective benefits of PA for mental 
health among adult populations. Meeting the PA guidelines was associated with decreased odds 
of elevated depressive symptoms in a study involving over 10,000 Irish adults (McDowell et al., 
2018a). In a study by McDowell et al., (2018b) a 40% reduction in prevalence of depression was 
observed in those meeting the PA guidelines compared to those below the guidelines. Available 
evidence suggests an inverse association between PA and both anxiety symptoms and disorders. 
The longitudinal associated of PA and anxiety were examined in a systematic review and meta-
analysis by McDowell et al., (2019a). Similarly in a study with over 4,000 Irish adults ≥ 50 yrs, PA 
was cross-sectionally associated with lower anxiety symptoms and status, and a potential dose-




adults, meeting the PA guidelines was associated with a 13.5% lower odds of anxiety (McDowell et 
al., 2020). Specifically in patients with CD, exercise training has been shown to significantly reduce 
symptoms of anxiety (Herring et al., 2010) and depression (Herring et al., 2012).  
Among individuals who participate in some MVPA but who fail to reach the recommended 
amount, there is a 22% reduced risk of mortality (Hupin et al., 2015) and greater survival (Loprinzi, 
2015) compared to those who undertake no MVPA.  A recent review by the American College of 
Sports Medicine, highlighted the potential health benefits of adding a little daily MVPA in those 
who currently perform little or no MVPA (US Department of Health and Human Services, 2018a). 
Similarly, the current Australian PA guidelines state that “if you currently do no physical activity, 
start by doing some” (Australian Department of Health, 2019).  In Ireland, the PA guidelines 
recommendations are at least 30 min a day of moderate activity on 5 days a week, but add that 
“some physical activity is better than none, more is better than some, and any amount of physical 
activity you do gains health benefits” (Department of Health & Children & Health Service Executive, 
2009).     
Physical Activity and Health-related Physical Fitness  
Health-related physical fitness is a state of wellbeing that reflects an individual’s ability to 
perform ADL with vigour and is related to their current and future health.  It encompasses  CRF, 
musculoskeletal fitness, body composition, flexibility and balance (US Department of Health and 
Human Services, 2018a). Regular PA can enhance or maintain the various components of health-




with PA considered a major contributing behaviour (figure 2.3).  Physical fitness a key predictor of 
health and improving physical fitness is central to how PA impacts health.  
 
Figure 2.3 The relation between behaviour, fitness and health  
(Blair et al., 2001) 
CRF is an integrated measure of the ability of the cardiovascular, respiratory and muscular 
systems to supply and utilise oxygen during sustained physical work.  It is an excellent marker of 
functional capacity and one of the strongest independent predictors of all-cause mortality and CVD 
mortality (Lee et al., 2010).  Small improvements in CRF are associated with significant health 
benefits.  An increase in functional capacity of one metabolic equivalent of task (MET) is associated 
with a 13% and 15% reduction in the risk of all-cause and CVD mortality, respectively (Kodama, 
2009).  Importantly, the greatest mortality benefits are achieved by those with the lowest initial 




CRF is a stronger predictor of current health than PA levels (Warburton & Bredin, 2016; 
Blair et al., 2001; Myers et al., 2004; Williams, 2001).  CRF and PA have independent and 
interrelated associations with health, in particular disease risk and premature mortality (DeFina et 
al., 2015; Myers et al., 2015).  PA and CRF have parallel benefits in relation to CVD outcomes 
(DeFina et al., 2015).  However, their beneficial effect on cardiovascular health may be explained 
by mechanisms specific to each activity.  
The physiological adaptations associated with increasing CRF include altered autonomic 
tone, improved endothelial function and altered thrombotic potential (Willerson et al., 2007).  
Resting heart rate is a well-recognised indicator of CRF, where a lower resting heart rate suggests 
better cardiac autonomic control.  In a study by Carroll et al., (2012), resting heart rate was not 
found to be a factor that explained the relation between PA and cardiovascular health.  Instead 
metabolic and inflammatory emerging were potential mechanisms.   
Among obese individuals, CRF and high levels of PA were found to be more important for 
improving health than improvements in body composition (Gill & Malkova, 2006; Lee et al., 2012a; 
Pedersen, 2007).  The risk for all-cause and CVD mortality are lower in individuals with a high BMI 
and optimal fitness than those with a normal BMI and poor fitness (Fogelholm, 2010).  However, 
physically active individuals with a high BMI have a greater risk of T2DM, and CVD than those 
individuals with a normal BMI and low PA.  Regular PA improves CVD risk factors including blood 




glucose tolerance. While increasing PA levels can have a positive effect on health, improving CRF 
can evoke additional health benefits.   
Musculoskeletal fitness (MSKF) can be described as a combination of muscular strength, 
muscular endurance and muscular power along with joint flexibility (Katzmarzyk & Craig, 2002). 
Optimal MSKF is strongly related with functional capacity, reduced risk for CVD and fracture, 
functional independence, improved QoL and cognitive function (Pate et al., 2012; Warburton et 
al., 2001; Warburton & Bredin, 2016) and is an important determining factor in the ability to 
perform ADL (Kell et al., 2001).  In CD patients, reduced skeletal muscle mass and accompanying 
loss in strength and function is related to impaired QoL and increased risk of institutionalization 
(Wolfe, 2006).   
Resistance training is an effective approach to maintaining and/or improving MSKF 
(Abernethy et al., 1994; Reid & Fielding, 2012; Williams et al., 2007).  Numerous national guidelines 
for PA for both healthy adults and those with CD include recommendations for muscle-
strengthening exercise. The guidelines suggest that 8-10 resistance training exercises, of at least a 
moderate intensity for 8-12 repetitions, which targets all major muscle groups on 2 or more days 
a week should be conducted (Australian Department of Health, 2019; Chodzko-Zajko et al., 2009; 
Department of Health & Children & Health Service Executive, 2009; Tremblay et al., 2011; US 





Physical Activity in the Primary Prevention of Chronic Disease 
Primary prevention of CD refers to activities that aim to limit the incidence of disease, 
mainly by reducing risk factors that can negatively impact health and promoting factors that are 
protective of health (Gilford, 1988).  There is a strong evidence base linking PA to primary 
prevention of most CDs and all-cause mortality (Blair et al., 2001, Reiner et al., 2013).  A graded 
linear relation between the volume of PA and health status exists, where the most physically active 
people are at the lowest risk of disease development. Indeed, PA is believed to be an essential 
components in the primary prevention of at least 35 CDs (Booth et al., 2011).  
The role of PA in the primary prevention of CVD has been widely established. CVD is a 
progressive disease, with numerous manifestations across patient cohorts, often beginning with 
cardiovascular risk factors such as dyslipidemia and hypertension, which are known to induce 
oxidative stress and endothelial dysfunction. Classes of disorders under the umbrella term of CVD 
are diseases affecting the heart or circulatory system and includes CAD, cerebrovascular disease, 
peripheral arterial disease (PAD), rheumatic heart disease, congenital heart disease, heart failure 
and deep venous thrombosis. Although CVD is preventable, it is the leading cause of global 
mortality. The role PA plays the primary and secondary prevention of CVD is well established. The 
seminal work by Morris et al., (1953) on London bus drivers and conductors was perhaps the first 
to establish the link between PA and CVD.  Bus conductors, who spend the day walking up and 
down double-decker buses, had a 30% lower incidence rate of CAD than sedentary drivers. 




Lee Jr, 1998; Sesso et al., 2000) and the Nurses’ Health Study (Manson et al., 2002) have 
determined that meeting the recommendations for PA is associated with a reduction in relative 
risk of CVD of 20-35%.  A meta-analysis of 26 studies reporting on over 510,000 individuals found 
significant protection against CVD in those reporting moderate to high levels of leisure time PA 
(Sofi et al., 2008).  Greater engagement in MVPA is associated with more favourable cardiovascular 
biomarkers such as higher HDL-C and lower levels of total cholesterol, mean arterial pressure and 
C-reactive protein (CRP) (Loprinzi, 2015).  Mora et al., (2007) found that PA lowered the rate of 
CVD over a 10 year period through it effect on inflammatory biomarkers such as CRP, BP, lipids and 
body mass index (BMI).   
There is now emerging evidence that PA improvements in CVD outcomes can occur 
independent of their effects on traditional risk factors (Fiuza-Luces et al., 2018; Joyner & Green, 
2009).  This is due to the fact that several important physiologic and pathologic processes at play 
in patients with CVD are favourably modulated by PA.  Vascular dysfunction is one of the earliest 
events in the development of atherosclerosis, the most common form of CVD.  Damage to the 
endothelial occurs prior to angiographic detection of the disease.  Regular PA through its effect on 
shear stress, circumferential stress and hydrostatic pressure helps to maintain vascular structure 
and function across the lifespan (Davignon & Ganz, 2004).  In addition, PA results in cardiac 
remodelling including reduced ventricular stiffness and the development of coronary collaterals, 
improved autonomic nervous system balance, protection against ischemic-reperfusion injury and 




Similarly to CVD, there is compelling evidence for the role of PA in the primary prevention 
of T2DM. A review of prospective studies concluded that a 30% - 50% risk reduction of T2DM is 
associated with a physically active lifestyle, compared to a sedentary lifestyle (Skerrett & Manson, 
2002).  Physical inactivity and obesity are the primary non-genetic determinants of T2DM.  Even in 
the absence of weight loss, PA has been shown to decrease the risk of developing T2DM 
(Tuomilehto et al., 2001). Moreover, the Da Qing IGT and Diabetes Study in China found that 
exercise significantly decreased the development of T2DM in individuals diagnosed with 
prediabetes due to impaired glucose tolerance (Pan et al., 1997).  Both the Finish Diabetes 
Prevention Study (Tuomilehto et al., 2001) and the Diabetes Prevention Program (Diabetes 
Prevention Program Research Group, 2002) found that among individuals with impaired glucose 
tolerance, leisure time PA is associated with a 58% risk reduction in T2DM.  Glucose transportation 
from the circulation into the cells is primarily mediated by a membrane-bound glucose transport 
protein – GLUT4.  Exercise increases the muscle cell content of GLUT4 allowing more efficient 
removal of glucose from the circulation, which is independent of insulin action (Stanford & 
Goodyear, 2014).  In addition, exercise improves insulin sensitivity resulting in lower levels of 
insulin release from the beta cells of the pancreas (Stanford & Goodyear, 2014).  
Research investigating the effects of PA in the primary prevention of COPD is limited.  In 
a study of almost 7,000 participants, PA was associated with a decreased risk of COPD development 
over an 11 year follow-up period (Judith Garcia-Aymerich et al., 2007). Even for active smokers, 




inflammatory effects of smoking, through the enhancement of anti-inflammatory markers and 
antioxidant mechanisms.  
Forced expiratory volume in one second (FEV1) refers to the maximum volume of air that 
an individual can forcefully exhale in one sec after maximum inhalation, and is a commonly used 
measure of lung function (David & Edwards, 2019).  Among the general population, PA has been 
found to be associated with the decline in FEV1 over approximately 4 years, independent of 
smoking status (Jakes et al., 2002).  In a 25 year follow-up study, the mean decline in pulmonary 
function at the 10, 20 and 25 year follow-up was found to be significantly less in the highest PA 
tertile compared with the lowest and the beneficial effects of PA on pulmonary function was 
similar across all smoking categories (Pelkonen et al., 2003).  Likewsie, Cheng et al,. (2003) found 
PA to be associated with better respiratory function at baseline (BL) and remaining active was 
associated with higher FEV1 and forced vital capacity at follow-up of 24 years.  
Cancer is an umbrella term used to describe a large group of diseases characterised by 
abnormal cell growth (World Health Organization, 2018a).  There is a strong evidence base for PA 
in the prevention of colon and breast cancer, with the relative risk reduction for both men and 
women estimated to be as high as 30-40% (Hardefeldt et al., 2018; Lee, 2003; Wu et al., 2013).  A 
recent systematic review found that in addition to colon and breast cancer, PA is associated with 
10-20% relative risk reduction in endometrium, bladder, stomach, oesophagus and kidney cancer 
(McTiernan et al., 2019).  There is also evidence of a dose-response relation between PA and 




million participants found that higher leisure time PA was associated with lowering the risk of 13 
cancers (Moore et al., 2016).   
The mechanisms underlying the association between participation in physical activity and 
cancer prevention remain unclear.  Proposed pathways include reducing inflammation, preventing 
obesity, reducing the time it takes for food to travel through the digestive system, which decreases 
exposure of possible carcinogens to the gastrointestinal tract, preventing high levels of insulin, and 
controlling levels of sex hormones such as estrogen and growth factors that have been associated 
with cancer development (McTiernan, 2008; National Cancer Institute, 2020).  Obesity is an 
independent risk factor for cancer (Avgerinos et al., 2019) and it is well established the PA can 
reduce obesity (Jakicic & Davis, 2011), but this link in theory appears to apply to obesity-related 
cancers only.   
Physical Activity in the Secondary Prevention of Chronic Disease 
Secondary prevention of CD refers to actions that halt the progression of a disease, 
prevent complications or reduce the risk of premature mortality (Zafari & Wenger, 1998). Even for 
those with an established CD, PA has a major role to play in disease management and, in many 
cases has the potential to be a first-line treatment option (Luan et al., 2019).  PA can have 
simultaneous therapeutic and preventive benefits for individuals with CD.  As a therapeutic 
approach, PA can been used to treat a condition or disease in the same sense as treatment via 
pharmacotherapy.  As a preventive approach, PA can prevent the onset of additional health 




hypertension (Hegde & Solomon, 2015; Stamler et al., 1993).  Current public health policy 
recommends that individuals with one or more CD meet the same PA guidelines as a healthy adult 
(Department of Health & Children & Health Service Executive, 2009) and for those who are unable 
to achieve this level of PA, to do as much regular PA as abilities allow (US Department of Healt and 
Human Services, 2018b).  
Exercise Rehabilitation 
For many CDs, the health benefits of exercise surpass what could be achieved with 
conventional medications, and PA is now routinely included as part of the medical management 
plan (Durstine et al., 2013).  Structured exercise interventions for individuals with CD have 
consistently shown to have positive effects on a variety of health outcomes.  For people with CD, 
exercise rehabilitation has the potential to improve physical function, decrease symptoms, 
enhance QoL, decrease future use of healthcare services and reduce the risk of mortality (Anderson 
et al., 2016; Dunlay et al., 2014; Houchen-Wolloff et al., 2018; McCarthy et al., 2015; Puhan et al., 
2016; Shepherd & While, 2012).   
A recent meta-analysis, which included 84 studies, aimed to provide evidence-based 
knowledge for professionals in exercise medicine in relation to the role of exercise in CD treatment 
(Pasanen et al., 2017).  The main findings of this extensive review were that exercise interventions 
can improve physical functioning and health-related QoL across a variety of CD groups, including 
CVD, cancer, COPD, chronic kidney disease, osteoarthritis, rheumatoid arthritis and fibromyalgia, 




aerobic exercise, resistance exercise and a combination of both, as part of their exercise 
interventions, with much diversity in the delivery of the exercise components, highlighting that 
exercise in many forms has the potential to improve health outcomes across numerous CD.   
Cardiovascular disease 
Physical activity 
The mechanisms through which PA can attenuate the progression of CVD have been 
widely established.  PA can lower resting heart rate, systolic BP and increase heart rate reserve, 
which in turn decreases myocardial oxygen demand, and in patients with CVD reduces the risk of 
myocardial ischemia (May & Nagle, 1984; Oliveira et al., 2013; Ribeiro et al., 2012).  The beneficial 
effects of PA are thought to expand to neurovascular responses for patients with CVD, with 
improved functioning in the autonomic nervous system, which promotes a decrease in 
sympathetic tone and enhanced parasympathetic activity (Ribeiro et al., 2012; Rosenwinkel et al., 
2001).  Furthermore, PA has been shown to improve myocardial perfusion as a result of the 
combined effects of improved endothelial function and enhanced coronary circulation (Hambrecht 
et al., 2003).  Endothelial dysfunction is evident during all stages of atherosclerosis. The proposed 
mechanism by which PA enhances endothelial function is as a response to increases in blood flow-
mediated shear stress, which stimulates the endothelial production of nitric oxide, reducing the 




The anti-inflammatory effect of PA for patients with CVD has also been investigated. 
Atherosclerosis is considered a condition characterised by chronic low-level inflammation 
(Hansson, 2005; Liuzzo, 2001; Ross, 1999).  Circulating levels of systemic biomarkers of 
inflammation, namely circulating pro-inflammatory cytokines and CRP are reduced as a result of 
PA in individuals with CVD (Ribeiro et al., 2010).  Arterial stiffness, which is as an independent 
predictor of cardiovascular and all-cause mortality in individuals with CAD and post-myocardial 
infarction patients (Vlachopoulos et al., 2010), decreases in response to PA (Oliveira et al., 2015). 
Exercise rehabilitation 
Cardiac rehabilitation is a multidisciplinary treatment designed to facilitate lifestyle 
changes, improve exercise capacity, optimize medical treatment, address social and psychological 
issues and control risk factors following the onset of CVD.  It is now a well-established component 
for the management of various manifestations of CVD (Dalal et al., 2015; McMahon et al., 2017).  
Exercise training is consistently recognised as a central component of cardiac rehabilitation 
(Mampuya, 2012). Following a major coronary event, exercise rehabilitation is associated with 
significant improvements in QoL in the domains of general health, vitality and mental health (Seki 
et al., 2003). Numerous markers of cardiovascular health have been found to be positively affected 
by exercise training in a range of CVD patients including BMI, body fat percentage, plasma lipids, 
markers of inflammation and exercise capacity (Lavie et al., 2009; Lavie & Milani, 1997a; Lavie & 
Milani, 1997b;  Milani et al., 2004). Williams et al., (2006) present evidence for the efficacy of 




bypass graft surgery, stable angina, percutaneous coronary intervention, chronic heart failure, 
cardiac transplant and cardiac valve repair/replacement. The evidence suggests that exercise-
based cardiac rehabilitation affects the basic pathophysiology of CVD and the underlying disease 
processes through mechanisms which include increasing angina threshold, delaying the onset of 
ischemia and improving endothelial-dependent vasodilation of the coronary arteries. Meta-
analysis of cardiac rehabilitation with exercise as a primary component, for patients with CAD, 
observed a reduction in cardiac mortality ranging from 20% to 32% (Bobbio, 1989; O’Connor et al., 
1989; Oldridge et al., 1988; West, 1995).  Across the various forms of CVD, such as CAD, heart 
failure, stroke and PAD, PA is associated with reducing the impact of the disease, slowing the 
disease progression and preventing recurrences (Darden et al., 2013). A recent systematic review 
and meta-analysis of over 2,000 patients with CVD, found that aerobic and combined aerobic and 
resistance exercise can significantly improve atrial stiffness in this cohort (Zhang et al., 2018). In 
addition to improving physiological health, exercise has also been show to significantly augment 
psychological health (del Pozo-Cruz et al., 2018).  Cochrane reviews on exercise based cardiac 
rehabilitation for CAD (Heran et al., 2011) and heart failure (Sagar et al., 2015) reported significant 
improvements in QoL, across a number of validated QoL measures.  The benefits of cardiac 
rehabilitation have also extensively been demonstrated in stroke patients (Han et al., 2017; Pang 




Type 2 Diabetes Mellitus  
Physical activity 
For individuals with T2DM or prediabetes, the initiation and maintenance of PA is vital for 
blood glucose management in addition to overall health.  CVD mortality is a major cause of 
premature death in T2DM, and there is strong evidence that PA reduces the risk of CVD mortality 
in a dose-response manner (Sadarangani et al., 2014; US Department of Health and Human 
Services, 2018a).  Walking at least 2 hours per week has been associated with lower premature 
mortality in adults with T2DM (Gregg et al., 2003).  Current treatment for patients with T2DM is 
focused on glycemic control and the prevention of microvascular complications including 
nephropathy, retinopathy and neuropathy, all of which are strongly associated with 
hyperglycaemia (Stolar, 2010). 
Exercise rehabilitation 
A number of clinical trials in patients with diabetes have reported improved glycemic 
control in response to both aerobic and resistance exercise, with potentially greater benefits 
achieved with resistance training (Agurs-Collins et al., 1997; Cauza et al., 2005; Dunstan et al., 2002, 
2005; Holten et al., 2004; Honkola et al., 1997).  Blood levels of glycated heamoglobin (HbA1c), 
reflect average blood glucose levels over the previous 8-12 weeks.  A meta-analysis of 14 studies, 
which included over 500 diabetic participants, found that exercise resulted in statistically and 
clinically significant reductions in HbA1c (Boulé et al., 2001).  Indeed, the effects of exercise on 




Study Group, 1998).  A single bout of exercise has been shown to improve insulin sensitivity in 
individuals with diabetes for up to 72 h (Devlin et al., 1987) and chronic adaptations in glucose 
transport and metabolism in response to exercise training can bring blood glucose levels into the 
normal range (Borghouts & Keizer, 2000).   
Other factors associated with cardiometabolic health also improve with exercise in 
patients with T2DM, including BP, lipid profiles, autonomic regulation, vascular function, 
inflammation, body composition and cardiorespiratory fitness (CRF)  (Chudyk & Petrella, 2011; 
Després & Lamarche, 1994; Kemps et al., 2019; Loimaala et al., 2003; Rees et al., 2017; Zoppini et 
al., 2006).   Type 2 diabetics who participate in cardiac rehabilitation following  a myocardial 
infraction, have a lower all-cause mortality rates and lower rate of incidents that required 
revascularization (Jiménez-Navarro et al., 2017).  
Chronic Obstructive Pulmonary Disease 
Physical activity 
Many of the clinical characteristics of patients with COPD, such as disease severity, 
comorbidities, exacerbations and behavioural factors are related to levels of PA (Henrik Watz et 
al., 2014).  Of clinical importance, device-measured PA shows moderate positive associations with 
FEV1, and less exacerbations in patients with COPD (Belza et al., 2001; Pitta et al., 2005; Steele et 
al., 2000; Walker et al., 2008; Waschki et al., 2012; Watz et al., 2009a, Waschki et al., 2012).  The 




Nussbaumer-Ochsner & Rabe, 2011; Vanfleteren et al., 2013).  However increased levels of PA is 
associated with a reduced risk of developing systemic inflammation and cardiac dysfunction 
(Henrik Watz et al., 2008), metabolic syndrome (Henrik Watz et al., 2009b) or T2DM (Garcia-
Aymerich et al., 2004).  In a cohort of newly diagnosed COPD patients, PA was found to have a 
stronger association with the presence of comorbidities than airflow obstruction (Van Remoortel 
et al., 2014).  Across a variety of measures of physical fitness, positive correlations between PA and 
physical fitness are evident in individuals with COPD (Eliason et al., 2011; Pitta et al., 2005; Waschki 
et al., 2012; Watz et al., 2009a).   
Exercise rehabilitation  
Compared to the lack of evidence for PA in the primary prevention of COPD, exercise-
based pulmonary rehabilitation is established and widely implemented as a secondary prevention 
strategy (Nici et al., 2006; Ries et al., 2007; Spruit et al., 2013).  Participation in exercise can be 
difficult for patients with COPD, as a result of symptoms that arise with this condition, principally 
dyspnea or breathlessness.  The sensation of breathlessness while exercising can induce anxiety 
and further exacerbate symptoms (McCarthy et al., 2015). Due to the substantial impact of 
dyspnea and fatigue on functional capacity and QoL in COPD (May & Li, 2015), the research on 
exercise rehabilitation has been centred around these outcomes (McCarthy et al., 2015; Puhan et 
al., 2016; Spruit et al., 2013).  In two extensive Cochrane systematic reviews of pulmonary 
rehabilitation versus usual care (McCarthy et al., 2015) and pulmonary rehabilitation after hospital 




found to improve dyspnea, fatigue, exercise capacity, HRQoL, emotional function, and the patients’ 
sense of control over their condition. More recently, research has found exercise-based pulmonary 
rehabilitation to be associated with survival rates for patients with COPD (Houchen-Wolloff et al., 
2018).  
Although the primary pathophysiology of COPD involves airflow obstruction, secondary 
complications, including skeletal muscle wasting and dysfunction, osteopenia, cardiac dysfunction 
and depression, are common (Agusti, 2005; Agusti et al., 2003; Nici et al., 2006). Exercise training 
has the potential to address many of these other clinical manifestations.  In fact, adaptations 
associated with exercise in COPD seem to primarily involve the muscular system and the 
cardiovascular system, which in turn relieve dependence on ventilation when participating in 
higher intensity activities (Butcher & Jones, 2006).  
Even for patients with severe COPD, an exercise intensity can be achieved to elicit skeletal 
muscle adaptations (Maltais et al., 1996) including remodelling of both type I and type II muscle 
fibres to increase their oxidative capacity and increased capillary density (Antonucci et al., 2003).  
The improvements in skeletal muscle function are associated with enhanced exercise capacity, 
even in the absence of observed changes in lung function.  Furthermore, with improvements in 
oxidative capacity and efficiency of skeletal muscles, the requirement of alveolar ventilation at a 
given work rate is reduced. This can potentially reduce dynamic hyperinflation and in turn reduce 
exertional dyspnea (Nici et al., 2006).  Cardiovascular adaptations include increases in blood 




potential reductions in BP, all of which can contribute to improvements in endurance capacity for 
patients with COPD (Maltais et al., 1996).   
Cancer 
Physical activity 
There is evidence to support the therapeutic role of PA at all stages of the cancer journey, 
from the point of diagnosis, through treatment and into survivorship.  PA has been prompted by 
many organisations and governing bodies, such as The American College of Sports Medicine, The 
British Association of Sports and Exercise Sciences and The American Cancer Society, to publish 
specific PA recommendations for individuals with cancer (Campbell et al., 2012; Rock et al., 2012; 
Schmitz et al., 2010).  PA can improve overall health and wellbeing throughout the cancer journey 
and is associated with reductions in recurrence and mortality (Lahart et al., 2015; Schmid & 
Leitzmann, 2014).  The current recommendations by the American Cancer Society (2020) for cancer 
patients both during and after cancer treatment are to avoid inactivity and aim to achieve 150 min 
of exercise per week.   
Among postmenopausal women with breast cancer and a BMI < 25 kg/m2, a 66% 
reduction in overall mortality was observed in physically active women compared to sedentary 
(Emaus et al., 2010).  Cancer-related fatigue is one of the most frequent and distressing side effects 
of treatment within this cohort (Jones et al., 2016). Lower rates of fatigue were observed in cancer 




patients who are more physically active, have been reported to have lower psychological distresses 
and greater resilience (Matzka et al., 2016).   
Exercise rehabilitation 
Exercise can counteract the adverse effects of cancer and its treatment.  It is also 
associated with improvements in patient outcomes and treatment-related side effects along with 
decreased risk of cancer recurrence and cancer mortality (Ashcraft et al., 2019; Cormie et al., 2018; 
Haydon et al., 2006; Holmes et al., 2005).  The accumulating body of research demonstrating 
exercise as a safe and effective intervention in individuals living with and beyond cancer has led to 
recommendations that exercise be embedded into standard cancer care as an adjunct therapy 
(Cormie et al., 2018).    
During cancer treatment, exercise may improve a patient’s ability to withstand strenuous 
medical interventions such as surgery and chemotherapy.  Pre-operative exercise training has been 
shown to improve functional capacity and clinical outcomes for cancer patients (Boereboom et al., 
2016; Singh et al., 2013).  In lung cancer, pre-operative training has been found to reduce the risk 
of post-operative complications by 48%, and the length of hospital stay by three days when 
compared to controls (Steffens et al., 2018a).  Evidence of the effect of pre-operative exercise 
training on post-operative outcomes in other cancer diagnosis has not yet been established but is 
being investigated (Steffens et al., 2018b; Wallen et al., 2018). Cachexia is commonly associated 
with cancer and can negatively impact surgical outcomes (Bachmann et al., 2013; Barber et al., 




training was highly effective in reducing the effects of cachexia while enhancing physical fitness 
and additionally health-related QoL in breast and rectal cancer patients.  
Responses to exercise including increases in blood flow, pH regulation, heat production, 
sympathetic activation and endocrine effects have the potential to regulate tumor growth kinetics, 
metastatic potential, tumor metabolism and the immunogenic profile of the tumor (Hojman et al., 
2018).  The effects of exercise may also enhance the effects of the immune system in infiltrating 
tumors.  Exercise can promote T-cell trafficking by increasing the circulating levels of interlukin 6, 
a cytokine involved in the upregulation of adhesion molecules located on the tumor vascular 
endothelium.  Moreover, exercise can acutely increase the number and function of natural killer 
cells, which have a cytotoxic effect on cancer cells (Ashcraft et al., 2019; Bigley et al., 2014; L. 
Pedersen et al., 2016). 
The is evidence that during neoadjuvant chemotherapy, exercise training can positively 
affect patient symptoms and response to treatment and, potentially alter tumour phenotype 
(Ashcraft et al., 2019; Jones et al., 2013a).  Improvements in vascular function associated with 
exercise may have implications for the delivery and efficacy of systemic anticancer agents.  An 
increase in the number of functional tumor microvessels, will potentially increase chemotherapy 
exposure to a larger proportion of tumor cells (Ashcraft et al., 2019).  Finally, tumor hypoxia is 
associated with poor radiotherapy outcomes and increased propensity towards metastasis 
(Ashcraft et al., 2019).  Exercise has been shown to increase tumor radiosensitivity by reducing 




consensus statement by Campbell et al., (2019) highlighted the growing evidence-base supporting 
exercise prescription in cancer cohorts after diagnosis and during treatment. Their review 
concludes that there is currently strong evidence for the positive effects of exercise on many 
common side effects of treatment including anxiety, depressive symptoms, fatigue, the impact on 
HRQoL and physical functioning. Although Campbell states that gaps still remain with regards to 
the prescription of exercise in terms of types of cancer and timing of treatment, the current 
evidence should guide clinicians in advising patients to be active, with a goal of achieving 30 mins 
of exercise on ≥ 3 days per week. Similarly, in a recent call to action by Schmitz et al., (2019) a step 
by step approach for clinicians dealing with cancer patients is outline on how they can effectively 
assess and advise on exercise participation in this cohort. The guidelines for clinicians are as 
follows; 
1. Assess current PA at regular intervals; 
2. Advise patients with cancer on their current and desired levels of PA and convey the 
message that moving matters; and  
3. Refer patients to appropriate exercise program or to the appropriate health care 
professional who can evaluate and refer to exercise.   
Improvements in cancer diagnosis and treatment have contributed to increased survival 
rates for this population (Allemani et al., 2018; Bluethmann et al., 2016).  The challenges facing 




transitioning to survivorship, particularly with limited supports (Cormie et al., 2018; Kantsiper et 
al., 2009).  Exercise interventions improve body composition, physical functioning, cancer-related 
fatigue, QoL, self-esteem and reduce anxiety, depression, the risk of cancer reoccurrence, cancer 
mortality and all-cause mortality in cancer survivors (Fong et al., 2012; Ibrahim & Al-Homaidh, 
2011; Meneses-Echávez et al., 2015; Schmitz et al., 2010; Speck et al., 2010; Spence et al., 2010). 
Indeed, cancer-related fatigue is one of the major causes of distress for cancer survivors (Akechi et 
al., 1999). Cancer-related fatigue is distinct from the typical fatigue that is experienced as a result 
of normal daily living. It is disproportional to levels of activity and is not relieved by sleep or rest 
(Ryan et al., 2007). In a systematic review and meta-analysis by Kessels et al., (2018) exercise was 
found to have a large positive effect on cancer-related fatigue of cancer survivors. Currently, the 
National Comprehensive Cancer Network (2020) promote the use of exercise as a strategy for 
reducing cancer-related fatigue. Although exercise has been shown to reduce cancer-related 
fatigue among patients both during and after cancer treatment, exercise interventions appear to 
have a greater effect in reducing cancer-related fatigue post treatment (Puetz and Herring, 2012). 
Exercise is reported to have a palliative effect on cancer-related fatigue in patients undergoing 
treatment and a restorative effect in patients post treatment.   
Exercise Setting  
Exercise rehabilitation, delivered primarily through hospital-bsaed outpatient 
departments, is part of standard care in the majority of cardiac and many pulmonary settings.  




suboptimal.  Less than 35% of eligible patients participate in cardiac rehabilitation (Bethell et al., 
2008; Mosleh et al., 2015) and non-attendance rates among those referred to pulmonary 
rehabilitation are between 8-50% (Keating et al., 2011). 
Commonly cited barriers to participation in exercise rehabilitation programmes include 
environmental factors, such as distance to the facility and lack of transport and health system 
resources (Cox et al., 2017; Keating et al., 2011; Ruano-Ravina et al., 2016).  Delivering exercise 
rehabilitation in non-hospital settings such as the home or community setting has been 
demonstrated as safe, while also resulting in similar benefits compared to hospital-based 
programmes (Clark et al., 2015; Man et al., 2004; Neves et al., 2016; Waterhouse et al., 2010).  
Embedding exercise services within the community may remove many of the barriers associated 
with poor participation rates in hospital-based rehabilitation programmes.   
CBER can be delivered in local fitness centres, gyms and community centres.  McNamara 
et al., (2016) conducted semi-structured interviews with individuals who had attended both 
hospital- and CBER programs.  The convenience of accessing the community venue, with close 
proximity to free parking was a major appealing factor for the CBER programs. Participants 
expressed how the community venue facilitated a positive rehabilitation experience and promoted 
a sense of “normality”, that exercise was a normal health behaviour as opposed to a treatment for 
their condition.  The community setting enabled participants to gain confidence to explore exercise 
in different settings in the future. The psychosocial benefits of CBER were identified through focus 




importance of the opportunity to integrate into the community and with community members.  
The experience of social connection with regular gym members provided a sense of feeling socially 
included and valued. Participants also received social support from the interactions with peers 
within the exercise group. The interpersonal relationships with the gym instructors contributed to 
the participants’ sense of safety and comfort with the program.   
Although an abundance of mainstream exercise programs are available within most 
communities, programs specific to individuals with CD have certain appealing qualities for this 
cohort.  Cancer patients have described that they are drawn to the condition specific programs as 
they offer an opportunity for social contact and mutual support within a safe environment and are 
led by instructors who have specific training to cater for their condition specific requirements (Catt 
et al., 2018; Moreton et al., 2018).  CEBR programmes can operate at a relatively low cost by 
utilizing available local leisure infrastructure (Mendes et al., 2016). Compared to hospital 
programs, CBER programs typically have more available space, equipment and staff (Bethell & 
Mullee, 1990), which results in greater potential for scalability.   
Community-based exercise programs for chronic disease 
CBER is a safe and effective model of delivering exercise rehabilitation (Desveaux et al., 
2014a) with research reporting similar benefits compared to hospital-based programmes (Clark et 
al., 2015; Neves et al., 2016).  Improvements in physical function and health-related quality of life 
have been reported in a variety of clinical populations following CBER, including cardiac (Mosleh 




stroke (Desveaux et al., 2014a), osteoarthritis (Kelley et al., 2011), and PAD  (Bendermacher et al., 
2007).  The evidence for CBER in the four major CDs (CVD, COPD, cancer and T2DM) are 
subsequently presented.  CBER is also frequently prescribed for neuromuscular and 
musculoskeletal conditions and therefore, the evidence for these conditions is also described. A 





Table 2.1 Studies examining the effects of community-based exercise rehabilitation on chronic disease populations 
Author 
Disease 
Cohort n Study Design CBER Intervention Duration Results 
Bethell & Mellee 
(1990) 
CAD 311 RCT Group circuit training supervised by 
GPs in local sports centre 
3 m ↑VO2max and perceived energy levels  
↓ Angina pectoris  
Kwan et al., (2016) CAD 136 Retrospective 
database analysis 
Supervised group aerobic and 
resistance exercise  
1 yr ↑ aerobic endurance 
↓ %body fat, total cholesterol LDL-C, 
TGs 
Taylor et al., 
(2016a) 
CAD 670 Retrospective trial of 
median 14 yr follow-
up 
Supervised group aerobic and 
resistance circuit based training 
12 wk ↑ fitness  
↓ risk of all cause morality in the least 
fit at baseline  
Cramp et al., 
(2010)  
Stroke 18 Time series 
experimental design 
Group exercise aerobic and 
resistance circuits led by fitness 
instructors 
14 wk ↑ lower limb muscle strength, paretic 
knee extension, walking velocity and 
balance 
Eng et al., (2003) Stroke 25 Single-arm repeated 
measures 
Group exercise classes focused on 
balance, mobility, functional 
strength and functional capacity 
8 wk ↑ functional capacity, aerobic capacity, 
balance and satisfaction and perception 
of physical performance 
Harrington et al., 
(2010) 
Stroke 243 RCT Group exercise focused on balance, 
endurance, strength, flexibility and 
function  
8 wk ↑ physical integration and 
psychological health 
Leroux (2005) Stroke 20 Single-arm repeated 
measures 
Group exercise classes focused on 
strength, balance, mobility and co-
ordination 
8 wk ↑ motor performance  
Marsden et al., 
(2016) 
Stroke 20 Pilot controlled trial Individually tailored home- and 
community-based exercise  
12 wk ↑ aerobic endurance  
 
Pang et al., (2005) Stroke 63 RCT Group progressive aerobic, strength, 
mobility and balance exercise  
19 wk ↑ CRF, paretic leg muscle strength 
Bendermacher et 
al., (2007) 
PAD 56 Time series 
experimental design 
Individual treadmill walking program 6 m ↑ absolute claudication distance 
Kruidenier et al., 
(2009) 
PAD 129 Prospective cohort 
study 
Individual treadmill walking program 12 m ↑ functional claudication distance and 






Table 2.1 continued 
Author 
Disease 
Cohort n Study Design CBER Intervention Duration Results 
Gallé et al., (2019) T2DM 69 Prospective 
controlled trial 
Supervised group aerobic and 
resistance circuit exercise 
9 m ↑ physical functional and physical activity 
↓ BMI, HbA1c, waist circumference 
Mendes et al., 
(2016) 
T2DM 43 Single-arm 
repeated 
measures 
Supervised group aerobic, 
resistance, balance and flexibility 
exercise 
9 m ↑ aerobic endurance, strength, balance and 
flexibility 
Mendes et al., 
(2017)  
T2DM 124 Non-randomised 
controlled trial 
Group supervised aerobic, 
resistance, balance and flexibility 
exercise 
9 m ↑ glycemic control, total cholesterol, LDL-C, 
HDL-C, TGs, SBP, DBP, BMI, waist 
circumference and 10-year risk of CAD 
Amin et al.,  
(2014) 
COPD 24 RCT Aerobic and resistance personal 
training in local health club 
12 wk ↑ aerobic endurance, strength and QoL 
Beauchamp et al., 
(2013) 
COPD 29 Single-arm 
longitudinal 
Minimally supervised self-
conducted aerobic and resistance 
exercise program 
12 m ↑PA levels, endurance, strength and QoL 
Effing et al., (2011) COPD 159 RCT Physiotherapist delivered aerobic 
and strength exercise program  
11 m ↑ maximal exercise capacity and step count 
↓ dyspnoea 
Godtfredsen et al., 
(2018)  
COPD 803 Single-arm 
repeated 
measures 
Multicentred program with 
supervised aerobic and strength 
exercise training 
6 – 12 
wk 
↑ aerobic endurance  and QoL 
Varas et al., (2018) COPD 33 RCT Exercise training combined with a 
walking plan 
8 wk ↑ step count, aerobic endurance and self-
reported PA 
↓ symptoms of COPD 
Christopher and 
Morrow (2004) 
Cancer 23 Single-arm 
repeated 
measures 
Supervised group aerobic, 
resistance and flexibility exercise 
12 wk ↑ psychological health and social wellbeing 







Group supervised aerobic, 
resistance, balance and flexibility 
training 
12 wk ↑ mobility, muscular strength, flexibility and 
balance  
↓ SB and DBPP 





Supervised group interval aerobic 
and musculoskeletal exercise 
12 wk ↑ physical function and psychological health  
Haas et al., (2012) Cancer 177 Single-arm 
repeated 
measures 
Individual monitored program of 
aerobic, resistance and flexibility 
exercise 







Table 2.1 continued 
Author 
Disease 










aerobic program on a 
treadmill  









Supervised group or home-
based aerobic, resistance 
and flexibility exercise  
12 wk ↑ BP, waist circumference, WHR, skin folds,  
↑ grip strength, flexibility, aerobic fitness and health-related 
QoL  
↑ BMI and RHR 
Rajotte et 
al., (2010) 
Cancer 221 Single-arm 
repeated 
measures 
Group supervised aerobic 
warm up with resistance 
exercise 




Cancer 224 Prospective 
cohort study 
Group supervised interval 
aerobic and 
musculoskeletal exercise 
30 wk ↑ aerobic endurance, PA levels, balance cancer-related 





55 RCT Supervised one-to-one 
resistance and mobility 
exercises 
16 wk  Improved sleep efficiency, total sleep time, time spent in 





31 RCT G1 traditional exercise       
(stretching, resistance, 
aerobic and balance) 
G2 boxing training 
(stretching, boxing, 
resistance and aerobic) 
12 wk ↑ balance, mobility and quality of life in both groups 





38 RCT Supervised individual 
G1 progressive resistance 
training 
G2 stretching, balance and 
strength exercises  
24 m ↑ physical function and motor control off medication in both 
groups 
↑ strength and movement speed in progressive resistance 
training group only 








aerobic, resistance, mobility 
and balance exercises 
16 wk ↑ total body strength, leg power, single leg balance, 6 min 
walk test, QoL and improved sit to stand motor unit activation 
and muscle histology (myofiber hypertrophy, shift to less 
fatigable myofiber type profile and  ↑ mitochondrial complex 
activity 




Table 2.1 continued 








aerobic, resistance, mobility 
and balance exercises 
16 
wk 
Improved muscle mass, neuromuscular function (strength, 
power and motor unit activation), indices of neuromuscular 






99 RCT Individual gym-based aerobic 
and resistance exercise  





32 RCT Supervised group aerobic, 














oriented circuit exercise 
12 
wk 
↑ aerobic endurance and physical function  
Note: CAD = coronary artery disease; T2DM = type 2 diabetes mellitus; PAD = peripheral arterial disease; COPD = chronic obstructive pulmonary disease; RCT = 
randomised controlled trial; GP = general practitioner; G1 = group 1; G2 = group 2; wk = week; m = months; ↑ = increase ; ↓ =  decrease;  BMI = body mass 
index; LDL-C = low density lipoprotein cholesterol; TGs = triglycerides; HDL-C = high density lipoprotein cholesterol; SBP = systolic blood pressure; DBP = diastolic 





There is now a substantial body of evidence demonstrating the effectiveness of CBER 
programs in the secondary prevention of CVD.  A 12 week CBER program supervised by 
general practitioners in a local sports centre was found to be effective in increasing maximal 
oxygen uptake, perceived energy levels and reduced angina pectoris among 200 patients 
following an acute myocardial infarction (Bethell & Mullee, 1990).  A retrospective analysis of 
670 patients with CAD who participated in the ‘Heart Watch’ CBER program delivered by local 
council leisure centres found a reduced risk of all-cause mortality at 14 year follow-up (Taylor 
et al., 2016a).  Similarly, a retrospective analysis in 136 participants with CAD who had 
completed a one-year CBER program found improvements in aerobic endurance, body 
composition total cholesterol, LDL-C and TG Kwan et al., (2016). 
Cerebrovascular disease can have disabling effects including weakness, hemiplegia 
or paralysis (Irish Heart Foundtaion, 2020).  Similar to CVD, a number of studies have reported 
beneficial effects among  stroke survivors following their participation in home and 
community-based exercise rehabilitation programs.  A 12-week individually tailored home-
based exercise program delivered by a neurological physiotherapist and an exercise scientist 
to 20 stroke survivors resulted in a significant improvement peak oxygen uptake (VO2peak) and 
distance covered in a 6 min walk test (6MWT).  Pang et al., (2005) found significant 
improvements in both CRF and paretic leg muscle strength in 63 stroke patients who 
participated in a 19 week supervised group-based exercise rehabilitation.  Similarly, other 




improvements in functional capacity, aerobic capacity, balance and satisfaction, perception 
of physical performance (Eng et al., 2003), motor performance (Leroux, 2005) physical 
integration, psychological health (Harrington et al., 2010), lower limb muscle strength, paretic 
knee extension, walking velocity and balance (Cramp et al., 2010).  CBER has also been found 
to be an effective approach to rehabilitation among individuals with PAD.  Supervised 
treadmill walking programs undertaken in physiotherapy practices, have been shown to 
significantly improve absolute and functional claudication distance  in patients with PAD 
(Bendermacher et al., 2007, Kruidenier et al., 2009).   
Type 2 diabetes mellitus  
In patients with T2DM, a range of improvements have been associated with 
participation in CBER cohort.  Participation in supervised group-based exercise programs 
located in community sports centres results in significant improvements in aerobic 
endurance, strength, balance and flexibility, glycemic control, total cholesterol, LDL-C, HDL-C, 
TG, systolic blood pressure (SBP), diastolic blood pressure (DBP), BMI, waist circumference 
and 10-year risk of CAD in men and women with T2DM (Mendes et al., 2016, Mendes et al., 
2017).  Recently, Gallé et al., (2019) found significant improvements in PA levels, physical 
functioning, BMI, HbA1c and waist circumference in individuals with T2DM following 




Chronic Obstructive Pulmonary Disease 
COPD patients who attended an 8-week CBER program which combined exercise 
training with a plan to increase daily step count, had a significant improvement on exercise 
capacity, and a 45% increase in daily step count (Varas et al., 2018).  Similarly, Effing et al., 
(2011) reported an increase in daily step count and maximal exercise capacity in COPD 
patients attending a CBER program that involved a combination of one to one supervised 
exercise in a private physiotherapy practice and unsupervised home-based training. 
Significant improvements in aerobic endurance, strength and QoL, were observed in 24 COPD 
patients by Amin et al., (2014) after 12 weeks of personal training in a local health club.  In a 
longer-term study, Beauchamp et al. (2013), found significant improvements in PA levels, 
endurance, strength and QoL, in 29 patient with COPD, after 12 months of individual exercise 
rehabilitation in a local fitness centre, with minimal formal supervision from fitness centre 
staff.  Finally, Godfredsen et al., (2019), reported significant improvements in aerobic 
endurance and QoL among 800 patients following their participation in a supervised 
community-based pulmonary rehabilitation program.  
Cancer 
In a comprehensive study by Rajotte et al., (2012) with a mixed cohort of 221 cancer 
survivors, the benefits of a 12 week, supervised group-based exercise program located in 
community centres, encompassed improvements in SBP, DBP, upper and lower body 
strength, aerobic endurance, flexibility and overall QoL.  In a more recent study involving 52 




mobility, strength, flexibility and balance, after a 12 week group-based exercise program 
supervised by fitness instructors in local community centres.  Among 224 cancer survivors, 
Santa Mina et al., (2017) reported significant improvements in cancer-related fatigue, SBP 
and social wellbeing after 30 weeks of supervised group-based exercise, located in 
community-based centres.  
A reduced health-related QoL is often associated with cancer (Nayak et al., 2017) and 
there is strong evidence that participation in a CBER program can significantly increase QoL 
in cancer survivors.  Improvements in psychological health and social wellbeing were 
observed by Christopher and Morrow (2004) in 23 female cancer survivors, who participated 
in a 12 week, group-based exercise rehabilitation program. Similarly, Foley et al., (2018) found 
significant improvements in physical function and psychological health in 52 breast cancer 
survivors, after 12 weeks of supervised group-based exercise training in local community 
centres. Significant improvements in QoL were observed by Knobf et al., (2014), in 26 breast 
cancer survivors after participation in 4 – 6 months of supervised individual exercise training 
in community fitness centres.  In a mixed cancer population, long term improvements in all 
sub-scales of QoL were found after 24 months of individualized exercise in a community gym 
(Hass et al., 2012).  
The majority of CBER studies in cancer cohorts have focused on survivorship.  
However Leach et al., (2015) demonstrated the feasibility and safety of supervised exercise 
in a community-based exercise facility and home based exercise for breast cancer patients 




in counteracting the usual declines in physical and psychosocial outcomes that patients 
experience during chemotherapy and radiotherapy.   
Neurological and musculoskeletal disorders 
Parkinson’s disease is a condition often associated with impaired functioning and 
may be linked to muscle weakness (Cano-de-la-Cuerda et al., 2010).  Significant 
improvements in physical function and motor control were found in Parkinson’s patients (off 
medication) following a 24 month progressive resistance training program that included 
stretching and balance exercise and delivered one to one by a personal trainer (Corcos et al., 
2013).  Paliakoff et al., (2013) also found significant improvements in lower body motor 
functioning and reaction time, after 10 – 20 weeks of gym-based group exercise classes in 
individuals with Parkinson’s disease. In addition to improvements in strength, power, motor 
unit activation, endurance and QoL, Kelly et al., (2014) reported positive adaptations in 
skeletal muscle histology after 16 wk of exercise training in Parkinson’s disease patients. The 
skeletal muscle adaptations identified included myofiber hypertrophy, a shift to less fatigable 
myofiber type profiles and increased mitochondrial complex activity. A recent study, which 
incorporated the same 16 wk exercise training program as Kelly et al., (2014) reported similar 
improvements in strength, power and motor unit activation while also identifying 
improvements in indices of neuromuscular junction integrity, cognition and well-being (Lavin 
et al., 2020). Transcriptome-wide skeletal muscle gene expressions were generate for a sub-
sample of 5 participants in this study, to identify transcriptional networks that may underpin 




of this novel analysis found that following the program 304 genes were significantly 
upregulated, which were notably related to remodelling and nervous system / muscle 
development. In addition, 402 genes, which were primarily associated with negative 
regulators of muscle adaptations, were downregulated. Sleep disorders affect 74% - 98% of 
individuals with Parkinson’s disease (Lees et al., 1988; Nausieda et al., 1982). In a 16 wk 
exercise training program by Amara et al., (2020) objective sleep outcomes were improved 
including sleep efficiency, total sleep time, time spent in slow-wave sleep and wake after 
sleep onset.  
The beneficial effects of CBER in patients with neurological conditions extend beyond 
Parkinson’s disease.  In a study cohort that included 99 participants with a range of 
neurological conditions,  three months of individual, gym-based exercise training, delivered 
by fitness instructors resulted in significant improvements in aerobic endurance, strength and 
QoL (Elsworth et al., 2011).  Similarily, Salbach et al., (2014), found significant improvements 
in aerobic endurance and physical function in 14 participants with a range of neurological 
conditions following participation in a 12 week, group-based circuit exercise training, 
delivered by physical therapists and fitness instructors in community centres.  
Improvements in measures of mobility were found in mixed cohort of individuals 
with multiple sclerosis, motor neuron disease, neuro-muscular disorders, Parkinson’s disease 
and cerebral palsy following their participation in community based exercise program 
(Elsworth et al., 2011).  Likewise, Salbach et al., (2014), reported that a community-based 
model of exercise delivery for individuals with stroke, acquired brain injury and multiple 




Currently the majority of rehabilitation programs available for individuals with a CD 
are disease specific.  However, individuals with CD often experience the same manifestations 
such as fatigue, decrements in psychological health, peripheral muscular deconditioning and 
reduced functional capacity.  CBEPs that cater for a variety of CDs groups maximizes the 
utilization of resources and relieves some of the demand on the clinical service. 
A recent meta-analysis reported that CBER programs that catered for multiple CDs 
simultaneously was effective at improving both functional capacity and QoL among CD 
populations, when compared with standard care (Desveaux et al., 2014a). All CBEPs included 
in the analysis were well tolerated across all settings.  A limitation of this review is that a 
limited number of CDs were included in the analysis (osteoarthritis, stroke, COPD and T2DM), 
which reduces the generalizability of the review.  Although the results endorse the 
simultaneous inclusion of multiple CDs in CBEPs, further research which supports these 
findings across a wider variety of CDs is required.  
The benefits and efficacy of CBER for individuals with CD has been widely 
established. Currently the majority of exercise rehabilitation programs available for 
individuals with a CD are segregated by disease.  A systematic review of the structure and 
delivery of CBER programmes across CD populations identified that the design and 
components of programmes were similar, irrespective of CD (Desveaux et al., 2014a).  The 
primary components of > 85% of the programmes included a combination of aerobic and 
resistance exercise.  Such programmes can be easily applied across a range of conditions with 
minimal disease-specific adjustments.  Similarities in the clinical manifestations between CD, 




prevalence of MM, appears to negate the need for separate programmes for SCD.  An 
integrated model is likely to represent a more resource efficient approach however the 
evidence-base supporting the mixed approach to CBER is limited. The integrated model has 
potential to widen access for CD patients to CBER while also reducing the burden on 
overwhelmed clinical-based services for delivering exercise rehabilitation. In addition, the 
health enhancing effects of CBER on CD cohorts has the potential to reduce future hospital 
admissions and use of clinical healthcare services. Investigations evaluating the efficacy of the 
integrated approach to CBER are warranted. 
Sedentary Behaviour and Health Status 
Relative to the extensive literature on the effects of PA on health, much less is known 
about the physiological responses and health outcomes associated with SB.  The published 
research to date indicates that there are substantial health hazards associated with excessive 
SB.  Importantly, SB is associated with an increased risk of all-cause and CVD mortality, which 
appear to be independent of PA (Patterson et al., 2018; Rezende et al., 2014).  Furthermore, 
high levels of SB are associated with the development of a number of CD and the relation 
appears to be independent of PA and other risk factors, including diet and BMI (Katzmarzyk 
et al., 2009; Patel et al., 2010; van der Ploeg et al., 2012).   
The relative risks associated with prolonged sitting become more pronounced in 
individuals who are also insufficiently active (Biswas et al., 2015; Bouchard et al., 2015; 
Ekelund et al., 2016).  PA may attenuate some of the risk associated with SB.  Ekelund et al., 




the least active individuals were at the greatest risk in their meta-analysis which included data 
of more than one million individuals. However, the magnitude of increased risk with sitting is 
mitigated with PA, and completely attenuated when  achieving 60 – 75 min of MVPA per day.  
The level of PA that must be achieved to attenuate the risk associated with SB is of a duration 
and intensity, that  is beyond the abilities of most individuals, particular those with a CD.   
In a more recent meta-analysis, Ekelund et al., (2019) found a non-linear dose-
response relation between high PA levels of any intensity and a reduced risk of all-cause 
mortality, while accounting for SB.  However, the risk of mortality gradually increased with SB 
> 7.5 h/day. Similarly, Chau et al., (2013) estimated that the mortality risk is 34% higher in 
individuals who sit for > 10 h/day even after taking PA into account.  
The associations between SB and mental health have also been explored. Overall 
sitting time has been associated with depression and anxiety in observational research (Rebar 
et al., 2014). In a meta-analysis by Zhai et al., (2014), the pooled risk of depression for highest 
levels of SB compared to occasional SB was 31% greater in cross-sectional studies and 14% 
greater in longitudinal studies. Similarly, Teychenne et al., (2015) found moderate evidence 
for a positive relation between overall SB and risk of anxiety. More recent research suggest 
that the context of SB may influence the association of SB with mental health. Hallgren et al., 
(2018) found a lower risk of depression for those who participated in mentally-active SB such 
as office-work and a positive association between depression and passive SB, such as 
watching TV. More recently, Hallgren et al., (2020a) reported that substituting 30 min per day 




Hallgren et al., (2020b) reported that higher volumes of SB in the leisure context may be 
associated with frequent symptoms of depression and anxiety.   
Self-reported sedentary behaviour 
The Canada Fitness Survey of 7278 men and 9735 women used a lifestyle 
questionnaire to assess the amount of time spent sitting during work, school and housework 
(Katzmarzyk et al., 2009). At 12-year follow-up, there was a dose-response relation between 
sitting time and mortality from all causes and CVD. The dose-response relation was 
independent of leisure time PA, and was similar among non-smokers, former smokers and 
current smokers and all BMI categories.  Self-report of television viewing is commonly used 
surrogate to measure SB.  A study involving 8800 adults found that each one h increment in 
television viewing per day was associated with an 11% and 18% increased risk of all-cause and 
CVD mortality, respectively (Dunstan et al., 2010). In addition, greater than 4 h per day 
watching television increased the risk of all-cause and CVD mortality by 46% and 80%, 
respectively, when compared to those watching television for ≤ 2 h per day.  In a U.S. study 
of 7,744 male participants, > 10 hours per week riding in a car or > 23 hours per week of 
combined television viewing and riding in a car were associated with an 82% and 64% higher 
risk of CVD mortality than men who reported < 4 hours per week or < 11 hours per week, 
respectively (Warren et al., 2010).  Self-report SB has been found to be negatively associated 
with subjective-well-being, in particular within the subscales of physical well-being, 




Device-measured sedentary behaviour 
Self-report measures of SB usually involve recall, which in some cases can be a highly 
complex cognitive task, particularly for older adults.  SB because of its habitual nature appears 
even more difficult for older adults to recall than PA (Wullems et al., 2016).  Device-measured  
PA and SB can avoid subjective bias and enable more accurate and robust measures.  
Accelerometers are the primary tool utilised by researchers to objectively measure SB and PA 
in free-living conditions over a number of days (Pate et al., 2008). Such devices not only 
provide the cumulative time spent sedentary but also the time spent in each sedentary bout 
and the frequency of breaks in SB (Wullems et al., 2016).  
The use of devices to assess SB has grown rapidly in recent years.  The findings are 
in agreement self-report studies that SB negatively impacts health, often independent of PA 
levels. In 2015, a systematic review of accelerometer-measured SB and cardiometabolic 
biomarkers reported consistent unfavourable associations between SB and insulin sensitivity, 
independent of PA (Brocklebank et al., 2015).  There was also some evidence of unfavourable 
associations between SB and fasting insulin levels, insulin resistance and TG.  A systematic 
review of biomarkers associated with accelerometer-derived SB in older adults found that 
most of the biomarkers associated with SB were of a cardiometabolic nature.  There was 
negative impact of SB on markers of body composition, blood lipids, glycemic biomarkers 
(Wirth et al., 2017).  A recent systematic review and meta-analysis by Powell et al., (2018) 
investigated the cross-sectional associations between device-measured SB and 
cardiometabolic biomarkers in adults. This extensive review, which included 46 studies and a 




associations of clinical significance with fasting glucose, fasting insulin, TG, HDL-C and waist 
circumference. Moreover, it is suggested that to offset the effect size identified for increased 
SB on cardiometabolic health, several weeks of aerobic training is required.   
Accelerometers are not without limitations, in particular in relation to the 
thresholding of accelerometer counts.  SB is commonly classified as inactive periods of 
accelerations below a defined threshold, e.g. < 100 counts per min, which is specific to each 
brand of monitor (Byrom et al., 2016). Such an approach can misclassify standing as SB. Bouts 
of standing are physiologically distinct from sitting and lying and have been associated with 
beneficial impacts on physiological processes such as glucose metabolism (Edwardson et al., 
2017).  Accelerometers that incorporate an inclinometer can determine the posture of the 
wearer and distinguish between sitting and standing.  Powell et al., (2018) examined the 
influence of  the device using when investigating the associations between SB and markers of 
cardiometabolic health and reported that the activPAL device offers the most precision.  
Patterns of Sedentary Behaviour 
SB is often described as total daily sedentary time, which has been useful in 
investigating the health risk associated with this behaviour.  The pattern in which SB is 
accumulated appears to also be of clinical relevance. Prolonged or less fragmented SB is 
potentially more detrimental to health. A single day of uninterrupted SB in healthy adults was 
shown to reduce insulin action by 39% (Stephens et al., 2011).  Following 5-7 d of 
uninterrupted bed rest, glucose and TG levels were found to be elevated by 34% and 34.8%, 




of unbroken SB, the immediate negative responses to this behaviour cannot be ignored, in 
particular with regards to patients with CD where periods of symptom exacerbation may 
result in similar SB patterns.  
A definitive threshold of what is considered a prolonged sedentary bout that induces 
negative physiological responses is yet to be established.  However, sedentary bouts of ≥10 
min in duration were shown to be positively associated with waist circumference (Judice et 
al., 2015). The odds of abdominal obesity were 7%, 11%, 15% and 48% higher for each 
sedentary bout of 10-20 min, 20-30 min, 30-60 min and > 60 min, respectively.  
Breaking up SB can have a beneficial effect on cardiometabolic risk and other indices 
of health, which may be independent of total sedentary time.  Research has reported 
favourable associations between the number of breaks in sedentary time and measures of 
adiposity, blood lipids, glucose control and inflammation (Bankoski et al., 2011; Dunstan et 
al., 2012; Healy et al., 2008a; Healy et al., 2011).  In a cross-sectional study of 168 participants, 
Healy et al., (2008a) found the number of breaks in sedentary time, defined as interruptions 
in sedentary time of > 100 accelerometer counts/min, was inversely associated with waist 
circumference, BMI, TG and 2 h plasma glucose, independent of total sedentary time, MVPA, 
and the mean intensity of the breaks.  
Among the first experimental studies to investigate the effects of breaking up 
prolonged sitting, Dunstan et al., (2012) compared the effects of seven h uninterrupted sitting 
and sitting interrupted every 20 min with 2 min of LIPA or MVPA on postprandial glucose and 




were reduced with sitting interrupted by LIPA and MVPA compared with uninterrupted 
sitting.  The effects were similar irrespective of whether the breaks consisted of LIPA or MVPA. 
Subsequent acute experimental studies have confirmed the positive effects of breaking up 
sedentary time on metabolic outcomes.  Benatti and Ried-Larsen (2015) found that replacing 
sitting time with LIPA appears sufficient to counteract the negative effects of prolonged sitting 
in those who are physically inactive or have T2DM.  MVPA may be required obtain such 
benefits in those who are habitually physically active.  Recent evidence reports that 
reallocating 30 min from sleep sedentary time or standing time to LIPA is associated with 
significant reductions in BMI, body fat and fat mass (Powell et al., 2020).  
The chronic effects of breaking sedentary time has been much less researched.  An 
uncontrolled trial reported significant decreases in waist and hip circumferences, LDL-C, total 
cholesterol, and glycosylated haemoglobin with the introduction of treadmill desk 
workstations for nine months in 12 overweight/obese adults (John et al., 2011).  In a quasi-
experimental trial of 32 non-obese healthy adults, sit-stand workstations were associated 
with improvements in HDL-C after three months compared with control (Alkhajah et al., 
2012).  There were no differences in anthropometrics, fasting glucose or other lipid markers.  
Breaking up sedentary time has also been found to be associated with functional 
capacity in cross-sectional studies, including upper and lower body strength and an overall 
physical functioning score independent of total sedentary time (Sardinha et al., 2015). In older 
adults, breaks in SB was associated with better lower extremity functioning (Davis et al., 2014) 




Physiological Mechanisms Associated with Sedentary Behaviour 
The physiological mechanisms responsible for the unfavourable associations 
between SB and health are not fully understood.  A number of mechanisms have been 
proposed.  One involved the impairment of lipid metabolism due to suppression of lipoprotein 
lipase (LPL) activity.  LPL is the rate-limiting enzyme for the hydrolysis of the triacylglycerol 
component of circulating lipoproteins. A reduction in LPL activity impairs tissue-specific 
uptake of lipoprotein-derived fatty acids and abnormalities in LPL function have been found 
to be associated with a number of pathophysiological conditions, including atherosclerosis, 
obesity, insulin resistance and diabetes (Mead et al., 2002). LPL may also have a role in 
regulating inflammation (Ziouzenkova et al., 2003).   
The primary physiological regulator of LPL activity in the vasculature of the skeletal 
muscle is local contractile activity/inactivity. In rodent models of inactivity involving 10 h/day 
of unloading, almost all of the LPL activity associated with vascular endothelium of oxidative 
muscle fibers was lost within one day (Bey & Hamilton, 2003). The reduction was localized to 
the immobilized muscles and the inactivity was also associated with a local reduction of TG 
uptake into muscle and a decrease in HD-C concentration compared to low intensity 
ambulatory controls.  The decrease in LPL activity occurred in the absence of a change in LPL 
mRNA concentration. Instead there was a decrease in LPL protein mass, suggesting the 
possible involvement of the transcriptional inhibitor actinomycin D.  The effects of the 
transcriptional blockage were specific to the inactive group because there was no effect on 
LPL in standing/ambulatory rat (Hamilton et al., 2007).  LPL activity was restored within 4 h of 




lipids can acutely downregulate LPL activity and that this effect is augmented by inactivity 
(Zderic & Hamilton, 2006).   
A second potential mechanism for the detrimental responses to SB is that lower 
skeletal muscle blood flow resulting from excessive sitting leads to lower shear stress on 
vascular endothelial cells and, consequently decreased endothelial nitric oxide synthase 
expression (Stamatakis et al., 2011).  Vascular studies have shown that shear rate, flow 
mediated dilation and brachial artery diameter decrease, while endothelial cell damage and 
BP increase with increasing SB (Wullems et al., 2016).  
SB has been positively associated with increased arterial stiffness, even when 
controlling for MVPA, resting heart rate, adiposity and metabolic syndrome (Huynh et al., 
2014). SB has also been associated with ankle-brachial index, a vascular measure that is an 
indicator of PAD and predictor of cardiovascular events (Parsons et al., 2016). Every additional 
30 min of SB was associated with an OR of 1.19 for a low ankle-brachial index.  Considered 
together, these findings provide preliminary evidence that the mechanisms associated with 
SB relate to impaired vascular function and structure.   
Systemic inflammation has also been implicated in the negative physiological effects 
of SB. CRP, a low-grade inflammatory marker, was shown to be doubled in individuals who 
engaged in > 4 hours/day of screen time compared with < 2 hours per day (Stamatakis et al., 
2011).  More recent research found that MVPA and CRF (when above an estimated median 
value) attenuated the risk of elevated CRP (Edwards & Loprinzi, 2018).  Additionally, continual 




muscle atrophy (Stamatakis et al., 2011).  SB may change the balance between bone 
resorption and deposition, mainly by a rapid increase in bone resorption, without changes in 
bone formation. This would reduce bone mineral content and increases the risk of 
osteoporosis.    
Finally, poor diet quality and increased caloric intake are behaviours associated with 
sitting, in particular television watching, suggesting the detrimental effects on health might 
stem from the dietary intake associated with sitting time, rather than sitting itself (Patterson 
et al., 2018).  However, the association between TV viewing time and cardiometabolic 
biomarkers remains significant after controlling for dietary intake. 
Several hypotheses have been proposed to describe the potential mechanisms 
underlying the association between SB and mental health. The social withdrawal hypothesis, 
which proposes that the more frequently people watch television or use computers, the less 
they engage in social interactions, is suggested as a potential mechanisms (Kraut et al., 1998; 
Lewinsohn, P., 1974). In contrast, Shaw and Grant (2002) argue that SB while using the 
internet can involve communication with others (e.g. emailing and chat rooms), and suggest 
that not all SB are applicable to the social withdrawal hypothesis. A second possible 
explanation for the positive associations between SB and risk of depression, is that SB may 
displace potential PA, and PA is strongly associated with reducing the risk of depression 
(Teychenne et al., 2008; Zhai et al., 2015).  The associations between depressive symptoms, 
SB and inflammatory markers has also been explored. Longitudinal associations between SB 
and low grade inflammation over a 4 year follow-up was reported by Hamer et al., (2015) and 




Miller, 2007) it is feasible to hypothesize that the associations between SB and depressive 
symptoms might partly be explained by underlying inflammatory mechanisms (Hamer and 
Smith, 2018). 
 The potential biological pathways between SB and anxiety may include central 
nervous arousal (Wang et al., 2006), sleep disturbances (Dworak et al., 2007) or poor 
metabolic health (Mommersteeg et al 2012). On the contrary, Sabiston et al., (2007) suggest 
that those suffering from anxiety may be more inclined to engage in SB as a means of coping 
with anxiety. 
Recent evidence proposes differential associations of passive and mentally active SB 
with mental health (Hallgren et al., 2018; Hallgren et al., 2020a). Furthermore, Hallgren et al., 
(2020b) suggest that SB which occurs during leisure-time (e.g. television-viewing) may be the 
predominate cause of SB associated depressive symptoms. Prolonged television viewing is 
often associated with social-isolation, which may limit people opportunities for supportive 
and mood-enhancing interactions. SB which involves screen-based devices may also 
contribute to sleep or mood disturbances. Finally, as SB frequently occurs indoors, away from 
direct sunlight, the potential that SB might reduce vitamin D synthesis has also been suggests.  
Physical activity and Sedentary behaviour in individuals with chronic disease  
A very small proportion of individuals with CD achieve the recommended daily PA 
(Bernard et al., 2018; Fox et al., 2015; Loprinzi et al., 2013; Morrato et al., 2007; Serrano-
Sanchez et al., 2014).  Mean daily MVPA has been reported as 17 min per day in adults with 




Eliason et al., 2011), 11.4 min per day in individuals with angina (Evenson et al., 2014), 10 
min/day in cancer survivors (Loprinzi et al., 2013), 8.6 min per day among those with heart 
failure, (Evenson et al., 2014), and 3.7 min per day in breast cancer survivors (Lynch et al., 
2010).   
Tudor-Locke et al., (2009) reported the lowest daily steps count of 2237 steps per 
day in patients with COPD and the highest number at 8008 steps per day in type 1 diabetes.  
Other studies in COPD report step count ranges of 4782 steps per day to 7232 step per day, 
with evidence that step count reduces with increasing disease severity (Bernard et al., 2018; 
Moy et al., 2012).  Daily step counts of between 4,000 and 6,000 have been reported 
individuals with Parkinson’s disease (Benka Wallén et al., 2015; Christiansen et al., 2017; Lord 
et al., 2013), intermittent claudication (Lauret et al., 2014), impaired glucose tolerance (Yates 
et al., 2014).   
Research comparing PA levels of individuals with CD to their healthy counterparts 
has produced mixed findings.  Among 300,000 adults in the US, individuals with CHD 
participated in less self-reported PA at the recommended level than those without CHD (Zhao 
et al., 2008). Adults > 65 years of age with T2DM were found to be less likely to engage in self-
reported physical activity than those without T2DM (Zhao et al., 2011).  In small scale studies 
of COPD (Pitta et al., 2005) and intermittent claudication (Lauret et al., 2014), accelerometer-
derived PA was significantly less than in healthy controls.  The Canadian Health Measures 
Survey of over 6000 participants found no difference in accelerometer-derived PA levels 
between individuals with a single CD and those with no CD.  However, PA levels were 




CD and with no CD (Hains-Monfette et al., 2019).  COPD patients with moderate to severe 
disease were found to engage in significantly less MVPA than healthy individuals (Bernard et 
al., 2018).  In contrast, cancer survivors were more likely to report engaging in PA compared 
to non-cancer participants in analysis of data from the NHANES (Kim et al., 2013).  
There are current no guidelines in relation to what is considered excessive SB.  There 
is evidence that individuals with CD engage in more SB than their healthy counterparts.  For 
example, stroke patients were found to accumulate more daily SB in longer uninterrupted 
bouts than healthy controls (English et al., 2016, Lewis et al., 2016).  Similarly, patients with 
COPD spent more time sedentary than sedentary healthy elderly subjects (Pitta et al., 2005) 
and spousal carers (Lewis et al., 2016).  Participants who completed cardiac rehabilitation and 
to whom active living had been promoted, spent eight h per day in SB (Prince et al., 2016).  In 
the Canadian Health Measures Survey, individuals with MM had significantly higher levels of 
SB compared to individuals with a single CD and those with no CD.  
The Effect of Exercise Rehabilitation on Physical Activity Levels and Sedentary Behaviour 
A substantial amount of research has investigated the effects of exercise 
rehabilitation on health-related outcomes and compelling evidence supports the beneficial 
effects of exercise rehabilitation on health-related outcomes such as functional capacity, 
disease-related symptoms, QoL, mortality and the disease burden on healthcare services, 
(Anderson et al., 2016; Dunlay et al., 2014; Houchen-Wolloff et al., 2018; McCarthy et al., 
2015; Puhan et al., 2016; Shepherd & While, 2012).  However, the research to date reports 




A previous systematic review reported that cardiac rehabilitation services are not 
consistently successful in increasing everyday PA in patients with cardiac disease (Jolliffe & 
Taylor, 1998). Similarly, Ter Hoeve et al., (2015) compared the effectiveness of both centre-
based and home-based cardiac rehabilitation studies and found conflicting evidence  for their 
effectiveness in improving PA levels. Centre-based programs did not have an effect, long-
term, on PA, however moderate evidence was found that home-based programs were more 
effective in long term. More recently, Dibben et al., (2018) conducted a systematic review 
and meta-analysis investigating the effects of cardiac rehabilitation on both CAD and heart 
failure which included 47 studies. Of the 145 cardiac rehabilitation versus control 
comparisons reported across all studies, 26% of results reported statistically significant 
improvements in PA with cardiac rehabilitation, demonstrating moderate evidence for the 
effects of cardiac rehabilitation on PA levels. Pooled meta-analysis results found  an increase 
in mean daily step count of 1423 steps/day (95% CI 757.1 to 2089.4). This is potentially a 
clinically meaningful improvement as Demeyer et al., (2016) estimated the threshold for a 
clinically meaningful change in daily step count for COPD to range between 600 to 1100 
steps/day.   No differences were found between control vs cardiac rehabilitation groups for 
SB, LIPA or MVPA for pool analyses of these measures. A review of 32 studies that evaluated 
the effects of pulmonary rehabilitation on PA showed inconsistent result, with 19 studies 
demonstrating a positive effect and 12 revealing no effect on PA (Shioya et al., 2018). A 12 
month hospital based exercise rehabilitation program for cancer patients, found significant 




Limited research exists investigating the effects of CBER on PA levels. The evidence 
available indicates those who are currently participating in CBER or have previously attended 
CBER, have higher levels of PA and lower levels of SB compared to those have do not 
(Hernandes et al., 2013; Simoes et al., 2009). Interestingly, median daily step count remained 
higher, even on days when they did not attend the classes in adults who participated in CBEPs 
compared to those who do not. On the contrary, Schutzer and Graves (2004) outline evidence 
suggesting that elderly populations lack the knowledge and the understanding of the role of 
daily PA for maintaining health. Hence, it is possible that exercise programs may not improve 
overall activity levels as individuals who participate may reduce activity levels outside of the 
program, as they could feel satisfied with their exercise participation.   Further investigation 
is required to provide a clearer indication of the role of CBER in increasing PA and reducing 
SB.  Specifically in CD cohorts, research indicates that habitual PA increases with CBER. In 
patients with T2DM, nine months of CBER resulted in significant improvements in self-
reported PA (Gallé et al., 2019). Similarly, self-reported PA increased in individuals with COPD, 
after a 12 month CBER program (Beauchamp et al., 2013). Device-measured PA shows 
promising results. Daily step count increased  in individuals with COPD after an 11 month 
CBER program (Effing et al., 2011). Daily steps per day were also found to increase after eight 
weeks of CBER in a study by. Varas et al., (2018) for individuals with COPD.  
A focus on increasing PA levels has dominated research in the area of health for 
decades, however, only in more recent times has the focus started to shift and recognize the 
role of decreasing SB. It is too often assumed that an increase in MVPA automatically results 




unintended effect of also increasing SB, resulting the possible offset of the PA related health 
benefits (Siddique et al., 2018). A systematic review and meta-analysis by Prince et al., (2014) 
provides some supporting evidence that small reductions in SB can result from PA focused 
interventions. Interventions that target both PA and SB also resulted in modest reductions in 
daily SB, however SB focused interventions may be the most effective in resulting in large and 
clinically meaningful reductions in daily SB.  
Determinants of Physical Activity 
Adherence to health-related behaviours is defined by the WHO as “the extent to 
which a person’s behaviour corresponds with agreed recommendations from healthcare 
providers” (World Health Organization, 2003). In medical research, adherence is generally 
expressed as a percentage of the prescribed dose of a medical treatment that has been 
completed across a specific time period (Osterberg & Blaschke, 2005). In the example of CBER 
adherence can refer to the percentage of classes attended of the recommended dose (Herring 
et al., 2014). In contrast, compliance to exercise therapies describes the degree to which 
subjects completed the prescribed exercise intensity (Miller et al., 2014). In the healthcare 
setting, the term “adherence” is often favoured over “compliance” because it implies an 
agreement between the patient and healthcare professional on the treatment plan 
(Osterberg & Blaschke, 2005). Compliance depicts a more one-sided interaction, where a 
clinician decides on a suitable treatment, which the patient is required to comply to 
regardless of suitability (Chakrabarti, 2014).   
 Adherence to these behaviours, of which PA is one, is a complex behavioural 




the factors associated with PA adherence, is an important component to consider in the 
design and delivery of interventions aimed at increasing PA participation. Tailoring an 
intervention to target factors that are known to influence PA behaviour in a particular 
population can contribute to the success of the intervention in increasing and maintaining PA 
levels. Many cross-sectional studies report significant associations between a range of 
personal, social and environmental variables and levels of PA. For example, a study may 
report that socioeconomic status is associated with PA behaviours. Such relations inform 
correlates of PA, however, do not identify causal inferences. The logic of causality is 
fundamental to building an understanding of factors associated with increasing the 
probability of an outcome. The term ‘determinant’ is most when defining causal factors / 
predictive relations to behaviours such as PA (Bauman et al. 2002).  
In the literature, demographics (e.g. age, gender), psychological factors (e.g. self-
efficacy, perceived enjoyment), social factors (social support from family and friends), and 
physical environment factors (e.g. living/built environment, access to facilities) have been 
described as determining factors in PA adherence (Brochado et al., 2010). In a recent 
systematic review, a range of positive and negative environmental factors were reported as 
determinants of PA for adults and older adults (Carlin et al., 2017). At the neighbourhood 
level, negative street characteristics, such as lack of sidewalks and street lights were reported 
as barriers to PA. Street connectivity and availability/access/proximity of public transport 
were positivity associated with general walking and cycling in adults. Overall socioeconomic 
status was identified as a significant positive determinant of overall PA and leisure time PA in 
adults and older adults and a negative determinant of occupational PA in a systematic review 




and belief where positive determinants of PA in a systematic review by Cortis et al., (2017). 
Barriers to PA, lack of knowledge of PA benefits, pain/fatigue/weakness, fear to go out alone, 
fear of injuries or falling, lack of support and emotional distress were reported as negative 
determinants of PA. Behavioural determinants of PA for adults and older adults include 
positive associations with baseline activity level and negative associations for smoking 
(Condello et al., 2017). When investigating determinants of PA in CD cohorts, research has 
primarily focused on physical factors, such as functional capacity or disease severity (Gimeno-
Santos et al., 2014; Stewart et al., 2013).  This is unlikely to provide a complete understanding 
of what determines PA levels in this population. 
Behaviour change theories can assist in the understanding of the determinants of 
behaviour, guide the development of interventions to successfully change behaviour and 
provide insights into the mechanisms underpinning successful behaviour change. The 
Transtheoretical Model (also known as the Stages of Change Model) received a lot of 
attention in the exercise domain. The Transtheoretical Model suggest that individuals 
progress through multiple stages when changing their exercise behaviour, with each stage 
transition requiring different determinants and possibly different interventions (Courneya et 
al 2001; Prochaska et al., 1994). The TTM proposes five stages of change that reflect the 
temporal dimensions of change in health behaviours and describe an individual’s motivation 





Figure 2.4 The Transtheoretical Model of Behaviour Change  
(Prochaska et al., 1994) 
 
Precontemplation: Individuals are not engaged in the recommended health 
behaviour and have no intention of changing in the foreseeable future. 
Contemplation: Individuals have formed an intention to change in the near future 
but are still not performing the behaviour.  
Preparation: Individual intends to take action in the immediate future and may have 
a detailed plan for taking action or made some small steps towards behaviour 
change. 




Maintenance: The behaviour has been maintained at the target level for at least 6 
months.  
Other research in the exercise domain have used Ajzen’s (1991) Theory of Planned 
Behaviour to understand and predict the stages of change. The Theory of Planned Behaviour 
suggests that a person’s intention to perform a behaviour is the primary determinant of that 
behaviour. Three conceptually independent variables (attitude, subjective norms and 
perceived behavioural control), in turn, determine intentions. Attitudes in this context refer 
to a positive or negative evaluation of performing the behaviour. Subjective norms represents 
the perceived social pressure an individual may feel to perform or not perform a certain 
behaviour. Perceived behavioural control describes the perceived ease or difficulty of 
performing the behaviour.  
The Social Cognitive Theory (SCT) (Bandura, 1998) is one of the most widely used 
theories in health behaviour research and one of the most effective theories for determining 
PA behaviour (Taylor et al., 2016b).  The theory proposes that learning occurs in a social 
context with a dynamic and reciprocal interaction between personal, environmental and 
behavioural factors (figure 2.4). In relation to PA, personal factors can include age, race, 
gender and cognitive factors such as self-efficacy. Environmental factors include social 
support, such as modelling from family and friends, support from exercise partners and 
feedback received from exercise instructors. Behavioural factors which are vital to sustained 
PA participation predominantly involve self-regulatory behaviours, including the ability to 
self-monitor and set goals (Anderson-Bill et al., 2011). Although the SCT recognises that 
environments shape behaviour, the theory focuses on the individual’s potential abilities to 





Figure 2.5Social Cognitive Theory  
(Bandura, 1998) 
The SCT encompasses eight key concepts, namely reciprocal determinism, outcome 
expectancy, self-efficacy, collective efficacy, observed learning, incentive motivation, 
facilitation, self-regulation and moral disengagement. These constructs explain 40–70% of the 
variance in PA behaviours in adults (Anderson-Bill, Winett, & Wojcik 2011; Ayotte et al., 2010; 
Phillips & McAuley, 2013; Rovniak et al., 2002; White et al., 2012).Self-efficacy, which 
describes a person’s beliefs about their ability to perform behaviours successfully and achieve 
an intended outcome, plays a pivotal regulative role in the multifaceted causal structure of 
the SCT. Bandura et al., (1999) state that self-efficacy is the single, most necessary 
motivational element involved in pushing individuals to take actions.  Particularly in relation 
to task orientated behaviours, self-efficacy is a vital component (Bandura, 2004). Self-efficacy 
is considered a key determinant of PA participation. Self-efficacy for exercise specifically 
refers to beliefs in one’s ability to exercise, even given constraints and impediments such as 
feeling tired or being busy. It is suggested as the primary determining constraint of achieving 
health promoting levels of PA (Bandura et al., 1999) and the relationship between exercise 




determined by other factors, including outcome expectations and sense of controllability 
(Neupert et al., 2009). An individual can have high self-efficacy for exercise but does not 
believe beneficial effects can be achieved by engaging in the behaviour. Self-efficacy is not an 
individual concept, however it is often depicted this way in research. Task self-efficacy 
describes an individual’s confidence in the ability to perform the elemental aspects of a task 
(e.g. the ability to walk for 30 mins at a moderate intensity), while coping self-efficacy refers 
to an individual’s confidence in their ability to perform tasks under challenging conditions 
(e.g. confidence in the ability to exercise while in a bad mood) (Rodgers & Sullivan, 2001). In 
patients who participated in cardiac rehabilitation, maintenance self-efficacy, which refers to 
beliefs about one’s ability to  sustain a behaviour regardless of barriers specific to the 
maintenance period, and recovery self-efficacy, which describes an individual’s beliefs about 
their ability to resume action after relapses, predicted participation in PA eight months after 
cardiac rehabilitation (Luszczynska & Sutton, 2006).    
For those with CD, self-efficacy plays a significant role in exercise adherence. Self-
efficacy predicts exercise behaviour in individuals with CVD and cardiac rehabilitation can 
have a positive effect on exercise self-efficacy in this cohort (Blanchard et al., 2015; Carlson 
et al., 2001; Lemanski, 1990). A higher self-efficacy has been shown to be independently 
associated with greater PA levels in patients with COPD (Belza et al., 2001; Hartman et al., 
2013; Steele et al., 2000). Self-efficacy was a stronger predictor of attendance to and 
functional improvement from pulmonary rehabilitation compared to demographics and 
clinical indicators (Selzler et al., 2016). Exercise behaviours in cancer patients have been 
shown to be highly associated with exercise-self-efficacy (Pinto et al., 2009; Rodgers et al., 




described among individuals with diabetes (Dutton et al., 2009; Plotnikoff et al., 2000). Dutton 
et al., (2009) investigated the effect of a 1-month print-based PA intervention, which was 
individually tailored based on theoretical constructs including self-efficacy, on PA levels in 
individuals with T2DM. After controlling for all potential cofounders, the improvements in PA 
levels were found to be completely accounted for by the improvements in self-efficacy. In a 
mixed CD cohort, a cross sectional study of 483 patients reported that PA was positively 
correlated with self-efficacy (Daniali et al., 2017). Sex, self-efficacy and fatigue explained 87% 
of the variance of PA. It was suggested that a focus on psychological factors such as self-
efficacy has the potential to improve the self-care of CD patients.  
Other potential psychosocial factors associated with PA in a mixed CD was explored 
by Shin et al., (2005). Prior exercise experience, perceived health status, exercise benefits and 
barriers and exercise social support were identified as significant determinants of PA 
participation. The role of social support and social connectedness in maintaining or initiating 
behaviour change is well recognised and is a component of many theoretical models of 
behaviour change, including the SCT (Ajzen, 1991; Bandura, 2004; Bronfenbrenner, 1977; 
McLeroy et al., 1988; Rosenstock et al., 1988). Key themes have been identified when 
describing social support, which include social relationships that are reciprocal, accessible and 
reliable and provide any means of supportive resources (Williams et al., 2004). Social support 
can include social-emotional support (expressing feelings, values and attitudes), practical 
support (the provision of the necessary facilities and resources), information support 
(providing information, recommendations and guidelines) and social belonging (sense and 




Perceived social support is believed to have a direct influence on exercise behaviour 
(Resnick et al., 2002). It was identified as a primary determinant of PA in community dwelling 
older adults, especially when social support came from family members (Smith et al., 2017). 
Social support can influence PA levels and potentially strengthen exercise self-efficacy in 
patients with CDs, such as CVD and diabetes (Adeniyi et al., 2012; Aliabad et al., 2014; Won 
& Son, 2017). Social support has also been identified as a positive determinant of PA in cancer 
survivors (Barber, 2012). Recently, low levels of social support for PA have been found in 
T2DM (Morowatisharifabad et al., 2019), which are thought to be due to a number of factors 
such as reduced awareness of individuals and families about the impact of PA on the 
improvement of patient health, along with cultural perspectives and concerns about PA.    
The importance of increasing PA levels for patients with CD is well recognised and 
understanding and targeting the factors that determine this behaviour is likely to contribute 
to greater success in this effort. Determinants of PA can guide the investigation of an 
intervention to identify both how it achieved its desired outcome, or explain why it may not 
have been successful. Interventions can be refined or tailored based on these discoveries in 
order to optimally support patients to enhance their PA behaviour. Behaviour change 
techniques are defined as techniques designed to enable behaviour change by augmenting 
factors that facilitate behaviour change, or by mitigating factors that inhibit behaviour change 
(Carey et al., 2019). In the chronic disease population, there is strong evidence that PA 
interventions can have  health enhancing outcomes, however it remains unclear how the 
efficacy of such interventions could be enhanced. Research has identified strategies to 
increase self-efficacy for PA in clinical and non-clinical populations. Behaviour change 




of their behaviour change process where successful in improving exercise self-efficacy 
(Williams & French, 2011). Behaviour change techniques that facilitate self-regulation (e.g. 
goal setting or self-monitoring) where identified as important components of physical activity 
behaviour change in older adults, in a systematic review by Samdal et al., (2017). Behaviour 
change techniques reported as effective in changing diet and exercise in patients with T2S 
include ‘instructions on how to perform the behaviour’, ‘behavioural practice/rehearsal’, 
‘action planning’ ‘feedback and monitoring’ and ‘demonstration of the behaviour’ (Cradock 
et al., 2017).  The optimal combination of an exercise intervention which incorporates 
successful behaviour change techniques remains unknown, and future research should 
investigate the efficacy and feasibility  of behaviour change techniques to enhance CBER for 
individuals with CD.    
Conclusion  
 CD is an umbrella term for a range of long-term, medical conditions that can develop 
in response to genetic, environmental and lifestyle related risk factors. CVD, cancer, T2DM 
and chronic lung conditions are currently the most prevalent CDs from a global perspective. 
All CDs have the potential to limit the functional capacity and QoL for the individuals who live 
with them.  
 The role of PA in both the primary and secondary prevention of CD is widely 
established. Despite the evidence, the levels of PA in CD cohort is consistently reported as 
low and SB as excessive.  The majority of previous studies examining the levels of both PA and 
SB in CD populations have involved  primarily single disease cohorts. Currently, there is limited 




MM are excluded. Differential methods of measures PA and SB in previous research prevents 
comparison of the available evidence across disease groups. Consequently, the evidence base 
regarding PA levels and potential benefits of PA in CD cohorts remain segregated. 
 There is compelling evidence that CBER is a successful intervention for the secondary 
prevention of CD. Substantial evidence supports the efficacy of CBER in enhancing physical 
functioning and QoL for individuals with CD. The effects of CBER on habitual PA levels and SB 
in CD cohort remains unclear and further investigation is warranted.  In line with the current 
research trends on PA levels in CD cohorts, the current model of CBER delivery is primarily 
restricted to single disease cohorts. The effectiveness of an integrated model of CBER deliver 
which  caters  for individuals with a range of CD diagnosis and those with MM is yet to be 
established. Research building on the evidence base for an integrated approach to CBER has 













MedEx Wellness is a unique CBER program for individuals with CD in Ireland. As 
opposed to usual SCD delivery of CBER, MedEx Wellness offers an integrated approach to the 
delivery of CBER. Individuals with a range CD including CVD, pulmonary disease, T2DM and 
cancer, and those with MM attend and participate together within the same supervised 
exercise classes. Patients are referred to the program by hospital consultant physicians and 
their teams, phase III (outpatient) cardiac rehabilitation teams and general practitioners.  The 
MedEx Wellness Chief Medical Officer provides clinical oversight to the program, which is 
coordinated by exercise scientists and delivered by exercise instructors certified in cardiac 
prevention and rehabilitation.  The program is not a fixed duration.  Participants can attend 
the program on a continuous basis and are encouraged to establish a lifelong relationship 
with MedEx Wellness. The program is a user-pay model, with options to pay per class (€7 with 
a medical card, €8 without) or per month (€50) for leisure centre membership.  
This PhD was part of a larger trial, funded by the Health Service Executive (HSE) to 
determine the effect of the MedEx Wellness program on physical, clinical and psychological 
health. This research was undertaken at the MedEx Wellness program located at Dublin City 
University (DCU). The program was coordinated by members of academic staff from the 
School of Health and Human Performance and the Sports Service department in DCU.  The 




of 25 supervised classes per week and there were no restrictions on how often participants 
could attend. There were approximately 700 participant visits per week to MedEx Wellness. 
Referral to the service was a rolling process, and weekly inductions were conducted involving 
approximately 10-15 new participants each week.  
Study Design 
A quasi-experimental study was conducted. Participants were recruited at induction 
to the MedEx Wellness program following referral from a healthcare professional and were 
observed over the course of 12 months of participation in the programme. Outcomes were 
assessed at BL and 3, 6 and 12 months.  Figure 3.1 outlines the study algorithm.  As the study 
setting was within an established programme in the community, withholding service to allow 
for a controlled trial was not considered ethically appropriate.  A cluster-controlled design 











Recruitment   
Patients with a range of chronic diseases were referred to 
the MedEx Wellness program by healthcare professionals. 
Patients were invited to attend a program induction 
session. Potential participants were informed of the study 
and invited to participate. Participants were asked to 
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Men and women (aged > 18 yr) with one or more documented CDs referred to the 
MedEx Wellness program were recruited.  The most common primary diseases were CVD, 
respiratory disease, metabolic disease (including T2DM and impaired glucose tolerance), 
cancer, or neuromuscular or musculoskeletal disorders (including arthritis, Parkinson’s 
disease and multiple sclerosis).  Exclusion criteria included an uncontrolled CVD condition or 
a significant musculoskeletal condition, neurological condition, mental illness or intellectual 
disability that restricted participation in a physical training programme.  
Recruitment 
Consultant physicians, hospital-based exercise rehabilitation teams and general 
practitioners issued a referral letter to the MedEx Wellness program for patients with 
established CD.  Upon receipt of the referral letter, patients were invited to attend a program 
induction session during which they were fully informed of the purpose and design of the 
study and the experimental procedures.  They were provided with a plain language statement 
(Appendix A) before giving written informed consent (Appendix B) in accordance with the 
Research Ethics Committee at Dublin City University (DCUREC:2014/227).  Rolling recruitment 
took place from September 2015 to July 2016 at the weekly induction sessions, involving 10-
15 individuals per week. 
Sample size 
The critical determination of the sample size was the standard deviation of the 




estimate used was 90 m (Polkey et al., 2013).  The minimum difference to be detected was 
25 m (Holland & Nici, 2013). For a power of 80% and two-sided significance of 5%, a sample 
size of 104 participants was required.  This PhD was part of a larger trial, funded by the Health 
Service Executive (HSE).  The primary outcome for this PhD is the change in physical activity 
and sedentary behaviour and was not considered as part of the power calculation.  
Intervention: MedEx Wellness 
Induction 
Induction to the MedEx Wellness program involved three visits over an eight day 
period.  Visit one introduced participants to the program and provided information on the 
program purpose, structure and logistics, such as accessing the facility, car parking, class times 
and venues.  The second visit took place six days later and involved an exercise consultation, 
(described in detail later).  Visit three took place 24 h after the second visit and consisted of 
a beginner exercise class. The class followed the same format as regular MedEx Wellness 
classes but involved smaller group sizes and included demonstrations and teachings on the 
exercise techniques and equipment.  The beginner exercise was a component of the MedEx 
Wellness service which aimed to improve self-efficacy and foster social support to improve 
programme initiation and adherence.   
Exercise classes  
Following the three day induction process, participants were advised to attend two 




same classes every week in order to promote social-support and habit formation. Classes 
were 60 min in duration and consisted a 15-min warm up, the main exercise training 
component and 5-10 min cool down.  Exercise involved a combination of moderate intensity 
aerobic exercises and resistance training using a range of ergometers, weighted machines, 
free weights and body weighted exercises. Table 2.1 summaries the class structures 
depending on class size and program.  
The warm up involved a combination of aerobic and range of motion exercises.  Due 
to limited availability of equipment (e.g. ergometers and machine weights) and space 
participants were divided into 2 or 3 groups for the main exercise component of the class. If 
≤30 participants were present, the class was divided into two groups that alternated between 
20 min of aerobic ergometer exercise and 20 min of resistance exercise.  If > 30 participants 
were present, the class was divided into three groups that rotated between 10 min of aerobic 
ergometer exercise, 10 min of resistance exercise and 10 min of a combined aerobic and 
resistance circuit. The reduced main phase component in classes >30 participants, allowed 
for a 1-2 minute change over period between each group.  
The aerobic ergometer exercise involved the use of a range of exercise ergometers 
depending on participant preference and ability and included treadmills, cycle, rowing and 
elliptical ergometers. Classes catered for all abilities and participants were encouraged to 
work at a moderate to vigorous.  For aerobic components of the class, the prompts employed 
by instructors to assist participants in interpreting the prescribed intensity was to work at an 
intensity at which they “feel moderately breathless, have a read face and sweat” or 
“moderately breathless but can still hold a conversation”.  To prompt participants on how to 




advised participants to work at a slow, controlled pace, using a weight or resistance in which 
the participant could complete 10 – 15 repetitions at a comfortable intensity. Compliance 
with the prescribed exercise intensity during the classes has previously been established 
(Hurley et al., 2017). This research indicated that participants exercised at at an exercise 
intensity corresponding to 61.3 ± 9.2 %VO2peak and 76.9 ± 9.5% HRpeak, and concluded that 
participants could effectively self-regulate participation at a moderate intensity during the 
MedEx Wellness classes.  
  The cool down consisted of aerobic exercises that gradually decreased in intensity, 
range of motion exercises and stretching. A social area was set up after class where 
participants were offered tea or coffee.  
MedEx Wellness classes were ongoing, allowing participants to engage in the 
program on an open ended basis.  With one exception, all classes included mixed CD groups.  
The stand-alone 12-week ‘Move On’ program was limited to individuals recovering from 
cancer related treatment. Shorter term programs are common in cancer survivorship 
rehabilitation (Christopher & Morrow, 2004; Foley & Hasson, 2016; Leach et al., 2015). The 
general characteristic of the cancer survivors cohort, warranted a program design focused on 
aiding participants to “Move On” from cancer treatment back to general public habits of 
exercise participation. On completion of the program, participants were encouraged to 
maintain exercise participation in general public exercise classes in local gyms. Two 12-week 
cycles of the Move On program were included in this study.  The functional capacity and 
general health of the participants attending the Move On program allowed for a more flexible 




Classes were led by DCU sports complex employees. A ratio of 1:15 instructor to 
participant ratio was adhered to while conducting classes. At least one instructor in every 
class has British Association for Cardiovascular Prevention and Rehabilitation Specialist 
Exercise Instructor Level 4 qualification.  
 
Table 3.1 Exercise prescription of MedEx Wellness classes 
 ≤ 30 participants ≥ 30 participants Move On 
Warm up  15 min aerobic and range 
or motion exercises 
15 min aerobic and range 
or motion exercises 
15 min aerobic and range 
of motion exercises 
    
Main Phase Aerobic: 20 min continuous 
on a treadmill, stationary 
bike or cross-trainer 
 
Resistance: 20 min circuit 
based using a combination 
of machine weights or free 
weight.  
1 min work/20-30 s rest 
Aerobic: 10 min continuous 
on a treadmill, stationary 
bike or cross-trainer 
 
Resistance: 10 min circuit 
based using a combination 
of machine weights or free 
weight.  
1 min work/20-30 s rest 
 
Combination: 10 min 
interval body weight 
resistance exercises and 
aerobic (e.g. jumping jacks, 
high knees) 
30 – 1 min work / 10 – 30 s 
rest 
The main phase of this 
program varied each class. 
A combination of the 
following was included:  
 
Aerobic: continuous or 
interval on a treadmill, 
stationary bike or cross-
trainer  
 
Resistance: circuit based 
using a combination of 
machine weights or free 
weight.  
1 min work/20-30 s rest 
 
Instructor lead: step 
aerobics, combination of 
aerobic and resistance 
circuits, spinning, Pilates 
and total body resistance 
(TRX) suspension training  
 
    
Cool down  
 
5 – 10 min low intensity 
aerobics, range of motion 
exercises and stretching   
5 – 10 min low intensity 
aerobics, range of motion 
exercises and stretching   
5 – 10 min low intensity 
aerobics, range of motion 
exercises and stretching   








An exercise consultation was delivered to participants during the induction process 
and was repeated at 1, 3 and 6 months.  The purpose of the consultation was to use behaviour 
change techniques to improve exercise adherence.  Previous research was conducted in the 
MedEx Wellness service, to identify factors associated with uptake and adherence to the 
program (O’Leary E, 2019).  Self-efficacy to exercise, intentions for exercise and social support 
to exercise were found to be significantly different between individuals who never attended 
the program following induction (non-uptake) and those initiated the program (attend at 
least one class following induction)   
The exercise consultation was delivered in a group setting, which has previously been 
reported to promote peer social support and allow for group problem solving with specific 
focus on barriers identified during decisional balance work.  The exercise consultations were 
designed by an academic in PA and behaviour change. The delivery of exercise consultations 
were led by an academic with expertise in applied psychology and researchers trained in 
exercise consultation delivery. The researchers adhered to a motivational interviewing style, 
where the approach was client-centred, emphasised personal choice and incorporated 
negotiating strategies between the participants and researches. Behaviour change 
techniques included in the exercise consultations were goal setting, problem solving, action 
planning, pros and cons, instructions on how to perform the behaviour, review of behaviour 
goals, feedback on behaviours and focus on past success. During the exercise consultations 
at 1, 3 and 6 months, participants were given the opportunity to review previously set 




report (Appendix C) that outlined results from physical function tests at BL and subsequent 
assessments.  
Outcomes 
Outcomes were assessed at BL and 3, 6 and 12 months.  Assessments at each time 
point were conducted over 2 days, separated by 6 days. BL assessments were integrated with 
the induction process to the MedEx Wellness program, as outlined in Figure 3.2.  During the 
first visit a fasting blood sample was taken, body composition, strength and flexibility were 
assessed and participants completed a questionnaires to obtain demographic information (at 
BL only), barriers to self-efficacy for exercise, intentions for exercise and family support for 
PA (Appendix D).  Selected participants were provided with an accelerometer to wear for 6 
days and a take home questionnaire to assess HRQoL, self-regulatory self-efficacy for exercise 
and friend support for PA (Appendix E). Participants were encouraged to complete 
questionnaires independently but where required, a member of the research team or a family 
member or friend provided assistance. Visit 2 involved an assessment of CRF.  Table 2.2 









Table 3.2 Test battery  






 Median household income 
 Educational status 
 Marital status 
 Working status  
 Smoking status  
Chronic disease 
 Primary CD diagnosis  
 SCD or MM  
Physical activity   Accelerometer 
Physical Function 
Aerobic capacity  6MTT 
Strength 
 Sit-to-stand test 
 Handgrip test  
Flexibility  Sit-and-reach test 
Body composition  
 Height and weight 
 Body mass index 
 Waist circumference 
 Hip circumference 
 Waist to hip ratio 
Biomarkers Blood sample 
 Fasting glucose 
 Lipids 
 hsCRP 
Quality of Life 
Symptoms of depression   PHQ8 
Self-rated health  EQ-VAS 
Satisfaction with life  SWLS 




 Barriers self-efficacy 
 Self-regulatory self-efficacy 
 Intention for exercise 
 Social support for exercise 
Note: CD = chronic disease; SCD = single chronic disease; MM = multimorbidity; hsCRP = high sensitivity C-
reactive protein; PHQ8 = 8-item Patient Health Questionnaire; EQ-VAS = EuroQoL Visual Analogue Scale; SWLS 














Induction and baseline assessment 
 
Visit 1  Visit 2  Visit 3 









Assessment  Take home  Assessment   




 Accelerometer  6MTT   







    
Questionnaire      
Demographics 
Barriers self-efficacy  
Intentions for exercise 
Family Support 
     
     
     
     
Body composition       
Weight and height 
Waist and hip 
circumferences 
      
      
 
Flexibility       
Sit and reach       
Strength       




     
 
 
3 , 6 and 12 month assessments  
 
 
Visit 1     Visit 2  
Assessments  Take home  Assessment 




 Accelerometer  6MTT 







 Exercise consultation 
Questionnaires   (3 m & 6 m only) 
Barriers self-efficacy  
Intentions for exercise 
Family Support for PA 
   
   
  Feedback report 
Body Composition     
Weight and height 
Waist and hip 
circumferences 
    
    
    
Flexibility     
Sit and reach      
Strength     
Sit to stand 
Handgrip  
    
    
6 days 1 day 
6 days 
Figure 3.2 Overview of program induction and outcome assessments 
Note: CRP = c-reactive protein; PA & SB = physical activity & sedentary behaviour; PHQ8 
= 8-item Patient Health Questionnaire; EQ-VAS = EuroQoL Visual Analogue Scale;  SWLS 
= Satisfaction with Life Scale; SWEMWBS = The Short Warwick Edinburgh Mental 






Participants completed a self-report questionnaire at BL to provide information on 
age, sex, residential locality, and educational, marital, employment and smoking status.  
Residential address was used to estimate median household income based on the 
geographical profiles of income in Ireland (Central Statistics Office, 2019).  
Chronic Disease 
Participants’ primary CD diagnosis and co-morbidities, to indicate whether the 
participant had a SCD or MM, were obtained (with participant consent) from the patient 
referral letter provided to the MedEx Wellness program by the referring healthcare 
professional.   
Physical Activity and Sedentary Behaviour  
The activPAL3 micro (PAL Technologies Ltd. Glasgow, Scotland) was used to quantify 
free-living activity behaviours. Device-based measures of PA and SB have demonstrated 
higher validity and reliability relative to self-report measures (Chastin et al., 2018; Healy et 
al., 2011; Sylvia et al., 2014)  A limited number of devices were available and a sub-sample of 
randomly selected participants were issued an accelerometer.  The device measures bodily 
accelerations using a triaxial accelerometer sampling at 20 Hz for 15 s epochs.  An inbuilt 
inclinometer measures thigh inclination and detects the postural orientation of the wearer.  
The device was worn on the midpoint of the anterior aspect of the right thigh.  It was covered 




(Kooperationspartner Wundversorgung, Germany) adhesive dressing.  Participants were 
instructed to wear the device continuously, 24 h per day, for 6 consecutive days, except 
during water immersion activities, i.e., swimming and bathing.   
Accelerometer Data Processing 
Raw acceleration data were processed and stored in a range on file formats, 
including csv files or 15 s epoch summary files.  Proprietary algorithms classified activities into 
sitting/lying time, standing time, stepping time, step count and activity counts. Tudor-Locke 
et al., (2011a) defined 100 steps/minute as the threshold for MVPA in older adults. Based off 
this threshold, MVPA was classified as ≥25 steps within a 15 sec epoch. Trost et al.  (2005) 
suggest a minimum of 3  to 5 days is required to reliably estimate the outcome variables 
measures with accelerometery. Only datasets that provided ≥ 4 valid days of activity data, 
including one weekend day, were processed for analysis.  A valid day was defined as ≥ 600 
min of recording during daytime hours, i.e., 7 am to 11 pm (Trost et al., 2005).  Non-wear time 
was defined as ≥ 60 min of consecutive zero accelerometer counts (Dowd et al., 2012).  
SB characteristics were examined using a customized MATLAB® (version 7.0.1, The 
Mathworks Inc, Natick, MA, USA) software programme (Dowd et al., 2012).  The MATLAB® 
program examined the sedentary output file of the activPAL3 micro accelerometer epoch-by-
epoch.  Initially, the program binary coded each epoch (15 s) using the following sequence: a 
sedentary epoch, defined as an epoch spent entirely in sedentary activity, (i.e., sitting or lying) 
was coded as 1.  A non-sedentary epoch, defined as an epoch containing more than zero s of 
standing or stepping, (an epoch with less than 15 s spent in sedentary activity), was coded as 




the end time for each one in hh:mm:ss format. Sleep time for each participant was manually 
identified by examination of the sedentary epoch Microsoft Excel output produced by 
MATLAB®. The first break in a SB after 6am each day was selected as the rise time. The last 
registered non-sedentary epoch of the day, which was followed by a prolonged, 
uninterrupted sedentary period (> 2 h) was selected as the time the subject went to bed. This 
method allowed for the differentiation between sleep time and daily SB. The number and 
duration of day time sedentary bouts per day was calculated.  Sedentary bouts were 
categorized by specific durations, namely < 10 min, 11-30 min, 31-60 min and > 60 min.  The 
number of sedentary bouts and the total duration in sedentary bouts in each category were 
calculated.  
Physical Function 
Cardiorespiratory Fitness: was assessed using 6MTT (Ayán-Pérez et al., 2017; 
Bergmann et al., 2014).  The 6MTT demonstrates high reliability (interclass correlation 
coefficient: 0.97; 95% CI: 0.96-0.99) (Ayán-Pérez et al.,2017). The test was undertaken with 
5-6 participants at a time.  No warm-up was permitted before the 6MTT.  Participants were 
instructed to cover as much distance as possible in 6 min while walking and/or running 
between two cones placed 20 m apart on a flat 20 m indoor course.  They received a standard 
set of instructions and standard encouragement according to the ATS guidelines for the 
6MWT (Enright, 2003).  The total distance was calculated to the nearest meter by adding the 




Muscle Strength: Lower body strength was assessed using a 10 repetition sit to stand 
test from a seat height of 43-45 cm (Csuka & McCarty, 1985). High test-retest reliability  has 
been demonstrated for the 10 repetition sit to stand test in individuals undergoing 
haemodialysis (interclass correlation coefficient: 0.88; 95% CI: 0.79-0.94) (Segura-Ortí & 
Martínez, 2011).    From a starting position with their arms crossed, feet placed flat on the 
floor pointing parallel to each other and approximately shoulder width apart, participants 
were instructed to stand up and sit down 10 times as fast as possible.  Legs had to be fully 
extended and hips had to touch off the chair during the squat descent for the repetition to 
be valid.  Participants were not allowed bounce from the chair when transferring from a 
seated to standing position.  The time taken to complete 10 repetitions was measured using 
a stopwatch.  Each participant performed two trials separated by 2 min. To control for the 
risk of a learning effect between the two trials, the best score was recorded.  
Handgrip strength was measured in the dominant arm using a hand dynamometer 
(Takei 5401 Hand Grip Dynamometer (Digital)). High test-retest reliability  has been 
demonstrated for the  handgrip strength test  for both the left (interclass correlation 
coefficient: 0.95; 95% CI: 0.89-0.98)  and right (interclass correlation coefficient: 0.91; 95% CI: 
0.80-0.96)  hands in community-dwelling older adults (Bohannon & Scheubert, 2005). The 
test was administered in a standing position with the upper arm held tight at the trunk and 
forearm at a right angle to upper arm.  The gripping handle was adjusted to ensure the middle 
of their four fingers was resting on the handle.  The handle was squeezed at maximum force 




score was recorded. Mathiowetz et al., (1984) suggest that the mean of three trail is a more 
accurate measure than one trail of even the highest score of three trails.  
Flexibility: was assessed using a sit and reach test (Baumgartner & Jackson, 1995),.  
Participants sat on the bench with their legs fully extended and feet flat against a sit and reach 
box (Eveque Leisure Equipment Ltd, Cheshire, UK).  The sit and reach test demonstrates high 
reliability (interclass correlation coefficient: 0.92; 95% CI: 0.88-0.95)(Ayala et al., 2012).  They 
were instructed to flex forward, with arms fully extended and one hand on top of the other 
and to reach their fingertips as far as possible along the measurement scale while keeping the 
legs fully extended.  The distance reached on the box was recorded (cm). Rest interval 
between trials was at the participants discretion (approximately 10 – 20 s). To control for the 
risk of a learning effect between the three trials, the best score was recorded.  
Body Composition 
Height  and body mass were measured using a stadiometer and electronic scale 
(model 707 balance scales (Seca GmbH, Hamburg, Germany).  Footwear and any heavy 
clothing were removed prior to the measurements.  Height was recorded to the nearest 0.01 
cm and body mass was measured to the nearest 0.1 kg.  BMI was calculated as body mass in 
kilograms divided by squared height in metres.   
Waist and hip circumferences were measured in cm by a trained researcher using a 
tape measure.  Participants removed any bulky clothing and were instructed to stand with 
feet together, arms by their side and to breathe normally.  Measurements were taken over 




at the narrowest point as viewed from the front of the body.  The hip circumference was 
taken around the widest portion of the buttocks. The tape was snug to the body during both 
measurements.  Waist to hip ratio (WHR) was derived by dividing the waist measurement by 
the hip.    
Biomarkers 
Venous blood samples were taken following an overnight fast.  Serum vacutainers 
were allowed to stand for 30 min before centrifugation at 3000 rpm (1600 g) for 15 min at 
4°C.  Serum plasma was aliquoted into collection tubes, labelled and stored in a freezer at -
80°C.  Before analysis samples were defrosted.  Serum triglycerides, total cholesterol, HDL-C, 
LDL-C, high sensitivity C-reactive protein (hsCRP) and fasting glucose were determined using 
spectrophotometric assays, performed on an automated bench-top clinical chemistry system 
(ACE®, Alfa Wassermann B.V., Netherlands) using the appropriate reagents, calibrators and 
controls (Randox Laboratories, UK).  
Psychological Health  
Depressive Symptoms: were measured using the 8-item Patient Health 
Questionnaire Depression Scale (PHQ8), a validated diagnostic and severity measure of 
depression in the general population (Kurt Kroenke et al., 2009). Satisfactory validity and 
reliability (Cronbach  α=0.82)  has also been demonstrated in individuals with chronic heart 
failure (Pressler et al., 2011).  Participants indicated how frequently they had experienced 




Likert scale that ranged from “Not at all”  to “Nearly every day”. A higher score indicated 
greater severity of symptoms of depression in the PHQ8 scale.  
Self-rated Health: was measured using the EuroQoL Visual Analogue Scale (EQ-VAS)  
(Dyer et al., 2010). Evidence of high validity and reliability of the EQ-VAS in a range of CD 
cohorts has been established (interclass correlation coefficient: 0.78; 95% CI: 0.75-0.82) 
(Sakthong et al., 2015). Participants rated their health on a vertical visual analogue scale 
ranging from 0 – 100, where the endpoints are labelled ‘best imaginable health state’ (100) 
and ‘worst imaginable health state’ (0).  
Satisfaction with Life: was measured using the Satisfaction with Life Scale (SWLS), a 
valid and reliable 5-item scale designed to measure global cognitive judgments of one’s life 
satisfaction (Pavot et al., 1991). Additional evidence supports the use of the SWLS in adults 
over the age of 50 y (Cronbach  α=0.74) (López-Ortega et al., 2016). Participants indicated 
how much they agreed or disagreed with each of the statements for example, “In most ways 
my life is close to ideal”, using a 7-point scale, where 1 means “strongly disagree” and 7 means 
“strongly agree”. A higher score on the SWLS indicated greater satisfaction with life.  
Positive Mental Health: was measured using The Short Warwick Edinburgh Mental 
Wellbeing Scale (SWEMWBS), a validated 7-item positively worded mental health scale that 
captures a range of concepts including affective-emotional aspects, cognitive-evaluation 
dimensions and psychological functioning (Tennant et al., 2007). In a large population sample 
ranging from ages 16 – 95 y high internal consistency has been demonstrated from the 




on a 5-level Likert scale ranging from “None of the time” to “All of the time” for statements 
such as “I’ve been feeling optimistic about the future”, with a higher score indicating greater 
positive mental health. 
Psychosocial Determinants for Physical Activity 
Barrier  self-efficacy: was assessed using a validated 13-item scale (E. McAuley, 
1992).  Participants were asked to rate their confidence in their capability to be physically 
active in the presence of common barriers, for example bad weather or exercising alone.  
Participants indicated their response on a Likert scale from 0 (not confident at all) to 100 (very 
confident). 
Self-regulatory self-efficacy for exercise:  was assessed using a modified 11-item 
scale (Luszczynska & Sutton, 2006). Task, scheduling and recovery self-efficacy were also 
assessed within the scale.  Questions began with the stem “How confident are you that you 
can…” and were followed by statements such as “plan exercise session that will be at least 
moderately difficult (e.g. have you breathing a little hard, your heart rate increases)?” or 
“Schedule exercise session into your weekly routine so that you get at least 30 minutes of 
exercise a day, 3 times per week?”.  Participants rated their confidence on a Likert scale which 
ranged from 0 (not confident at all) to 10 (very confident).  
Intentions for exercise: was assessed  using a modified 6-item measure, which 
investigated intentions for exercise in general, along with intentions to attend the CBER 
(Sniehotta et al., 2005).  Questions began with the stem “I intend to…” and were followed by 




week”. Participant responses were recorded on a Likert scale from 1 (completely disagree) to 
4 (totally agree), with a higher score indicating greater intentions.   
Social support for physical activity from family and friends: was assessed using a 
validated 10-item questionnaire (Sallis et al., 1987).  Participants were required to indicate on 
a Likert scale of 1-5, how frequently over the past three months “a family member offered to 
exercise with me”,  or “gave me encouragement to stick with my exercise plan” for example. 
Higher scores represented greater social support.  
Attendance  
During induction participants were assigned a personal fob wristband which they 
were required to scan each time they entered the facility.  Attendance to the program was 
monitored via the number of scanned entrances to the facility.   
Program initiation: Initiation of the program was defined as participants who 
attended at least one exercise class following induction to the program.  Those who never 
attended following induction were defined as ‘non-uptakers’.  
Drop-out: Individuals who initiated the program, but stopped attending before the 
12 month assessment were defined as ‘drop-outs’. Participants were contacted via phone call 
to confirm attendance to each assessment and if participant confirmed during the call that 
they were no longer attending, the reason for drop-out was requested.    
Completers: Participants who attending ≥ 1 sessions between BL and 12 months and 




Adherence: Adherence to the program was based on the recommendation that 
participants attend at least 2 MedEx Wellness classes per week.  MedEx Wellness offered 
classes on 46 weeks of the year, with a three week break in service both during the summer 
and at Christmas.  Adherence was defined as the percentage of the 92 classes attended.  
Attendance recorded at 92 classes or more between BL and 12 months was defined as 100% 
adherence.  
Safety 
Any adverse events where recorded and reported to the MedEx Wellness Chief 
Medical Officer and an incident report was filled with the DCU Sports Complex.  Adverse 
events included training-related accidents or injuries or any other adverse event that 
interrupted participation in the program. Serious adverse events were defined as all-cause 
mortality or hospitalization for medical complications.  If deemed necessary by the Chief 
Medical Officer or management within DCU sport, participants were required to provide 





Procedures for data checking and entering  
Measures of physical function where manually recorded during assessment by 
researchers on individual data collection sheets assigned to each participant (Appendix F).  
Hardcopy questionnaires were completed by participants.  To minimise data entry error, a 
double data entry and cleaning process was employed while entering data to encrypted excel 
spreadsheets.  
Statistical Analysis 
A diagram representing the timepoints included in the analysis for each study is 
present in figure 3.3.  All analysis was conducted using IBM SPSS statistics software (version 
25).  Data cleaning was conducted by checking each variable for outliers.  Outliers identified 
as a possible error were checked against original data collection files including paper files or 
original activPAL downloaded file. Data was checked for normal distribution using 
Komolgorov-Smirnoff test of normality.  A significant (p ≤ 0.05) Komolgorov-Smirnoff value 
was identified for many of the variables, indicating deviations from normal distribution.  
Ghasemi and Zahediasl (2012) suggest that when a sample size is large than 30 participants, 
it is still appropriate to use parametric procedures for analysis.  As the sample size for this 
study was > 30 for all analysis, parametric procedures were employed. Specific statistical 




Study 1 (Chapter 4) describes a cross-sectional analysis of the BL data. The purpose 
of this study was to describe the daily PA and SB of a diverse CD population with SCDs and 
MM and investigate the association between PA and SB with indices of health. 
Study 2 (Chapter 5) describes the quasi-experimental study  trial.  The primary aim 
of this study was to investigate the effects of a mixed CBER program on PA levels and SB of a 
diverse CD population with SCDs and MM.  The secondary aim of this study was to investigate 
effects of the mixed CBER program on physical, psychological and clinical measures of health.  
Study 3 (Chapter 6) investigates factors associated with an effective response to 
participation in a CBER, in terms of a measurable change, in men and women with SCD and 
MM. A secondary aim was to establish the minimum attendance at a CBER needed to achieve 
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Chapter 4  
Study I 
Exploring Daily Step Count and Sedentary Behaviour in a Diverse 
Chronic Disease Population 
Introduction 
CD are conditions lasting at least 1 year in duration, require continuous medical 
attention and can limit ADL  (Moorman et al., 2007).  The burden of CD on the Irish health 
care system is substantial with almost 30% of the total adult population in Ireland living with 
one or more CDs (Department of Health, 2019).  MM refers to the coexistence of two or more 
long-term medical conditions or diseases and is associated with advancing age and a higher 
risk of premature death,  hospital admission, reduced functional capacity and QoL compared 
to those with a SCD. (Bayliss et al., 2004; Fortin et al., 2004; Smith & O’Dowd, 2007; Wallace 
et al., 2015). Currently, over 70% of Irish older adults have MM (Hernández et al., 2019).  The 
ongoing management of MM patients is challenging due to their complex care needs and the 
involvement of multiple healthcare professionals (Kuipers et al., 2020).  Patients with MM are 
at higher risk of safety issues related to poor integration of health care, diagnostic errors, 
inappropriate prescription, poor medication adherence, adverse drug events, advanced age, 
cognitive impairment, limited health literacy and comorbidity of depression or anxiety 




Several of the biological risk factors including hypertension, obesity, insulin 
resistance, hyperglycemia, dyslipidemia and chronic inflammation that are shared across CD 
groups are positively impacted by PA (Koene et al., 2016; Nesto, 2019; Warburton et al., 2006; 
World Health Organization, 2005b).  Indeed, there are exceptionally few CDs in which the 
burden of the disease, comorbidities related to the disease, or HRQoL are not improved with 
PA (Desveaux et al., 2014a; Kelley et al., 2011; Pasanen et al., 2017).   
To attain optimal health-related benefits for the secondary prevention of CD it is 
recommended that CD patients undertake 150 min/week of MVPA (US Department of Healt 
and Human Services, 2018b).  Unfortunately, a very small proportion of CD patients achieve 
the daily recommended dose of PA. Bernard et al., (2018) reported individuals with COPD to 
participate in significantly less MVPA than health controls (6.7 min/day vs 11.7 min/day). 
Morrato et al., (2007) found 39% of adults with CD to meet the guidelines for MVPA compared 
to 58% of health controls. In a large population sample the proportion of the population 
completing no MVPA was 46% for those with no CD, 49% for one CD, 59% for 2 MM and 61% 
for those with three or more MM (Serrano-Sanchez et al., 2014). This may be due in part to 
the fact that many individuals with a SCD or MM have a low functional capacity secondary to 
their sedentary lifestyle and/or a disease related limitation that limits their ability to 
undertake MVPA (Brown & Flood, 2013; Kujala et al., 2019; Welmer et al., 2013).   
SB is defined as any waking behaviour characterized by an energy expenditure ≤ 1.5 
metabolic equivalents of task (METs), while in a seated, reclined or lying posture (Tremblay 
et al., 2017). It is distinct from physical inactivity, where an individual does not perform the 
recommended amount of MVPA. Epidemiological investigations and meta-analysis (Chau et 




SB and CVD and all-cause mortality.  Furthermore, high levels of PA (≥ 35.5 MET-hour per 
week or 60-75 min of daily MVPA) appear to attenuate the negative cardiovascular 
consequences of SB (Ekelund et al., 2016). However such levels of PA are typically 
unattainable for individuals with CD.  
LIPA characterized by an energy expenditure ranging from 1.5 to 3.0 METs may be 
central to improving or maintaining health-related outcomes, particularly among individuals 
with one or more CDs and reduced functional capacity. Research has indicated that increasing 
LIPA can have beneficial effects in obesity, markers of lipid and glucose metabolism and 
mortality (Fuezeki et al., 2017a). Specifically in CD patients, increases in LIPA are significantly 
associated with reduced hospitalizations, a lower risk of mortality and improvements in lipid 
profiles (Beddhu et al., 2015; Donaire-Gonzalez et al., 2015; Li et al., 2019). Breaking up 
prolonged bouts of sitting with 2 min bouts in LIPA every 20 min has a positive impact on 
metabolic health (Dunstan et al., 2012). Longitudinal data also suggest that replacing 
sedentary time with LIPA is significantly associated with a reduced risk of all-cause and CVD 
mortality (Dohrn et al., 2018).   
Reallocation of SB with either MVPA or LIPA is associated with immediate health 
benefits, primarily by increasing energy expenditure  (Biswas et al., 2018). Therefore, “moving 
more at any intensity” has the potential to be an effective public health message (Stamatakis 
et al., 2019). The number of steps taken per day is an all-encompassing measure of 
ambulatory activity. Step count has been described as a means of bridging the gap between 
research and clinical practice, where research has the opportunity to have real word 
application (Tudor-Locke et al., 2012). Step count is an understandable common metric which 




has been highlighted in both popular press and academic literature (Bassett & Tudor-Locke, 
2004). However more recent evidence revealed that as few as approximately 4400 steps/d 
was significantly associated with lower mortality rates (49% risk reduction) when compared 
to approximately 2700 step/d. With more steps, mortality rates continued to decrease, 
however no additional risk reduction was achieved above 7500 step/d in older women (Lee 
et al., 2019). Moreover, stepping intensity was not clearly associated with lower levels of 
mortality when accounting for total daily steps per day. The possible role of step count 
guidelines in eliciting increased PA participation over MVPA guidelines was demonstrated by 
Samuels et al., (2011). Participants in this study received PA counselling advising participants 
to increase daily PA by increasing daily step count or achieving 30 min of MVPA daily. The 
10,000 step/d guidelines resulted in the greatest increase in PA in terms of both daily step 
count achieved and MVPA. In terms of public health application, the evidence suggest that 
advise on daily step count may have greater efficacy in increasing PA participation while also 
inducing health enhancing effects.  
Recent advancements in movement senor technologies have allowed for the 
development of devices which objectively measure both SB and PA, however limitations still 
exist with the classification of SB using device-measurements. The characterization of SB as < 
100 - 200 accelerometer counts per min (Matthews et al., 2008; Mitchell et al., 2012; Ridgers 
et al., 2012) often fails to distinguish between standing and sitting. The ActivPAL™ PA monitor 
(PAL Techologies Ltd, Glasgow, UK) is equipped with an inbuilt inclinometer that detects 
postural orientation and allows for direct measurement of SB.  
The majority of previous studies examining the levels of both PA and SB in CD 




research examining such behaviours in a mixed CD population and frequently individuals with 
MM are excluded. Differential methods of measures PA and SB in previous research prevents 
comparison of the available evidence across disease groups. Consequently, the evidence base 
regarding PA levels and potential benefits of PA in CD cohorts remain segregated. The 
purpose of this study was to describe the daily PA and SB of a diverse CD population with 
single and MM and investigate the association between PA and SB with selected indices of 
health. It was hypothesized that total daily PA will be low, SB will be high and will be 
accumulated in prolonged bouts in men and women with CD and MM and higher PA and 













A cross-sectional design was employed and the detailed methodology is described in 
Chapter 3.  In summary, individuals with one or more CDs were recruited at induction to the 
MedEx Wellness program following referral from a healthcare professional. Participants 
primary CD diagnosis, namely CVD, respiratory disease, cancer, metabolic disease or 
neuromuscular/musculoskeletal disorders (neuro/MSK), and information on whether that 
participant had a SCD or MM was obtained from the referral letter provided by the referring 
healthcare professional. Data collection was conducted over two visits separated by 6 d 
(figure 4.1).  PA and SB were assessed for 6 d using the activPAL ™ PA monitor (PAL 
Techologies Ltd, Glasgow, UK).  Physical function was assessed using a 6-min time trial 
(6MTT); sit to stand test, grip strength, and sit and reach test. Body composition was assessed 
with measures of BMI and waist and hip circumference. A fasting blood sample was taken to 
measure fasting glucose, triglycerides, total, HDL and LDL cholesterol and CRP. Indices of 
psychological health were evaluated with measures of depressive symptoms, self-rated 
health, satisfaction with life and positive mental health. Finally psychosocial determinants of 
PA including,  barriers to self-efficacy for exercise, self-regulatory self-efficacy for exercise, 








Data Collection  
   6 days     
Testing Day 1 Take-home Day 1 Testing Day 2 
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Intentions for exercise 
Family support for PA  
 





efficacy for exercise  
  
 Friend support for PA   
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Strength     
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Sit and reach test     
 
Figure 4.1 Outline of data collection procedures 
Note: PA = physical activity; SR health = self-rated health; EQ-VAS = EuroQoL Visual Analogue Scale; PHQ8 = 8-
item Patient Health Questionnaire; SWLS = Satisfaction with Life Scale; SWEMWBS = The Short Warwick 








Statistical Analysis  
Participants demographics, PA and SB, health-related  outcomes and psychosocial 
determinant of PA were reported using mean ± standard deviations (SD) or frequencies and 
percentages. Participants were categorized by i) primary CD diagnosis  and ii) SCD or MM.  
Differences in participant demographics between primary CD diagnosis and between those 
with SCD of MM were assessed using Chi-square tests.  Adjusted residual values were 
examined and computed to p-values to identify specific group differences.  In addition, 
differences in age between primary CD diagnosis and between those with SCD of MM were 
assessed using a univariate analysis of covariance (ANCOVA). The ANCOVA controlled for sex, 
median household income, educational status, marital status, current work status and 
smoking status.   
Preliminary analysis revealed a high degree of correlation among many of the 
variables derived from the activPAL ™ monitor.  To control for type 1 error further analysis 
included only measures of step count and sedentary time. Participants were also categorized 
as ≥ MVPA guidelines or <MVPA guidelines. Differences in step count and sedentary time 
between primary CD diagnosis and between SCD and MM was assessed using a multivariable 
analysis of covariance (MANCOVA) controlling for participant demographics.  Bonferroni-
adjusted post hoc analysis was conducted to investigate pairwise comparison between 
groups where a significant main effect was present.      
Preliminary analysis identified a high degree of correlation among the measured 
health-related outcomes body composition, physical function, blood biomarkers, 




a type 1 error while using these health-related outcomes and psychosocial determinants of 
PA in further analysis, two statistical analyses approaches were conducted.   
The first approach involved using all health-related measures and psychosocial 
determinants of PA as dependent variables in general linear models to assess their association 
with step count, sedentary time and category for achieving the guidelines of MVPA 
(independent variable).  Guidelines recommended by Pallant (2013) for the suitability of 
dependent variables for either ANCOVA or MANCOVA include; if there is a bivariate 
correlation coefficient ≥ 0.6 between any two dependent variables, one of the variables 
should be excluded.  Dependent variables within a bivariate correlation coefficient ranging 
from 0.30 to 0.59 are suitable for MANCOVA and dependent variables with a bivariate 
correlation coefficient ≤ 0.29 are suitable for ANCOVA.   
Person’s correlation coefficient matrix was examined for all health-related variables 
and psychosocial determinants of PA.  Dependent variables suitable for ANCOVA (r ≤ 0.29) 
were sit and reach, handgrip strength, fasting glucose, triglycerides, HDL-C, LDL-C and hsCRP.  
Sit to stand and 6MTT had a degree of correlation suitable for dependent variables on a 
MANCOVA. Measures of BMI and waist to hip ratio (WHR) were highly correlated (r ≥ 0.6 ) 
with waist and hip circumference measures.  BMI and WHR are well established as primary 
descriptors of body composition and were included in the MANCOVA as their correlation 
coefficient was between 0.30 to 0.59  (Esmaillzadeh et al., 2004; World Health Organization, 
2011b). SWEMWBS was highly correlated (r ≥ 0.6) with all other measures of health-related 
wellbeing and excluded from further analysis.  With the exception of self-efficacy, the 
correlation coefficients between psychosocial determinants of PA were ≥ 0.60.  PHQ8, SWLS, 




All ANCOVA and MANCOVA models included health-related variables and 
psychosocial determinants of PA as dependent variables, with step count and sedentary time 
as independent variables.   In a separate model category for achieving the guidelines of MVPA 
was included as an independent variable in place of step count and sedentary time. ANCOVA 
and MANCOVA controlled for participant demographics primary CD diagnosis and SCD or 
MM.  Bonferroni-adjusted post hoc analysis was undertaken to investigate mean differences 
for health-related variables and psychosocial determinants of PA.   
The second statistical approach used principal component analysis (PCA) on the 
health-related variables and psychosocial determinants of PA to reduce the risk of committing 
a type 1 error.  To ensure factors derived from the PCA were orthogonal, varimax rotation 
was used and minimum eigenvalue for extracted was set as 1.  Factors produced from the 
PCA were included in a series of ANCOVAs as dependent variables.  Step count and sedentary 
time were included as independent variables. A separate model included category for 
achieving the guidelines of MVPA as an independent variable. All models were controlled for 
participant demographics, primary CD diagnosis, SCD and MM. Bonferroni-adjusted post hoc 
analysis was undertaken to investigate mean differences for health-related variables and 
psychosocial determinants of PA.   
Partial eta squared was used to interpreted effect sizes. A value of ≥0.01 was defined 






A total of 403 participants were recruited. Table 4.1 and 4.2 summarizes the 
participant demographics, health-related outcomes and psychosocial determinants of PA.  
The mean (± SD) age was 62.98 ± 10.99 yr and 50.6% were men.  More than one-third (37.7%) 
of participants had a primary CD diagnosis of CVD which included CAD, PAD, hypertension, 
and stroke, 18.6% respiratory disease which included COPD, chronic bronchitis asthma and 
pulmonary hypertension, 22.8% cancer including breast, colorectal and prostate, 11.2% 
metabolic disease including type 1 and 2 diabetes and impaired glucose tolerance, 6.7% 
neuro/MSK disorders including arthritis, Parkinson’s disease and multiple sclerosis and the 
primary CD of 6.0% of participants was not specified. The proportion of participants with a 
SCD and MM was 52.4% and 47.6%, respectively. Due to limitations with available 
accelerometers, a subsample of 283 participants were issued ActivPAL activity monitors, with 
237 providing valid ActivPAL datasets for analysis.  Reasons for missing datasets included non-





Table 4.1 Participant demographics for the entire cohort, primary chronic disease, single chronic disease and multimorbidity 




















Age (years)  62.98 ± 11 66.52 ± 8.1 64.94 ± 9.5 57.54 ± 11.2 58.49 ± 11.3 67.33 ± 12.9 60.75 ± 14.9 61.8 ± 11.3 64.3 ± 10.4 
Sex (men) 204 (50.6) 103 (72.9) 32 (42.7) 28 (30.4) 23 (51.1) 8 (29.6) 11 (45.8) 107 (52.5) 93 (50.3) 
Income (€)          
64,393 – 105,943 82 (21.2) 23 (16.9) 11 (15.7) 24 (27.3) 10 (22.2) 6 (32.1) 8 (38.1) 42 (21.5) 36 (20.2) 
51,535 – 64,278 163 (42.2) 62 (45.6) 25 (35.7) 33 (37.5) 25 (55.6) 11 (42.3) 7 (33.3) 81 (41.5) 77 (43.3) 
42,309 – 51,517 97 (25.1) 39 (28.7) 21 (30.0) 23 (26.1) 4 (8.9) 5 (19.2) 5 (23.8) 51 (26.2) 43 (24.2) 
< 33, 493 44 (11.4) 12 (8.8) 13 (18.6) 8 (9.1) 6 (13.3) 4 (15.4) 1 (4.8) 21 (10.8) 22 (12.4) 
Educational status          
Some primary  45 (11.8) 18 (13.3) 15 (22.4) 2 (2.2) 2 (4.4) 5 (20.0) 3 (13.6) 23 (11.7) 22 (12.7) 
Junior cert or equiv. 81 (21.1) 32 (23.7) 19 (28.4) 9 (10.0) 11 (25.6) 5 (20.0) 5 (22.7) 36 (18.3) 42 (24.3) 
Leaving cert or equiv.  79 (20.7) 28 (20.7) 12 (17.9) 22 (24.4) 9 (20.9) 5 (20.0) 3 (13.6) 40 (20.3) 36 (20.8) 
Diploma or cert 81 (21.2) 25 (18.5) 7 (10.4) 27 (30.0) 13 (30.2) 4 (16.0) 5 (22.7) 52 (26.4) 28 (16.2) 
Degree or post grad  96 (25.1) 32 (23.7) 14 (20.9) 30 ( 33.3) 8 (18.6) 6 (24.0) 6 (27.3) 46 (23.4) 45 (16.2) 
Marital status           
Married / partner 258 (67.7) 101 (74.8) 39 (57.4) 63 (70.8) 24 (55.8) 17 (68.0) 14 (66.7) 144 (72.7) 106 (62.4) 
Divorced or widowed  64 (16.8) 20 (14.8) 19 (27.9) 11 (12.4) 6 (14.0) 4 (16.0) 4 (19.0) 26 (13.1) 36 (21.2) 
Single  59 (15.5) 14 (10.4) 10 (14.7) 15 (16.9) 13 (30.2) 4 (16.0) 3 (14.3) 28 (14.1) 28 (16.5)  
Working status          
Working or studying 106 (29.3) 36 (27.5) 8 (12.1) 35 (44.9) 20 (46.5) 4 (16.0) 3 (15.8) 66 (35.3) 38 (23.3) 
Unemployed 88 (24.3) 19 (14.5) 29 (43.9) 18 (23.1) 9 (20.9) 8 (32.0) 5 (26.3 37 (19.8) 45 (27.6) 
Retired 168 (46.4) 79 (58.0) 29 (43.9) 25 (32.1) 14 (32.6) 13 (52.0) 11 (57.9) 84 (44.9) 80 (49.1) 
Smoking status          
Current or past smoker 224 (59.1) 92 (70.2) 52 (73.2) 38 (43.2) 20 (48.8) 9 (36.0) 13 (56.5) 88 (45.1) 61 (35.5) 
Never smoked 155 (40.9) 39 (29.8) 19 (26.8) 50 (56.8) 21 (51.2) 16 (64.0) 10 (43.5) 107 (54.9) 111 (64.5) 
Number of CDs          
SCD 204 (52.4) 70 (50.7) 28 (38.4) 61 (67) 14 (32.6) 17 (68) 14 (73.7)   
MM  185 (47.6) 68 (49.3) 45 (61.6) 30 (33) 29 (67.4) 8 (32) 5 (26.3)    
Continuous variables are displayed as mean ± SD. Categorical variables are presented as n (%)  







Table 4.2 Health-related measures for the entire cohort, primary chronic disease, single chronic disease and multimorbidity 
   Primary Chronic Disease  Number of Chronic Diseases 
Variable n All CVD Respiratory Cancer Metabolic Neuro or MK Unspecified SCD MM 
Physical Function           
6MTT (m) 384 468 ± 136 470 ± 145 391 ± 126 556 ± 98.7 447 ± 107 442 ± 105 429 ± 147 498 ± 141 438 ± 126 
Sit to stand (sec) 400 22.8 ± 8.7 21.9 ± 7.0 26.2 ± 8.1 19.7 ± 5.5 23.4 ± 9 25.7 ± 12.7 25.7 ± 15.8 21.8 ± 8.3 23.7 ± 8.7 
Handgrip (kg) 401 26.1 ± 9.0 28.7 ± 9.5 23.6 ± 7.9 25.7 ± 9.1 26 ± 7.6 21.8 ± 8.0 25.0 ± 8.5 26.6 ± 9.4 25.7 ± 8.6 
Sit and reach (cm) 392 7.1 ± 9.4 6.0 ± 9.2 7.1 ± 8.2 9.9 ± 9.7 4.0 ± 10.1 6.9 ± 10.2 7.8 ± 8.1 7.7 ± 9.2 6.5 ± 9.5 
Body Composition           
Weight (kg) 402 83.5 ± 20.5 85.6 ± 17.3 78.5 ± 21.1 79.3 ± 18 95.2 ± 27 76.8 ± 16.6 88.9 ± 23.6 80.9 ± 20.5 86.2 ± 20.3 
BMI (kg/m2) 400 30.0 ± 6.7 29.9 ± 5.4 29.0 ± 7.6 28.3 ± 5.7 34.3 ± 8.9 29.0 ± 5.3 32.2 ± 6.8 28.8 ± 5.8 31.1 ± 7.2 
Waist circumference (cm) 403 100.9 ± 17.1 103.5 ± 14.4 99.2 ± 17.5 94.8 ± 15 110.9 ± 21.2 93.3 ± 13.1 104.7 ± 20.7 97.8 ± 16.0 104.2 ± 17.4 
Hip Circumference (cm) 401 108.0 ± 13.5 106.9 ± 10.6 106.0 ± 16 107 ± 10.1 115.5± 21.5 107.5 ± 10.1 110.5 ± 11.0 105.5 ± 11.7 110.4 ± 14.7 
Waist to hip ratio 401 0.9 ± 0.1 1.0 ± 0.1 0.9 ± 0.1 0.9 ± 0.1 1.0 ± 0.1 0.9 ± 0.1 0.9 ± 0.1 0.9 ± 0.1 0.9 ± 0.1 
Blood biomarkers (mmol/L)           
Fasting glucose 304 6.6 ± 2.2 6.5 ± 1.8 6.3 ± 1.6 5.8 ± 1.0 9.2 ± 4.0 5.5 ± 0.7 5.9 ± 1.0 6.1 ± 1.5 7.0 ± 2.7 
Triglycerides 336 1.2 ± 0.6 1.2 ± 0.7 1.2 ± 0.5 1.1 ± 0.7 1.3 ± 0.6 1.1 ± 0.4 1.2 ± 0.6 1.1 ± 0.6 1.2 ± 0.6 
Total cholesterol 335 4.6 ± 1.2 4.1 ± 1.2 5.1 ± 1.2 5.0 ± 1.1 4.2 ± 1.0 5.3 ± 0.9 4.9 ± 1.3 4.7 ± 1.2 4.5 ± 1.3 
HDL cholesterol 333 1.4 ± 0.5 1.2 ± 0.4 1.6 ± 0.5 1.4 ± 0.5 1.1 ± 0.3 1.6 ± 0.4 1.3 ± 0.5 1.4 ± 0.5 1.3 ± 0.5 
LDL cholesterol  333 2.4 ± 1.1 2.1 ± 1.0 2.7 ± 1.1 2.6 ± 1.1 2.2 ± 1.1 2.6 ± 0.9 2.5 ± 1.0 2.5 ± 1.0 2.3 ± 1.1 
hsCRP 282 6.9 ± 13.0 4.9 ± 5.0 12.5 ± 25.6 5.3 ± 6.1 8.9 ± 8.0 2.8 ± 1.9 5.2 ± 4.9 6.8 ± 16.4 7.0 ± 8.6 
Psychological health            
PHQ8 310 5.3 ± 5.0 4.5 ± 4.2 7.1 ± 5.7 5.7 ± 5.2 5.2 ± 5.0 4.0 ± 4.6 7.0 ± 5.7 4.9 ± 4.9 5.7 ± 5.0 
EQ-VAS 332 65.2 ± 18.4 68.1 ± 16.7 55 ± 18.9 68.1 ± 17 64.9 ± 17.6 66.9 ± 19.8 64.3 ± 23.2 67.4 ± 18.5 63.1 ± 18.3 
SWLS 325 23.7 ± 6.9 24.7 ± 6.1 21.0 ± 6.9 23.8 ± 7.5 24.2 ± 6.5 26.1 ± 6.6 20.2 ± 8.2 23.8 ± 7.0 23.7 ± 7.0 
SWEMWBS 324 26.6 ± 4.6 27.2 ± 4.4 26.3 ± 4.9 26.1 ± 4.5 26.4 ± 3.9 26.8 ± 4.6 25.3 ± 6.7 27.1 ± 4.4 26.1 ± 4.7 
Psychosocial determinants            
Barriers self-efficacy  343 60.6 ± 21.0 64.5 ± 22.2 52.5 ± 19.4 60.1 ± 19.8 58.7 ± 18.9 59.4 ± 18.3 64.8 ± 23.4 63.3 ± 20.9 57.6 ± 20.2 
Self-regulatory self-efficacy 252 76.3 ± 19.0 76.5 ± 17.9 64.8 ± 23.2 81.2 ± 15.0 74.1 ± 20.5 79.5 ± 17.3 69.4 ± 29.2 78.9 ± 17.8 73.6 ± 19.7 
Intentions for exercise 358 3.4 ± 0.5 3.4 ± 0.5 3.4 ± 0.5 3.5 ± 0.5 3.4 ± 0.4 3.2 ± 0.6 3.4 ± 0.7 3.5 ± 0.5 3.4 ± 0.5 
Family support 363 2.4 ± 1.2 2.4 ± 1.2 2.1 ± 1.0 2.5 ± 1.2 2.3 ± 1.2 2.2 ± 0.9 2.6 ± 1.4 2.4 ± 1.1 2.3 ± 1.2 
Friend support 277 2.1 ± 1.1 2.1 ± 1.2 2.0 ± 1.0 2.2 ± 1.0 2.2 ± 1.2 2.0 ± 0.8 2.3 ± 1.3 2.2 ± 1.1 2.1 ± 1.2 
Variables are displayed as mean ± SD  
Note: CVD = cardiovascular disease; neuro/MK = neuromuscular/musculoskeletal disorder; SCD =  single chronic disease; MM = multimorbidity; 6MTT = 6 minute time 
trial; BMI = body mass index;  PHQ8 = 8-item Patient Health Questionnaire; EQ-VAS = EuroQol Visual Analogue Scale; SWLS = Satisfaction with Life Scale; SWEMWBS = 




Participant demographics and chronic diseases 
There was a significant main effect for primary CD diagnosis (f(5,285)=4.04, p=0.001, 
partial eta squared =0.066) and  whether participants had a SCD or MM (f(1,285)=4.15, p=0.043, 
partial eta squared =0.014) on age. Participants with CVD were significantly older (estimated 
marginal means ± standard error (SE); 62.88 ± 61.13 yr) than those with metabolic disease 
(estimated marginal means ± SE; 57.42 ± 1.29 yr). No other primary CD diagnosis were 
significantly different in age.  Participants with MM were significantly older (estimated 
marginal means ± SE; 61.98 ± 0.85 yr) than those with a single CD (estimated marginal means 
± SE; 60.15 ± 0.60 yr).  
Chi square analysis found a significant difference between primary CD diagnosis and 
sex (X2 (5) = 49.57, p=0.000), educational status (X2 (20) = 39.36, p=0.006), working status (X2 
(10) = 46.68, p=0.000), smoking status (X2 (5) = 29.20, p=0.000) and whether participants had 
a SCD or MM (X2 (5) = 26.42, p=0.000).  A higher proportion (p < 0.000) of men (72.9%) than 
women (27.1%) had CVD. There were no other statistically significant differences in sex 
proportions across primary CD diagnosis. Examination of adjusted residual values did not find 
any significant differences between primary CD diagnosis on educational status, work status, 
smoking status or those with SCD or MM. 
There was a significant difference in working status between SCD and MM (X2 (2) = 
6.80, p=0.033).  However, examination of adjusted residual values did not indicate any 
specific group differences. There were no other statistically significant differences in 





Health-related outcomes and psychosocial determinants of physical activity  and chronic 
diseases 
Summary of main effects for primary CD diagnosis and SCD or MM on health-related 
measures are presented in table 4.3. The estimated marginal means ± SE generated for post 
hoc analysis are presented in the subsequent text. Appendix G presents results of main effects 
for participant demographics on health related outcomes and psychosocial determinants of 
PA.   
There was a significant main effect for primary CD diagnosis on 6MTT (p=0.001), sit 
to stand (p=0.000), BMI (p=0.041), WHR (p=0.012), and fasting blood glucose level (p=0.000).  
Distance achieved in the 6MTT was significantly higher in participants with cancer (507.40 ± 
13.93 m) than in those with respiratory disease (440.14 ± 17.68 m) (p=0.035) and neuro/MSK 
disorders (426.01 ± 24.89 m) (p=0.038).  Time to complete the sit to stand test was 
significantly slower in the unspecified condition (38.60 ± 4.64 s) than CVD (20.93 ± 1.23 s; 
p=0.003), cancer (21.99 ± 1.26; p=0.008) and metabolic disease (23.55 ± 1.88; p=0.045). BMI 
was significantly higher among participants with metabolic disease (33.93 ± 1.48 kg.m2) than 
cancer (28.59 ± 0.98 kg.m2) (p=0.022).  WHR was significantly higher among participants with 
metabolic disease (0.98 ± 0.02) than those with cancer (0.91 ± 0.01; p=0.029) and a 
neuro/MSK disorder(0.88 ± 0.02; p=0.020).   Fasting blood glucose was significantly higher in 
participants with metabolic disease (8.97 ± 0.41 mmol.L-1) compared to CVD (6.21 ± 0.27 
mmol.L-1; p=0.000), respiratory disease (6.03 ± 0.35 mmol.L-1; p=0.000), cancer (5.81 ± 0.30 




There was a significant main effect for SCD or MM on 6MTT and BMI. Distance 
achieved in the 6MTT was significantly higher (p=0.031) in individuals with a SCD (463.01 ± 
13.74m) than MM (433.56 ± 14.43 m). BMI was significantly higher (p=0.006) among 
participants with MM (31.61 ± 1.03 kg.m2) than SCD (28.93 ± 0.98 kg.m2) (p=0.006).  
Table 4.3 Summary main effects for primary chronic diseases diagnosis and SCD or MM on 
health-related measures and psychosocial determinants of physical activity. 
  Primary CD Diagnosis SCD or MM 
Variables n df F sig ηp2 df F sig ηp2 
Physical function          
6MTT 186 (5, 163) 4.4 .001 .118 (1, 163) 4.7 .031 .028 
Sit to stand 186 (5, 163) 5.1 .000 .135 (1, 163) 1.1 .301 .007 
Handgrip 188 (5, 165) 0.6 .670 .019 (1, 165) 1.6 .209 .010 
Sit and reach 185 (5, 162) 1.1 .359 .033 (1, 165) 0.0 .935 .000 
Body composition          
BMI 188 (5, 165) 2.4 .041 .067 (1, 165) 7.8 .006 .045 
Waist to hip ratio 188 (5, 165) 3.0 .012 .084 (1, 165) 0.9 .349 .005 
Blood biomarkers          
Fasting glucose 139 (5, 116) 10.6 .000 .313 (1, 116) 0.8 .387 .006 
Triglycerides 155 (5, 132) 1.3 .275 .046 (1, 123) 2.0 .161 .015 
LDL cholesterol 154 (5, 131) 0.7 .615 .026 (1, 131) 0.7 .405 .005 
HDL cholesterol 154 (5, 131) 2.2 .059 .077 (1, 131) 0.2 .647 .002 
hsCRP 124 (5, 101) 1.6 .175 .072 (1, 101) 0.1 .791 .001 
Health-related wellbeing          
PHQ8 132 (5, 109) 1.9 .103 .079 (1, 109) 1.0 .311 .019 
EQ-VAS 132 (5, 109) 0.5 .811 .020 (1, 109) 0.4 .527 .009 
SWLS 132 (5, 109) 0.5 .755 .024 (1, 109) 3.5 .064 .067 
Psychosocial determinants          
Barriers to self-efficacy for exercise 132 (5, 109) 1.6 .163 .069 (1, 109) 2.9 .092 .013 
Note: CD = chronic disease; SCD = single chronic disease; MM = multimorbidity; 6MTT = 6 mIn time trial; BMI = 
body mass index; PHQ8 = 8-item Patient Health Questionnaire; EQ-VAS = EuroQol Visual Analogue Scale; SWLS 
= Satisfaction with Life Scale; LDL = low density lipoprotein; HDL = high density lipoprotein; hsCRP = high 
sensitivity C-reactive protein 




Physical Activity and Sedentary Behaviour 
Among all participants, 9.5 ± 1.9 h of the waking day was spent sedentary.  On 
average participants spent 4.1 ± 1.6 h.day-1 standing, 1.4 ± 6 h.day-1 stepping, 1.1 ± 0.4 h.day-
1 in LIPA and 0.3 ± 0.3 h.day-1 in MVPA. The mean (±SD) daily step count was 6713.3 ± 3143.2 
steps. A total of 63.7% of participants did not meet the recommended 150 min of MVPA per 
week. Figure 4.2 summarizes the PA and sedentary time for all participants and individuals 
with SCD and MM. Figure 4.3 outlines the PA and sedentary time for each primary CD 
diagnosis.  Figure 4.4 illustrates the mean number of sedentary bouts and the total time 
accumulated in each sedentary bout duration. Participants accumulated 45.27 ± 14.73 
sedentary bouts per day.  Of the total waking sedentary time, 15.47% ± 7.31% was 
accumulated in bouts < 10 min in duration, 27.05% ± 8.36% was in sedentary bouts 11-30 
min, 25.41% ± 7.06% was in sedentary bouts 31-60 min and 32.07% ± 14.45% was in sedentary 
bouts > 60 min. A high degree of correlation was identified among PA variables and SB. To 
control for type 1 error further analysis included only measures of step count and sedentary 















Figure 4.2 Physical activity and sedentary time for all participants and individuals with a single 
chronic disease and multimorbidity 
Data presented as means and standard deviations 
Note; LIPA = light intensity physical activity; MVPA = moderate to vigorous physical activity; SCD = single chronic 
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Data presented as means and standard deviations 
Note: LIPA = light intensity physical activity; MVPA = moderate to vigorous physical activity; CVD = cardiovascular 
disease; Res D = respiratory disease; Met D = metabolic disease; Neuro/MSK =  neuromuscular/musculoskeletal 





Figure 4.4 Patterns of sedentary behaviour 








































































Step count and sedentary time, participants demographics and chronic diseases  
There were no significant differences in daily step count or sedentary time between 
primary CD, SCD or MM, age, sex, median household income, educational status, marital 
status and current work status.  There was a significant main effect of smoking status on step 
count (f(1,168)=6.73, p=0.010, partial eta squared =0.039).  Daily step count was significantly 
higher (p=0.010) in non-smokers than current/past smokers (estimates marginal mean ± SE; 
6769 ± 532 vs5562 ± 497 steps.day-1). 
Associations of step count and sedentary time with health-related measures 
Step count was positively associated with 6MTT (p=0.000) and self-rated health 
(p=0.031) and inversely associated with BMI (p=0.003) and WHR (p=0.045). Sedentary time 
was positively associated with performance in the sit to stand test (p=0.012), where an 
increase in the sit to stand score, indicated poorer lower body strength, and inversely 
associated with LDL-C (p=0.003) and PHQ8 score (p=0.016). An increase in PHQ8 results 
indicates worsening symptoms of depression. Results presented in table 4.4.  
Differences between individuals above and below the guidelines of MVPA for health 
related outcomes.  
 Individuals who participated in MVPA at or above the recommended level had 
significantly more favourable measures for the 6MTT (p=0.000), BMI (p=0.001), WHR 







Table 4.4 Relation of step count and sedentary time with health related outcomes 
Health-related outcomes  Step count Sedentary time  
 n df F sig ηp2 df F sig ηp2 
Physical function          
6MTT 186 (1, 163) 49.7 .000 .234 (1, 163) 0.0 .893 .000 
Sit to stand 186 (1, 163) 2.8 .097 .017 (1, 163) 6.4 .012 .038 
Handgrip  188 (1, 165) 2.3 .129 .014 (1, 165) 0.6 .445 .004 
Sit and reach 185 (1, 162) 0.4 .524 .003 (1, 162) 0.9 .358 .005 
Body composition          
BMI 188 (1, 165)  9.4 .003 .054 (1, 165) 3.2 .075 .019 
Waist to hip ratio  188 (1, 165) 4.1 .045 .024 (1, 165) 0.1 .801 .000 
Blood biomarkers          
Fasting glucose 139 (1, 116) 0.9 .335 .008 (1,116) 3.7 .057 .031 
Triglycerides 155 (1, 132) 3.2 .074 .024 (1, 132) 0.0 .901 .000 
LDL-C 154 (1, 131) 0.5 .477 .004 (1, 131) 8.9 .003 .064 
HDL-C 154 (1, 131) 1.4 .240 .011 (1, 131) 0.5 .475 .004 
hsCRP 124 (1, 101) 1.9 .172 .018 (1, 101) 0.1 .758 .001 
Psychological health          
PHQ8 132 (1, 109) 0.5 .497 .004 (1, 109) 6.0 .016 .052 
EQ-VAS 132 (1, 109) 4.8 .031 .042 (1, 109) 0.5 .480 .005 
SWLS 132 (1, 109) 1.6 .206 .015 (1, 109) 2.2 .145 .019 
Psychosocial determinants          
Barriers to self-efficacy for exercise 132 (1, 109) 0.1 .888 .000 (1, 109) 3.2 .078 .028 
Note: 6MTT = 6 minute time trial; BMI = body mass index;  PHQ8 = 8-item Patient Health Questionnaire; EQ-VAS 
= EuroQol Visual Analogue Scale; SWLS = Satisfaction with Life Scale; LDL-C = low density lipoprotein cholesterol; 
HDL-C = high density lipoprotein cholesterol; hsCRP = high sensitivity C-reactive protein.  





Table 4.5. Differences between individuals above and below the guidelines of MVPA for 






    
 n m±SE n m±SE df F sig ηp2 
Physical function         
6MTT (m) 68 490±12 118 413±14 (1, 164) 23.8 .000 .127 
Sit to stand (s) 68 25.9±1.5 118 27.4±1.2 (1, 164) 1.1 .294 .007 
Handgrip (kg)  69 25.2±1.2 119 24.5±1.0 (1,166) 0.4 .545 .002 
Sit and reach (cm) 69 6.8±1.8 116 8.7±1.6 (1, 163) 1.6 .212 .010 
Body composition         
BMI (kg/m2) 69 28.2±1.1 119 31.6±0.9 (1, 166) 10.5 .001 .060 
Waist to hip ratio  69 0.90±0.01 119 0.93±0.01 (1, 166) 6.0 .015 .035 
Blood biomarkers 
(mmol/L) 
        
Fasting glucose 50 6.6±0.3 89 6.7±0.3 (1, 117) 0.4 .552 .003 
Triglycerides 52 1.3±0.1 103 1.3±0.1 (1, 133) 0.4 .530 .113 
LDL-C 52 2.4±0.2 102 2.4±0.2 (1, 132) 0.0 .860 .000 
HDL-C 52 1.5±0.1 102 1.4±0.1 (1, 132) 0.3 .607 .002 
hsCRP 39 5.6±1.7 85 6.8±1.3 (1, 102) 0.6 .428 .006 
Psychological health         
PHQ8 49 5.5±0.9 83 5.9±0.8 (1, 110) 0.2 .661 .002 
EQ-VAS 49 70.0±3.9 83 61.8±3.4 (1, 110) 5.7 .018 .050 
SWLS 49 22.6±1.5 83 21.5±1.3 (1, 110) 0.7 .384 .007 
Psychosocial 
determinants 
        
Barriers to self-
efficacy for exercise 
49 59.9±4.2 83 60.1±3.6 (1, 110) 0.0 .953 .000 
Note: m±SE = mean ± standard error; 6MTT = 6 minute time trial; BMI = body mass index;  PHQ8 = 8-item Patient 
Health Questionnaire; EQ-VAS = EuroQol Visual Analogue Scale; SWLS = Satisfaction with Life Scale; LDL-C = low 
density lipoprotein cholesterol; HDL-C = high density lipoprotein cholesterol; hsCRP = high sensitivity C-reactive 
protein.  




Principal component analysis of health-related measures  
The PCA performed on the health-related measures produced seven distinct factors 
that accounted for 72.1% of the total variance in measures.  Item loading with values ≥ 0.30 
were used for interpretation of factors (Pallant, 2013).  Kaiser-Mayer measures of sampling 
adequacy for variables included in PCA was 0.630. Factors were interpreted to represent 
measures of psychological health, body composition, functional capacity and self-efficacy to 
be active, metabolic health, social support to be active, cholesterol and lipid profile. Table 4.5 






Table 4.6 Factor derived from principal component analysis of health-related measures 




Functional capacity & 
self-efficacy 
Metabolic health Social support Cholesterol Lipid profile 
BMI  .947      
Waist Circumference  .810  .510    
Hip Circumference  .946      
WHR    .785    
6MTT   .735     
Sit to stand   -.801     
Handgrip   .525 .520    
Sit and reach  -.326 .419 -.316    
PHQ8 -.850       
EQ-VAS .842       
SWLS .835       
SWEMBS .883       
Fasting glucose    .594    
Triglycerides       .905 
HDL cholesterol    -.470  .567 -.351 
LDL cholesterol      .834  
hsCRP  .619     .353 
Barriers self-efficacy   .312 .479  .392  
Self-regulatory self-efficacy .591  .489     
Intentions for exercise   .653     
Family support     .812   
Friend support     .888   
Extraction method: principal component analysis 
Rotation method: varimax with kaiser normalization. Rotated component matrix with factor loading. Values < 0.30 are not displayed.  
Note: BMI = body mass index; 6MTT = 6-minute time trial; PHQ8 = 8-Item Patient Health Questionnaire; SWLS = Satisfaction with Life Scale; SWEMWBS = The Short Warwick 




The relation of PCA derived factors with demographics, chronic disease, physical activity 
and sedentary behaviour   
The sample size was reduced to 52 as a result of excluding cases listwise during both 
the PCA analysis and ANCOVA. Table 4.6 presents the main effects for participant 
demographics, disease status, physical activity and sedentary time on factors derived from 
PCA. Results presented in the subsequent text are PCA factor scores and the estimated 
marginal means ± standard error generated for post hoc analysis. 
Participant demographics 
There was a significant main effect for sex on functional capacity and self-efficacy to 
be active (p=0.014), metabolic health (p=0.007), social support (p=0.031) and lipid profile (p-
0.021).  The score for functional capacity and self-efficacy to be active was significantly higher 
(p=0.014) for men than women (0.43 ± 0.24 vs.0.17 ± 0.19) indicating better functional 
capacity and self-efficacy to be active among men.  Metabolic health (p=0.007), social support 
to be active (p=0.031) and lipid profile (p=0.021) were significantly better in women than men 
participants. There was a significant main effect of current work status on lipid profile 
(p=0.037), however pairwise comparison did not indicate any significant group differences for 





There was a significant main effect of primary CD diagnosis on functional capacity 
and self-efficacy to be active (p=0.024). Pairwise comparisons did not indicate any significant 
group differences for primary CD diagnosis and functional capacity & self-efficacy to be active. 
 
Physical activity and sedentary behaviour 
Sedentary time was significantly inversely associated with functional capacity & self-





Table 4.7 ANCOVA main effects for participant demographics, disease status, physical activity and sedentary time on factors derived from 
principal component analysis 










Cholesterol Lipid profile 
 df F sig ηp2 df F sig ηp2 df F sig ηp2 df F sig ηp2 df F sig ηp2 df F sig ηp2 df F sig ηp2 
Demographics                              
Age (1, 29) 3.8 .062 .115 (1, 29) 0.4 .618 .014 (1, 29) 1.7 .207 .054 (1, 29) 0.3 .569 .011 (1, 29) 0.4 .549 .013 (1, 29) 0.1 .711 .005 (1, 29) 3.9 .058 .119 
Sex (1, 29) 0.6 .451 .020 (1, 29) 2.0 .165 .065 (1, 29) 2.3 .014 .190 (1, 29) 8.6 .007 .228 (1, 29) 5.2 .031 .151 (1, 29) 4.0 .054 .122 (1, 29) 5.9 .021 .170 
Income (3, 29) 1.4 .276 .123 (3, 29) 2.0 .140 .169 (3, 29) 0.2 .861 .025 (3, 29) 1.1 .378 .100 (3, 29) 1.5 .226 .137 (3, 29) 1.3 .289 .120 (3, 29) 0.5 .679 .050 
Education st. (4, 29) 0.6 .661 .007 (4, 29) 0.1 .996 .006 (4, 29) 0.6 .689 .072 (4, 29) 0.3 .906 .034 (4, 29) 0.8 .545 .097 (4, 29) 0.6 .683 .074 (4, 29) 1.3 .301 .150 
Marital st. (2, 29) 0.2 .788 .016 (2, 29) 0.7 .525 .043 (2, 29) 0.2 .789 .016 (2, 29) 2.1 .135 .129 (2, 29) 2.6 .088 .154 (2, 29) 1.1 .360 .068 (2, 29) 0.4 .687 .026 
Working st. (2, 29) 0.5 .629 .031 (2, 29) 0.02 .985 .001 (2, 29) 0.9 .405 .061 (2, 29) 0.003 .997 .000 (2, 29) 0.4 .664 .028 (2, 29) 0.6 .360 .037 (2, 29) 3.7 .037 .204 
Smoking st,  (1, 29) 2.6 .116 .083 (1, 29) 0.3 .567 .001 (1, 29) 1.2 .275 .041 (1, 29) 3.0 .096 .092 (1, 29) 0.1 .893 .001 (1, 29) 0.2 .675 .006 (1, 29) 0.1 .788 .003 
Disease status                             
Primary CD (5, 29) 0.2 .961 .033 (5, 29) 1.9 .121 .249 (5, 29) 3.1 .024 .346 (5, 29) 1.0 .811 .148 (5, 29) 1.7 .167 .226 (5, 29) 0.6 .686 .096 (5, 29) 0.4 .873 .058 
SCD/MM   (1, 29) 2.1 .159 .067 (1, 29) 1.7 .205 .055 (1, 29) 0.3 .599 .010 (1, 29) 0.4 .540 .013 (1, 29) 0.1 .883 .001 (1, 29) 0.3 .565 .012 (1, 29) 0.1 .913 .000 
PA & SB                              
SB (1, 29) 0.2 .632 .008 (1, 29) 0.3 .618 .009 (1, 29) 4.6 .041 .136 (1, 29) 0.5 .465 .019 (1, 29) 0.6 .446 .020 (1, 29) 5.2 .030 .152 (1, 29) 2.8 .103 .089 
Step count  (1, 29) 0.02 .881 .001 (1, 29) 0.5 .465 .019 (1, 29) 0.7 .419 .023 (1, 29) 0.1 .727 .004 (1, 29) 0.1 .785 .003 (1, 29) 3.7 .063 .114 (1, 29) 2.5 .128 .078 
MVPA gl.  (1,30) 0.3 .605 .009 (1, 30) 0.1 .823 .002 (1, 30) 0.9 .340 .030 (1, 30) 0.1 .757 .003 (1, 30) 0.1 .831 .002 (1, 30) 0.01 .612 .009 (1, 30) 3.3 .078 .100 
Note: Functional capacity & SE = functional capacity & self-efficacy to be active; Education st. = educational status; Marital st. = marital status; Working st. = working status; 
smoking st. = smoking status; Primary CD = primary chronic disease; SCD/MM = single chronic disease or multimorbidity; SB = sedentary behaviour; MVPA gl. =moderate to 
vigorous physical activity guidelines.     





Significant differences exist across the diverse CD population between participant 
demographics and health-related measures.  There were no significant differences between 
primary CDs or SCD and MM for PA or SB. Participants took on average 6,700 steps per day.  
Participants spent 9.5 h.day-1, 4.1 h.day-1, 1.4 h.day-1, and 0.3 h.day-1 sedentary, standing, in 
LIPA or MVPA observed, respectively.  The majority of sedentary time was accumulated in 
bouts lasting 30 min or more. A higher daily step count was associated with more favourable 
measures of body composition, aerobic fitness and self-rated health, with medium, large and 
medium effect sizes, respectively. Those achieving the recommended guidelines of MVPA had 
more favourable measures of aerobic fitness and body composition with a large effect size 
and self-rated health with a medium effect size. More sedentary time was associated with 
less favourable lower body strength, however the effect size of this association was small. In 
contrast, more SB was also associated with more favourable measures of LDL-C and 
depressive symptoms, both with a medium effect size observed.  
Low levels of PA are consistently reported in CD cohorts (Bernard et al., 2018; 
Christiansen et al., 2017; Eliason et al., 2011; Evenson et al., 2014; Lauret et al., 2014; Lynch 
et al., 2013; Wang et al., 2017). According to the classifications by Tudor-Locke et al., (2008), 
the mean daily step count of 6,700 steps in the present CD cohort is low. On average, the 
study participants failed to meet the recommended levels of 150 min MVPA per week. 
Similarly, the high levels of SB in the present study has been reported in a number of previous 
investigations involving CD populations (English et al., 2016; Lewis et al., 2016; Pitta at al., 
2005; Prince et al., 2016). It is important to note however, that the majority of previous 




disease cohorts. The current findings indicate that the levels of daily PA are low and SB high 
among individuals with either SCD or MM. There is a need for public health services to provide 
an integrated strategy to promote the engagement in PA and reductions in SB across all 






















Study II   
Effect of a Community-based Exercise Rehabilitation Program on Physical 
Activity Levels, Sedentary Behaviour and Health Outcomes in a Diverse 
Chronic Disease Population 
Introduction   
The beneficial effect of PA and reduced SB in the secondary prevention of multiple 
CDs is well documented (Anderson et al., 2016; Houchen-Wolloff et al., 2018; Jefferis et al., 
2015; Judice et al., 2015; McCarthy et al., 2015; Puhan et al., 2016; Sardinha et al., 2015). 
Regular PA and reduced SB mitigates many of the established risk factors that are associated 
with the development of a range CDs.  These include hypertension, dyslipidemia, 
hyperglycemia, hyperinsulinemia and obesity (Koene et al., 2016; Nesto, 2019; Warburton et 
al., 2006; World Health Organization, 2005b).  However, in CVD patients, the positive impact 
of PA and reduced SB on established risk factors accounts for only 50% of the reduction in 
morbidity and mortality in these patients. There is now emerging evidence that PA and 
reduced SB induces improvements in CVD outcomes that can occur independent of their 
effects on traditional risk factors (Fiuza-Luces et al., 2018; Joyner & Green, 2009).  This is due 
to the fact that several important physiologic and pathologic processes at play in patients 
with CVD are favourably modulated by PA and reduced SB. These include myocardial repair, 
positive vascular remodelling, coronary plaque stabilization and/or regression, development 




protection against ischemia–reperfusion injury and improvement in myocardial calcium 
sensitivity and contractility (Fiuza-Luces et al., 2018; Hambrecht et al., 2003; Nickolay et al., 
2019; Ribeiro et al., 2010, 2012; Vlachopoulos et al., 2010; Zhang et al., 2018). Although well 
established in CVD, it is likely that similar physiologic and pathological processes are 
associated with other CDs and are therefore positively affected by PA and reduced SB.   
In addition to the positive effects on physiologic and pathological processes, regular 
PA improves functional capacity and QoL in patients with CD (Arne et al., 2009; Han et al., 
2017; Sagar et al., 2015; Varas et al., 2018). All CDs have the potential to limit the functional 
capacity of the people who live with them (Harris & Wallace, 2012) and decrease functional 
independence, which can significantly impair QoL (Nihtilä et al., 2008). The benefits of PA for 
CD cohorts extend beyond what could be achieved by any other single treatment. 
The growing burden of CD mandates the development and delivery of exercise 
rehabilitation services for patients with CD and MM. Community-based programmes are a 
safe and effective mode of delivery for CD rehabilitation (Desveaux et al., 2014b) and allow 
for increased accessibility and scalability through a public health approach (Kelley et al., 
2011).   CBER programs allow for much of the burden in the delivery of PA programs to 
patients with CD to be removed from the healthcare system into the community.   
Poor long-term compliance to exercise following cardiac rehabilitation is a major 
problem with over 50% of patients returning to pre-rehabilitation levels of PA within 3 months 
of completing the program (Bock et al., 1997). Egan et al., (2012) found no significant changes 
in habitual PA levels after seven weeks of pulmonary rehabilitation, and at a one year follow-




had been sustained. Patients have reported a preference towards CBER programs compared 
to hospital-based exercise rehabilitation (McNamara et al., 2016). Patients expressed how 
CBER promoted a sense of ‘normality’ within the rehabilitation experience, distinguishing 
exercise as a normal behaviour as opposed to a treatment for their condition.  The community 
model may improve adherence by allowing for longer term or continual service provision or 
support.   
CBER programmes have historically accommodated specific individual CDs 
(Anderson et al., 2016; Kelley et al., 2011; Mccarthy et al., 2015; Swartz et al., 2017). However, 
it is well recognised that these programmes have similar structures and components, 
irrespective of the disease (Desveaux et al., 2014b) and therefore, there appears to be no 
compelling evidence to indicate that community-based programmes need to be disease-
specific (Kelley et al., 2011).  Considering the growing prevalence of MM (Violan et al., 2014), 
an integrated approach to community-based exercise for CD management represents a more 
resource efficient strategy.  Recent studies have found that CBER programs are an effective 
model for exercise rehabilitation across numerous CD groups (Gallé et al., 2019; Marsden et 
al., 2016; Pang et al., 2005; Santa Mina et al., 2017; Varas et al., 2018).  Increases in daily PA 
levels with CBER have been reported in CD cohorts (Moreton et al., 2018; Varas et al., 2018).   
There is compelling evidence that CBER is a successful intervention for the secondary 
prevention of CD. Substantial evidence supports the efficacy of CBER in enhancing physical 
functioning and QoL for individuals with CD. The effects of CBER on habitual PA levels and SB 
in CD cohort remains unclear, a further investigation is warranted.  In line with the current 
research trends on PA levels in CD cohorts, the current model of CBER delivery is primarily 




which  caters  for individuals with a range of CD diagnosis and those with MM is yet to be 
established. 
MedEx Wellness is a novel CBER programme for CD in Ireland.  Participants with a 
range of CD, including CVD, pulmonary disease, diabetes, and cancer, are referred to the 
programme by hospital physicians and their teams and general practitioners.  With medical 
oversight, MedEx Wellness offers a common CD programme of supervised group exercise 
classes.  The programme is not fixed in duration and participants can attend on a continuous 
basis. Participants are encouraged to establish a lifelong relationship with MedEx Wellness, 
which supports the development of habitual exercise participation, and fosters the 
maintenance of active living.   
The purpose of this study was to determine the effect of a CBER program (MedEx 
Wellness) on PA levels and SB in a diverse CD population and to assess its effect on selected 
health indices. It was hypothesized that participation in a CBER program will result in 









The study used a quasi-experimental study design.  Detailed methodology is 
described in Chapter 3.  Briefly, participants with one or more established CD recruited from 
patients referred by healthcare professionals to a CBER programme (MedEx Wellness) were 
observed over 12-month period.  Participants underwent an induction to the MedEx Wellness 
programme, which i) provided information on the programme structure and logistics; ii) 
involved a group exercise consultation and iii) a beginner exercise class.  Group exercise 
consultations were repeated at 1, 3, and 6 months.  Following induction, participants were 
recommended to attend 2 supervised group exercise classes per week. The classes were 60 
min in duration consisting of a combination of aerobic and resistance exercise.  Outcomes 
were assessed at baseline and 3, 6 and 12 months.  Figure 5.1 outlines the intervention and 
data collection timepoints.   
The primary outcome measures were PA and SB measured using the ActivPAL3 micro 
(PAL Technologies Ltd. Glasgow, Scotland).  Specifically, time spent in SB, standing, LIPA and 
MVPA; bouts of uninterrupted SB and mean daily step count were measured.  Secondary 
outcome measures were physical function, body composition, blood biomarkers, 








   Assessment  Assessment  Assessment 
         
Induction         
















Supervised Exercise Classes 
Frequency 2 classes per/week 
Intensity Moderate to vigorous intensity. Participants were advised to work at an intensity at which  they “feel moderately 
breathless and have a red face” 
Time  60 min including 15 min warm-up, 35-40 min main session and 5-10 min cool down depending on class size 
Type Combined aerobic, resistance and flexibility exercises 





Statistical Analysis  
Patterns of attendance to the program for all participants, completers and dropouts 
were presented using descriptive statistics. Independent t-tests and Chi Square analyses were 
used to compare differences between drop-outs and those who completed the program.  
Adjusted residual values were examined and computed to p-values, to identify group 
differences.  
A linear mixed model analysis (MMA) was used to assess longitudinal changes.  A 
MMA is a suitable approach to modelling time series data which contains repeated measures 
for several subjects (Haapalainen et al., 2008).  The MMA does not require complete data sets 
and does not exclude participants with missing data (Armstrong, 2017; Howell, 2015).  
Furthermore, MMA has less stringent assumptions than other repeated measures models 
(such as analysis of variance) and also exhibits increased power to detect treatment effects. 
In addition, MMA accommodates longitudinal designs where data collection does not have to 
take place at equally spaced intervals, e.g. 3, 6 and 12 months (Armstrong, 2017).  
The model was analysed for autoregressive, compound symmetry, diagonal, toeplitz 
and unstructured variance structures. The Akaike Information Criterion (AIC) and the 
Bayesian Information Criterion (BIC) were used as a metric to identify the best-fit model.  Time 
was treated as repeated measures and also incorporated as a fixed effect in the model. 
Categorical variables of primary CD diagnosis and SCD or MM were also included as fixed 
effects.  Total number of classes attended was included as a covariate.  The main effects for 




or MM were investigated.  To control for heterogeneity within the population, models were 
adjusted for baseline principal health-related variables.  
For primary outcome measures, models were adjusted for baseline measures of 
mean daily step count, 6MTT and BMI. For secondary outcome measures, models were 
adjusted for baseline measures of 6MTT and BMI.  Daily step count was not controlled for in 
secondary outcome measures as this resulted in a significant decrease in sample size for these 
variables. To determine the timepoints at which intervention effects occurred between 
baseline (BL), 3 months (3 m), 6 months (6 m) and 12 months (12 m), Bonferroni-adjusted 
post-hoc stratified analysis comparing estimated marginal means at each timepoint were 
performed for primary and secondary outcome measures that indicated a significant main 
effect for time. To decompose significant interaction effects, a Bonferroni-adjusted simple 
effects analysis was used.  Cohen’s D was calculated. A value of ≥0.2 was defined as a small 
effect size, >0.2-0.5 as medium and ≥0.8 as large (Pallant, 2013). 
Finally, Pearson’s correlation was used to investigate the relation between change in 
measures of physical activity between BL and 12 months and changes in psychosocial 
determinants of PA.  







Four hundred and three participants (mean age 62.98 ± 11.00 yr; 50.6% men) were 
recruited.  Forty-nine percent of participants were referred to the MedEx Wellness 
programme by hospital consultants and a further 14% from hospital-based phase IV cardiac 
rehabilitation.  GPs were responsible for 26% of referrals.  Participant demographics are 
described in Chapter 4.   
Uptake and Adherence   
Rates of programme initiation and drop-out and reasons for drop-out are 
summarised in figure 5.2.  Thirty participants (7.5%) did not attend an exercise class following 
induction to the programme and were classified as non-uptakers.  A total of 167 (41.4%) 
participants initiated the exercise classes but dropped out at a later stage. The dropout rate 
was 26.3% (n=106) between BL - 3 m, 5.0% (n=20) between 3 m - 6 m and 8.9% (n=36) 
between 6 m - 12 m.  Time of drop out could not be determined for 5 participants as 
attendance data was not obtained  
Attendance results are presented in table 5.1. Participants attended a mean of 22.97 
classes during the 12 months, with large fluctuations in mean attendance evident throughout 
the program.  Based on the recommendation of attending two exercise classes per week, and 
the program operating on 46 weeks of the year, adherence to the program over 12 months 




Program completers and dropouts had a mean attendance rate over the 12 months 
of 31.85 and 12.05 classes, respectively, with the highest mean attendance recorded in the 
first 3 months for both. Adherence for completers was estimated at 36%. There was a 
significant difference for number of sessions attended between completers and drop-outs at 
all time-points (p ≤ 0.000). 
Table 5.1 Number of classes attended for all participants, completers and drop-outs across all 
timepoints 
Timepoint All participants Completers Drop-outs  
BL – 3 m 10.82 ± 6.81 12.66 ± 6.5* 8.54 ± 6.52* 
3 m – 6 m 5.06 ± 6.99 7.54 ± 7.8* 2.01 ± 4.14* 
6 m – 12 m 7.06 ± 12.22 11.57 ± 14.56*  1.50 ± 4.08* 
BL – 12 m 22.97 ± 21.91 31.85 ± 24.26* 12.05 ± 11.5* 
* Indicts significant difference between groups (p ≤ 0.000) 
Note: BL = baseline; 3 m = 3 months; 6 m = 6 months; 12 m = 12 months 
 
BL participant demographics along with measures of physical, clinical, psychological 
and psychosocial characteristics for completers and drop-outs are presented in tables 5.2 – 
5.4.  Drop-outs were significantly younger (p=0.020, Cohen’s D=0.23) than completers.  
Compared to completers a lower proportion of drop-outs were male (p=0.033, Cramer’s V 
(V)=0.11), retired (p=0.006, V=0.19) and a higher proportion were unemployed (p=0.009, 
V=0.19). There was a higher proportion of completers with CVD (p=0.000, V=0.25). There 
were no significant differences between completers and drop-outs for PA levels at BL.  
Compared to drop-outs, completers had a greater number (p=0.013, Cohen’s D=0.33) and 
greater accumulated time (p=0.025, Cohen’s D=0.29) in sedentary bouts that lasted between 
31 – 60 min.  Drop-outs had significantly less favourable measures of BMI (p=0.016, Cohen’s 
D=0.24), hip circumference (p=0.004, Cohen’s D=0.30), triglycerides (p=0.048, Cohen’s 
D=0.22), total cholesterol (p=0.000, Cohen’s D=0.40), LDL-C (p=0.005, Cohen’s D=0.31) and 

















 Unable to contact: 49 
 Physical limitations due to ill health or injury: 34 
 No reason provided: 33 
 Work commitments: 13 
 Further medical treatment: 11 
 Living too far away: 10 
 Program was too difficult: 9 
 Not interested: 9 
 Career commitments: 6 
 Family issues: 5 
 Deceased: 5 
 Attending another gym: 4 
 Holidays: 4 
 Recruited to a different trial: 2 
 Financial issues: 1 
 Transport issues: 1 






  Drop-out 
(n=36) 
 






  Drop-out 
(n=20) 
 








Figure 5.2 Program completion and dropout flow chart 











n=196 p value Effect size  
Age (years)  64.22 ± 10.45 61.67 ± 11.40 .020 0.23 
Gender (male) 115 (55.8) 89(45.2) .033 0.11 
Income (€)    0.14 
64,393 – 105,943 42 (21.1) 40 (21.4) 1.00  
51,535 – 64,278 85 (42.7) 78 (41.7) .998  
42,309 – 51,517 49 (24.6) 48 (25.7) .997  
< 33, 493 23 (11.6) 21 (11.2) 1.00  
Educational status    0.16 
Some primary  23 (11.7) 22 (11.9) 1.00  
Junior cert or equiv. 44 (22.3) 37 (20.0) .989  
Leaving cert or equiv.  29 (14.7) 50 (27.0) .066  
3Diploma or cert 44 (22.3) 37 (20.0) .987  
Degree or post grad  57 (28.9) 39 (21.1) .537  
Marital status     0.05 
Married / partner 136 (69.7) 122 (65.6) .687  
Divorced or widowed  30 (15.4) 34 (18.3) .751  
Single  29 (14.9) 30 (16.1) .944  
Working status    0.19 
Working or studying 52 (27.8) 54 (30.9) .816  
Unemployed 33 (17.6)* 55 (31.4) .009  
Retired 102 (54.5) 66 (37.7) .006  
Smoking status    0.05 
Current or past smoker 75 (38.7) 80 (43.2) .364  
Never smoked 119 (61.3) 105 (56.8) .364  
Primary CD diagnosis    0.25 
CVD 95 (46.1) 45 (22.8) .000  
Respiratory disease 35 (17.0) 40 (20.3) .981  
Cancer 36 (17.5) 56 (28.4) .232  
Metabolic disease 20 (9.7) 25 (12.7) .970  
Neuro/MSK 12 (5.8) 15 (7.6) .665  
Unspecified 8 (3.9) 16 (8.1) .992  
SCD or MM    0.04 
SCD 110 (54.5) 94 (50.3) .409  
MM  92 (45.5) 93 (49.7) .409  
Continuous variables are displayed as mean  ± standard deviation. Categorical variables are presented  as n (%) 
Numbers in BOLD indicate p ≤ 0.05.  
Note: Equiv. = equivalent ; CVD = cardiovascular disease; neuro/MSK = neuromuscular/musculoskeletal 
disorders; SCD = single chronic disease; MM = multimorbidity 











n=111 p value Cohen’s D 
Sedentary Time (hr) 9.58±1.88 9.49±1.90 .716 0.05 
Standing Time (hr) 4.05±1.38 4.06±1.74 .957 0.01 
LIPA (hr) 1.14±0.41 1.07±0.43 .243 0.15 
MVPA (hr) 0.34±0.28 0.30±0.28 .277 0.14 
Step Count (steps/day) 6979±3189 6411±3077 .166 0.18 
Number of  SedB < 10 min 32.05±15.04 29.92±12.73 .244 0.15 
Time SedB < 10 min (min) 88.14±32.45 82.61±32.01 .189 0.17 
Number of  SedB 11-30 min 8.86±2.79 8.62±2.89 .526 0.08 
Time SedB 11-30 min (min) 156.71±49.84 151.24±50.86 .406 0.11 
Number of  SedB 31-60 min 3.67±1.20 3.30±1.11 .013 0.33 
Time SedB 31-60 min (min) 153.81±51.33 139.33±46.41 .025 0.29 
Number of  SedB > 60 min 1.94±0.95 2.04±0.93 .418 0.11 
Time SedB > 60 min (min) 183.50±100.26 202.75±115.64 .172 0.18 
Total number of. SedB 46.52±15.64 43.87±13.54 .169 0.18 
Variables are displayed as mean  ± standard deviation 
Numbers in BOLD indicate p ≤ 0.05 
















Physical Function      
6MTT (m) 202, 184 475.16±124.18 460.52±148.72 .294 0.11 
Sit to stand (sec) 204, 196 22.05±7.15 23.66±7.15 .066 0.19 
Handgrip (kg) 205, 196 26.59±9.23 25.55±8.81 .252 0.11 
Sit and reach (cm) 203, 189 7.42±9.43 6.66±9.30 .425 0.08 
Body Composition      
Weight (kg) 205, 197 81.72±18.51 85.39±22.25 .073 0.18 
BMI (kg/m2) 205, 195 29.16±5.62 30.78±7.53 .016 0.24 
Waist (cm) 206, 197 99.79±15.49 102.13±18.52 .171 0.14 
Hip (cm) 205, 196 106.09±10.98 110.03±15.42 .004 0.30 
Waist to hip ratio 205, 196 0.94±0.11 0.93±0.10 .216 0.12 
Blood biomarkers (mmol/L)      
Fasting glucose 157, 147 6.35±1.47 6.77±2.77 .100 0.19 
Triglycerides 173, 163 1.11±0.54 1.24±0.67 .048 0.22 
Total cholesterol 172, 163 4.36±1.26 4.86±1.17 .000 0.40 
HDL cholesterol 170, 163 1.31±0.47 1.39±0.47 .143 0.16 
LDL cholesterol  171, 142 2.21±1.01 2.53±1.07 .005 0.31 
hsCRP 145, 137 6.28±8.72 7.64±16.32 .379 0.10 
Psychological health       
PHQ8 179, 140 4.96±4.74 5.81±5.20 .134 0.17 
EQ-VAS 179, 153 66.58±18.90 63.64±17.78 .148 0.16 
SWLS 179, 146 24.35±6.75 22.94±7.09 .068 0.20 
SWEMWBS 175, 149 26.85±4.67 26.23±4.54 .231 0.13 
Psychosocial determinants of PA      
 Barriers self-efficacy for exercise 179, 164 61.66±20.64 59.36±21.30 .311 0.11 
Self-regulatory self-efficacy for exercise 157, 95 76.87±18.50 75.40±19.95 .555 0.08 
Intentions for exercise 189, 169 3.39±0.50 3.45±0.53 .348 0.10 
Family support for physical activity 186, 177 2.52±1.09 2.18±1.19 .005 0.29 
Friend support for physical activity 151, 126 2.11±1.07 2.19±1.18 .566 0.07 
N is displayed as completers, dropouts 
Variables are displayed as mean  ± standard deviation  
Numbers in BOLD indicate p ≤ 0.05  
Note: 6MTT = 6 minute time trial; BMI = body mass index; hsCRP = high sensitivity c-reactive protein; PHQ8 = 8-
item Patient Health Questionnaire; EQ-VAS = EuroQoL Visual Analogue Scale; SWLS = Satisfaction with Life Scale; 





There was one fatality during the trial, that resulted from a cardiac arrest following 
participation in a MedEx Wellness class. The participant was a male of 62 yr with a primary 
diagnosis of CVD and no MM.  He had been participating in the study for 10 months and had 
attended 52 classes.  
Outcomes 
Of the 403 participants who completed BL assessment, 264 (65.5%), 240 (59.6%) and 
206 (51.1%) participants completed repeat assessments at 3 months, 6 months and 12 
months, respectively. 
Primary Outcome: Physical Activity and Sedentary Behaviour 
Results of mixed model analyses on PA and SB variables are displayed in table 5.5. 
Statistically significant main effects for time were found for LIPA (p=0.016, Cohen’s D=0.14), 
number of sedentary bouts between 11-30 min (p=0.040, Cohen’s D=0.10), time in sedentary 
bouts of 11-30 mins (p=0.037, Cohen’s D=0.11) and total number of sedentary bouts 
(p=0.040, Cohen’s D=0.09).  The post-hoc analysis indicated that there was a significant 
improvements in LIPA between BL - 6 m (p=0.014, Cohen’s D=0.06) (figure 5.3),  but did not 
find a significant differences at any time point for the number of and time spent in bouts of 
11-30 min or total number of sedentary bouts (Figure 5.4).  A summary table of pairwise 
comparisons on primary outcome variables with a significant main effect for time is included 




A significant positive association was found between attendance and LIPA (p=0.006), 
MVPA (p=0.010) and step count (p=0.002).  There was a significant inverse association 
between attendance and time spent in sedentary bouts > 60 min (p=0.050).  There were no 














SCD or MM 
BL 3 m  6 m 12 m df F sig df F sig df F sig df F sig 
Sedentary Time (hr) 9.4±0.2 9.6±0.2 9.6±0.2 9.7±0.3 (3, 114) 0.3 .886 (1, 202) 1.0 .323 (15, 121) 1.2 .246 (3, 119) 0.6 .616 
Standing Time (hr) 4.2±0.1 4.1±0.2 4.2±0.2 4.3±0.2 (3, 117) 0.4 .787 (1, 192) 0.3 .568 (15, 127) 1.5 .124 (3, 125) 0.6 .699 
LIPA (hr) 1.1±0.04 1.2±0.05 1.3±0.1 1.2±0.1 (3, 119) 3.7 .016 (1, 206) 7.6 .006 (15, 134) 1.2 .305 (3, 124) 0.4 .726 
MVPA (hr) 0.33±0.03 0.38±0.03 0.36±0.03 0.36±0.05 (3, 116) 1.2 .310 (1, 217) 6.8 .010 (15, 134) 0.8 .669 (3, 123) 0.1 .989 
Step Count 
(steps/day) 
6885±273 7535±360 7671±397 7380±494 (3, 115) 2.4 .076 (1, 217) 9.4 .002 (15, 123) 1.2 .261 (3, 121) 0.2 .869 
No. SedB < 10 min 29.72±1.3 31.62±1.5 32.59±1.5 32.6±1.7 (3, 132) 2.2 .088 (1, 206) 0.1 .718 (15, 142) 0.9 .614 (3, 140) 0.6 .594 
Time SedB < 10 min 
(min) 
82.6±2.9 88.4±3.3 89.8±3.6 90.9±4.6 (3, 118) 2.6 .054 (1, 195) 0.5 .475 (15, 125) 1.0 .440 (3, 123) 2.2 .090 
No. SedB 11-30 min 8.5±0.3 9.3±0.3 9.3±0.4 9.3±0.4 (3, 120) 2.9 .040 (1, 110) 0.1 .875 (15, 125) 0.8 .714 (3, 123) 0.1 .982 
Time SedB 11-30 min 
(min) 
149.8±4.5 163.1±5.1 163.8±6.3 163.1±7.9 (3, 120) 2.9 .037 (1, 209) .01 .945 (15, 122) 0.8 .665 (3, 123) .03 .994 
No. SedB 31-60 min 3.5±0.1 3.5±0.2 3.5±0.2 3.4±0.2 (3, 125) 0.1 .968 (1, 202) 2.5 .117 (15, 141) 0.6 .859 (3, 133) 0.4 .737 
Time SedB 31-60 min 
(min) 
148.1±4.5 146.3±7.3 148.9±7.4 143.1±8.1 (3, 126) 0.2 .923 (1, 200) 1.9 .175 (15, 138) 0.8 .698 (3, 133) 0.3 .805 
No. SedB > 60 min 2.0±0.1 1.9±0.1 1.9±0.1 2.0±0.1 (3, 122) 0.8 .488 (1, 174) 3.7 .056 (15, 128) 1.1 .402 (3, 128) 1.2 .307 
Time SedB > 60 min 
(min) 
194.8±9.5 179.6±10.1 177.4±13.1 191.9±15.5 (3, 118) 1.0 .405 (1, 171) 3.9 .050 (15, 123) 0.9 .572 (3, 123) 1.3 .274 
Total No. SedB 44.3±1.4 46.8±1.6 47.8±1.6 47.6±1.8 (3, 125) 2.9 .040 (1, 211) 0.1 .716 (15, 134) 1.1 .346 (3, 135) 0.2 .919 
Data at each timepoint presented as estimated marginal means ± standard error. 
Note: CD = chronic disease; SCD = single chronic disease; MM = multimorbidity; LIPA = light intensity physical activity; MVPA = moderate to vigorous intensity physical activity; 





Figure 5.3 LIPA (BL-12m) pairwise comparisons 
Data presented as estimated marginal means and standard error  































   
 
Figure 5.4 Number of and time spent in sedentary bouts of 11-30 min duration and total number of sedentary bouts (BL-12m) pairwise 
comparisons 

































































































A summary of results for secondary outcomes are in table 5.6. Results with a 
significant main effect for time were subjected to pairwise comparisons. Results are 
summarized in table 5.7. 




Table 5.6 Type III analysis of time, attendance, time*primary chronic disease and time*SCD or MM effects for secondary outcomes 
Secondary outcome 
variables  






SCD or MM 
n BL 3 m  6 m 12 m df F sig df F sig df F sig df F sig 
Physical function                  
6MTT (m) 369 457.2 ± 8.6 508.6±10.4 522.7±11.3 532.1±12.2 (2, 221) 37.0 .000 (1, 361) 2.0 .157 (15, 222) 4.0 .000 (3, 220) 0.5 .673 
Sit to stand (secs) 369 23.1±0.5 20.4±0.5 19.9±0.6 20.4±0.6 (3, 231) 17.6 .000 (1, 317) 3.4 .067 (15, 240) 1.7 .052 (3, 227) 0.2 .873 
Handgrip (kg) 369 25.1±0.6 25.4±0.6 25.9±0.6 26.3±0.7 (3, 228) 3.8 .011 (1, 360) .004 .952 (15, 227) 0.9 .515 (3, 225) 1.2 .294 
Sit and reach (cm) 263 6.80±0.7 7.3±0.8 8.2±0.8 8.1±0.9 (3, 191) 2.6 .054 (1, 345) 3.3 .069 (15, 192) 0.6 .886 (3, 191) 3.8 .011 
Body composition                  
Weight (kg) 369 83.5±1.4 83.2±1.4 83.2±1.3 82.8±1.3 (3, 218) 1.0 .407 (1, 333) 4.2 .041 (15, 218) 1.7 .055 (3, 216) 1.3 .271 
BMI (kg/m2) 369 30.2±0.4 30.1±0.4 30.1±0.4 30.0±0.4 (3, 215) 0.7 .575 (1, 336) 4.2 .041 (15, 215) 1.7 .057 (3, 213) 1.2 .295 
Waist cir (cm) 369 100.7±1.1 99.0±1.1 99.2±1.1 97.9±1.1 (3, 230) 9.1 .000 (1, 324) 2.5 .112 (15, 231) 1.0 .412 (3, 229) 1.8 .142 
Hip cir (cm) 369 108.3±0.9 107.2±0.9 107.3±0.9 105.9±0.9 (3, 218) 14.4 .000 (1, 333) 6.0 .015 (15, 219) 1.1 .331 (3, 216) 2.3 .076 
Waist to hip ratio 369 0.93±0.01 0.92±0.01 0.92±0.01 0.92±0.01 (3, 229) 1.2 .314 (1, 344) 0.5 .483 (15, 228) 1.1 .382 (3, 225) 1.5 .208 
Blood biomarkers (mmol/L)                  
Fasting glucose 324 6.5±0.1 6.6±0.2 6.6±0.2 6.3±0.2 (3, 134) 2.3 .081 (1, 224) 1.8 .201 (15, 152) 0.8 .704 (3, 138) 0.5 .716 
Triglycerides 337 1.2±0.04 1.2±0.1 1.2±0.1 1.2±0.1 (3, 181) 0.4 .738 (1, 303) 1.2 .279 (15, 182) 0.7 .804 (3, 183) 1.1 .357 
HDL cholesterol 337 1.4±0.03 1.4±0.04 1.4±0.03 1.5±0.05 (3, 198) 1.9 .131 (1, 311) 0.2 .654 (15, 199) 1.0 .424 (3, 197) 0.8 .514 
LDL cholesterol 337 2.4±0.1 2.3±0.1 2.4±0.1 2.6±0.1 (3, 189) 3.7 .012 (1, 307) 0.04 .836 (15, 194) 1.1 .353 (3, 192) 1.5 .225 
Total cholesterol 337 4.8±0.1 4.8±0.1 4.8±0.1 4.8±0.1 (3, 193) 0.1 .964 (1, 323) 0.2 .661 (15, 212) 1.5 .141 (3, 194) 0.5 .663 




Table 5.6 Continued 
Secondary outcome 
variables 






SCD or MM 
n BL 3 m  6 m 12 m df F sig df F sig df F sig df F sig 
Psychological health                  
PHQ8 337 5.3±0.4 4.4±0.4 4.0±0.4 4.1±0.4 (3, 176) 5.9 .001 (1, 287) 15.8 .000 (15, 172) 1.8 .038 (3, 168) 0.4 .767 
EQ-VAS 346 65.8±1.3 69.7±1.4 72.3±1.5 72.3±1.6 (3, 204) 9.1 .000 (1, 281) 11.9 .001 (15, 196) 0.9 .546 (3, 188) 0.4 .750 
SWLS 338 23.7±0.5 24.5±0.5 25.2±0.5 24.5±0.6 (3, 186) 4.1 .008 (1, 294) 18.4 .000 (15, 185) 1.7 .049 (3, 176) 1.5 .225 
SWEMWBS 338 26.6±0.3 26.7±0.4 26.5±0.4 27.0±0.5 (3, 168) 0.4 .762 (1, 312) 5.9 .015 (15, 172) 2.4 .004 (3, 161) 2.8 .043 
Psychosocial 
determinants of PA  
                 
Barriers self-efficacy 
for exercise 
347 60.6±1.5 55.0±2.1 54.9±2.2 56.0±2.4 (3, 186) 2.8 .042 (1, 301) 7.3 .007 (15, 182) 0.9 .568 (3, 172) 0.4 .568 
Self-regulatory self-
efficacy for exercise 
299 77.1±1.5 74.8±1.7 71.2±1.8 72.2±2.2 (3, 179) 3.9 .009 (1, 269) 17.6 .000 (15, 173) 0.8 .727 (3, 164) 1.6 .184 
Intentions for exercise 347 3.4±0.04 3.3±0.04 3.2±0.05 3.2±0.06 (3, 195) 5.8 .001 (1, 301) 10.6 .001 (15, 192) 1.6 .068 (3, 188) 0.4 .778 
Family support for 
physical activity 
356 2.4±0.1 2.5±0.1 2.4±0.1 2.3±0.1 (3, 197) 1.4 .235 (1, 317) 2.6 .108 (15, 206) 1.4 .143 (3, 195) 0.5 .684 
Friend support for 
physical activity 
324 2.2±0.1 2.4±0.1 2.2±0.1 2.4±0.1 (3, 213) 1.7 .158 (1, 292) 0.6 .434 (15, 208) 0.6 .864 (3, 185) 0.2 .884 
Results are presented as estimated marginal means ± standard error.  
Numbers in BOLD indicate p < 0.05. 
Note: BL = baseline; 3 m = 3 months; 6 m = 6 months; 12 m = 12 months; BMI = body mass index; cir = circumference; 6MTT = 6 minute time trial; HDL = high density 
lipoprotein; LDL = low density lipoprotein; hsC-reactive protein = high sensitivity c-reactive protein; PHQ8 = 8-item Patient Health Questionnaire; EQ-VAS = EuroQoL Visual 




Table 5.7 Summary of pairwise comparisons on secondary outcome variables with a 
significant main effect for time 
Health-related  
measure Timepoint P 
Standard 
error df C.I Cohen’s D 
6MTT BL – 3 m .000 5.67 264.03 (-66.53, -36.39) 1.33 
BL – 6 m .000 7.10 255.47 (-84.45, -46.71) 1.54 
BL – 12 m .000 8.39 245.78 (-97.25, -52.63) 1.65 
3 m – 6 m .058 5.41 216.24 (-28.52, 0.29) 0.41 
3 m – 12 m .009 7.33 209.86 (-43.00, -3.95) 0.60 
 6 m – 12 m .822 6.27 170.85 (-26.09, 7.36) 0.29 
Sit to stand BL – 3 m .000 .439 289.06 (1.55, 3.88) 0.24 
 BL – 6 m .000 .483 260.01 (1.93, 4,49) 0.29 
 BL – 12 m .000 .513 271.51 (1.38, 4.10) 0.23 
 3 m – 6 m 1.00 .430 232.16 (-0.65, 1.64) 0.05 
 3 m – 12 m 1.00 .419 199.14 (-1.09, 1.15) 0.00 
 6 m – 12 m 1.00 .409 176.12 (-1.56, 0.62) 0.06 
Handgrip BL – 3 m 1.00 .355 274.37 (-1.24, 0.65) 0.03 
BL – 6 m .108 .339 248.95 (-1.71, 0.09) 0.09 
BL – 12 m .024 .400 220.42 (-2.23, -0.10) 0.12 
3 m – 6 m .761 .334 233.27 (-1.40, 0.38) 0.06 
3 m – 12 m .132 .376 212.90 (-1.87, 0.13) 0.10 
6 m – 12 m 1.00 .384 200.23 (-1.38, 1.40) 0.04 
Waist 
circumference 
BL – 3 m .000 .408 257.87 (0.55, 2.72) 0.16 
BL – 6 m .003 .422 252.29 (0.39, 2.63) 0.15 
BL – 12 m .000 .586 233.74 (1.21, 4.33) 0.24 
3 m – 6 m 1.00 .379 224.43 (-1.14, 0.88) 0.01 
3 m – 12 m .248 .553 223.31 (-0.34, 2.61) 0.10 
6 m – 12 m .080 .508 200.74 (-0.09, 1.14) 0.13 
Hip 
circumference  
BL – 3 m .001 .282 262.45 (0.37, 1.88) 0.13 
BL – 6 m .006 .300 236.56 (0.21, 1.80) 0.12 
BL – 12 m .000 .406 221.65 (1.40, 3.56) 0.26 
3 m – 6 m 1.00 .300 209.44 (-0.92, 0.68) 0.02 
3 m – 12 m .010 .423 220.87 (0.23, 2.48) 0.14 
6 m – 12 m .000 .362 162.79 (0.50, 2.44) 0.19 
LDL cholesterol BL – 3 m .505 .091 209.73 (-0.08, 0.40) 0.04 
BL – 6 m 1.00 .088 218.01 (-0.18, 0.28) 0.01 
BL – 12 m .452 .095 197.82 (-0.42, 0.08) 0.04 
3 m – 6 m 1.00 .097 202.93 (-0.37, 0.15) 0.02 
3 m – 12 m .008 .100 176.80 (-0.40, -0.06) 0.08 
6 m – 12 m .144 .096 176.11 (-0.48, 0.04) 0.05 
PHQ8 BL – 3 m .015 .312 215.00 (0.12, 1.79) 0.12 
BL – 6 m .001 .328 222.62 (0.41, 2.15) 0.15 
BL – 12 m .012 .384 204.84 (0.18, 1.23) 0.14 
3 m – 6 m 1.00 .301 160.65 (-0.48, 1.13) 0.05 
3 m – 12 m 1.00 .359 151.64 (-0.71, 1.21) 0.03 







Table 5.7 continued 
Health-related  
measure Timepoint p 
Standard 
error df C.I Cohen’s D 
EQ-VAS BL – 3 m .009 1.23 240.44 (-7.23, -0.68) 0.23 
BL – 6 m .000 1.47 222.23 (-10.52, -2.67) 0.36 
 BL – 12 m .000 1.57 212.76 (-10.75, -2.39) 0.36 
 3 m – 6 m .453 1.48 225.91 (-6.56, 1.29) 0.14 
 3 m – 12 m .627 1.48 200.51 (-6.88, 1.66) 0.15 
 6 m – 12 m 1.00 1.64 203.38 (-4.35, 4.40) 0.00 
SWLS BL – 3 m .356 .421 226.08 (-1.92, 0.32) 0.08 
BL – 6 m .003 .437 213.09 (-2.69, -0.36) 0.16 
BL – 12 m .883 .548 175.93 (-2.26, 0.67) 0.08 
3 m – 6 m .585 .439 213.86 (-1.90, 0.44) 0.08 
3 m – 12 m 1.00 .524 144.73 (-1.45, 1.45) 0.00 




BL – 3 m .066 2.19 253.08 (-0.21, 11.42) 0.24 
BL – 6 m .086 2.28 232.95 (-0.44, 11.67) 0.24 
BL – 12 m .446 2.54 204.66 (-2.21, 11.30) 0.20 
3 m – 6 m 1.00 2.20 180.17 (-5.86, 5.88) 0.00 
3 m – 12 m 1.00 2.37 157.55 (-7.39, 5.28) 0.05 




BL – 3 m .801 1.54 227.18 (-1.78, 6.43) 0.12 
BL – 6 m .007 1.80 224.99 (1.13, 10.71) 0.29 
BL – 12 m .137 2.13 163.49 (-0.80, 10.60) 0.26 
 3 m – 6 m .163 1.62 195.85 (-0.71, 7.90) 0.20 
 3 m – 12 m .973 1.84 142.71 (-2.33, 7.49) 0.16 
 6 m – 12 m 1.00 1.99 147.49 (-6.33, 4.30) 0.06 
Intentions for 
exercise 
BL – 3 m .232 .051 280.45 (-0.03, 0.24) 0.03 
BL – 6 m .001 .054 228.38 (0.07, 0.36) 0.06 
 BL – 12 m .011 .065 209.62 (0.03, 0.38) 0.06 
 3 m – 6 m .325 .056 198.75 (-0.04, 0.26) 0.03 
 3 m – 12 m .644 .060 157.15 (-0.06, 0.26) 0.03 
 6 m – 12 m .100 .060 157.39 (-0.17, 0.15) 0.00 
Numbers in BOLD indicate p < 0.05. 
Note: BL = baseline; 3m = 3 months; 6m = 6 months; 12m = 12 months; 6MTT = 6 minute time trial; PHQ8 = 8-
item Patient Health Questionnaire; EQ-VAS = EuroQoL Visual Analogue Scale; SWLS = Satisfaction with Life Scale; 





There was a significant main effect for time on 6MTT (p=0.000, Cohen’s D=0.17), sit 
to stand (p=0.00, Cohen’s D=0.14), and handgrip (p=0.011, Cohen’s D=0.04). Performance in 
the 6MTT significantly improved between BL - 3 m (p=0.000, Cohen’s D=1.33), BL - 6 (p=0.000, 
Cohen’s D=1.54), BL - 12 m (p=0.000, Cohen’s D=1.65) and 3 m - 12 m (p=0.009, Cohen’s 
D=0.60).  Sit to stand significantly improved between BL - 3 m (p=0.000, Cohen’s D=0.24), BL 
- 6 m (p=0.000, Cohen’s D=0.29) and BL - 12 m (p=0.000, Cohen’s D=0.23). Handgrip 
significantly improved between BL - 12 m (p=0.024, Cohen’s D=0.12). There were no 
significant associations between measures of physical function and attendance.  There was a 
significant interaction effect for time*primary CD diagnosis on 6MTT (p=0.000, Cohen’s 
D=0.57) (figure 5.5) and for time*SCD or MM on sit and reach (p=0.011, Cohen’s D=0.08) 
(figure 5.6).  
Individuals with cancer had a significantly higher 6MTT distance compared to all 
other primary CD diagnosis at BL, 3 m and 6 m (p < 0.05) and those with CVD (p=0.001) and 
respiratory disease (p=0.000) at 12 m. In addition, individuals with respiratory disease had a 
significantly lower 6MTT than those with CVD (p=0.001) at BL and those with CVD and 







Figure 5.5 BL – 12m for primary chronic diseases diagnosis 
Dates presented as estimated marginal means and SEM 
Note: CVD = cardiovascular disease; Neuro/MSK = neuromuscular/musculoskeletal; m = meters  
 
There were no significant differences between SCD and MM for the sit and reach test 
within the simple effects analysis.   
 
 
Figure 5.6 Sit and reach BL – 12m for single chronic disease and multimorbidity 
Dates presented as estimated marginal means and SEM 









































Body Composition  
 There was a significant time main effect for waist circumference (p=0.000, Cohen’s 
D=0.06) and hip circumference (p=0.000, Cohen’s D=0.06).   Waist circumference significantly 
decreased between BL - 3 months (p=0.000, Cohen’s D=0.16), BL - 6 m (p=0.003, Cohen’s 
D=0.15) and BL - 12 m (p=0.000, Cohen’s D=0.24).  Hip circumference significantly decreased 
between BL - 3 m (p=0.001, Cohen’s D=0.13), BL - 6 m (p=0.006, Cohen’s D=0.12), BL - 12 m 
(p=0.000, Cohen’s D=0.26), 3m - 12 m (p=0.010, Cohen’s D=0.14) and 6m - 12 m (p=0.000, 
Cohen’s D=0.19). There was a significant inverse association between attendance and weight 
(p=0.041), BMI (p=0.041) and hip circumference (p=0.015).   
Blood Biomarkers 
 There was a significant main effect for time on LDL (p=0.012, Cohen’s D=0.02). LDL 
significantly worsened between 3 m - 12 m (p=0.008, Cohen’s D=0.08). 
Psychological Health 
 There was a significant main effect for time on PHQ8 (p=0.001, Cohen’s D=0.09), EQ-
VAS (p=0.000, Cohen’s D=0.15) and SWLS (p=0.008, Cohen’s D=0.08).  PHQ8 improved 
between BL - 3 m (p=0.015, Cohen’s D=0.12), BL - 6 m (p=0.001, Cohen’s D=0.15) and BL - 12 
m (p=0.012, Cohen’s D=0.14).  EQ-VAS  improved between BL - 3 m (p=0.009, Cohen’s D=0.23), 
BL - 6 m (p=0.000, Cohen’s D=0.36) and BL - 12 m (p=0.000, Cohen’s D=0.36).  SWLS improved 
between BL - 6 m (p=0.003, Cohen’s D=0.16).  The was a significant inverse association 
between attendance and PHQ8 (p=0.000), and a significant positive association between 




 There was a significant interaction effect for time*primary CD diagnosis for PHQ8 
(p=0.038, Cohen’s D0.35) (figure 5.7), SWLS (p=0.049, Cohen’s D=0.37) (figure 5.8) and 
SWEMWBS (p=0.005, Cohen’s D=0.31) (figure 5.9).  There was a significant interaction effect 
for time*SCD or MM on SWEMWBS (p=0.043, Cohen’s D=0.08) (figure 5.10). 
  Individuals with respiratory disease had significantly higher PHQ8 score than those 
with cancer (p=0.043) at 3 m, CVD (p=0.022) and metabolic disease (p=0.025) at 6 m and those 
with CVD (p=0.000), metabolic disease (p=0.015) and cancer (p=0.000) at 12 m (Appendix J).   
 
Figure 5.7 8-item Patient Health Questionnaire BL – 12m for primary chronic disease diagnosis 
Dates presented as estimated marginal means and SEM 
































Individuals with respiratory disease had significantly lower SWL scores than those 
with cancer (p < 0.05) at BL and 6 m, and those with CVD (p=0.049) and cancer (p=0.000) at 
12 m (Appendix K).  
 
Figure 5.8 Satisfaction with Life Scale BL – 12m for primary chronic disease diagnosis 
Dates presented as estimated marginal means and SEM 
Note: CVD = cardiovascular disease; Neuro/MSK = neuromuscular/musculoskeletal disorders; PHQ8 = 8-item 































Individuals with respiratory disease had significantly lower SWEMWBS scores than 
those CVD (p = 0.008) and cancer (p = 0.001) at 12 m (Appendix L). 
 
Figure 5.9 The Short Warwick Edinburgh Mental Wellbeing Scale BL – 12m for primary chronic 
disease diagnosis 
Dates presented as estimated marginal means and SEM 
Note: CVD = cardiovascular disease; Neuro/MSK = neuromuscular/musculoskeletal disorders; SWEMWBS = The 



































There were no significant differences identified between those with SCD and MM 
for the SWEMWBS within the simple effects analysis. 
 
 
Figure 5.10 The Short Warwick Edinburgh Mental Wellbeing Scale BL – 12m single chronic 
disease and multimorbidity 
Dates presented as estimated marginal means and SEM 
Note: CD = chronic disease; SWEMWBS = The Short Warwick Edinburgh Mental Wellbeing Scale 
Psychosocial Determinants of Physical Activity    
 There was a significant main effect for time on barrier self-efficacy for exercise 
(p=0.042, Cohen’s D=0.10), self-regulatory self-efficacy for exercise (p=0.009, Cohen’s 
D=0.11) and intentions for exercise (p=0.001, Cohen’s D0.17).  Self-regulatory self-efficacy for 
exercise decreased between BL - 6 m (p=0.007, Cohen’s D=0.29) and intentions for exercise 
significantly decreased between BL - 6 m (p=0.001, Cohen’s D=0.06) and BL - 12 m (p=0.011, 
Cohen’s D=0.06).  Post hoc analysis did not indicate any significant differences in timepoints 
for barrier self-efficacy for exercise. There was significant positive association between 
attendance and barrier self-efficacy (p=0.007), self-regulatory self-efficacy (p=0.000) and 
























Psychosocial determinants of physical activity    
Change in MVPA was positively correlated with both change in self-regulatory self-
efficacy for exercise (r = 0.264, p=0.030) and the change in intentions for exercise (r = 0.321 
p=0.003).  Change in step count was significant correlated with the change in self-regulatory 
self-efficacy for exercise (r = 0.252, p=0.026) and the change in intentions for exercise (r = 
0.319 p=0.003).  Results are displayed in table 5.8.      
Table 5.8 Correlation between change in measures of physical activity and psychosocial 
determinants of physical activity between baseline - 12 months 
 LIPA MVPA Step count 
Psychosocial determents of physical activity r p r p r p 
Barriers to self-efficacy  for exercise .063 .570 .202 .068 .177 .110 
Self-regulatory self-efficacy for exercise .100 .385 .246 .030 .252 .026 
Intentions for exercise .204 .065 .321 .003 .319 .003 
Family support for physical activity .069 .650 .177 .238 .178 .238 
Friend support for physical activity .124 .554 .202 .333 .195 .349 
Note: LIPA = light intensity physical activity, MVPA = moderate to vigorous physical activity 










Participation in the MedEx Wellness CBER program was associated with a significant 
increase in LIPA, number and time spent in sedentary bouts of 11-30 min and total number 
of sedentary bouts. The observed effect size for all changes in PA and SB was small.  Greater 
attendance to the program was associated with improvements in LIPA, MVPA, step count, 
time in sedentary bouts > 60 min.  Significant improvements were also observed in measures 
of physical function, body composition and psychological health. Again all observed effect 
sizes where small, apart from CRF were a large effect size was identified for the change in this 
measures. With the exception of an increase in LDL-C, there was no significant change in any 
other of the other measured biomarkers. In addition, significant decreases in psychosocial 
determinants of PA were observed. Greater attendance was associated with improvements 
in body composition, all measures of psychological health, barrier self-efficacy for exercise, 
self-regulatory self-efficacy for exercise and intentions for exercise. Improvements occurred 
within 3 to 6 months of participation and were maintained at 12 months of participation. 
Significant interaction effects for time*primary CD diagnosis were observed for the CRF, 
symptoms of depression, satisfaction with life and positive mental health. The cancer cohort 
had higher CRF fitness across all timepoints, while those with respiratory disease were had 
significantly lower. Moreover, those with respiratory disease had less favourable measures of 
satisfaction with life and positive mental health. Significant interaction effects for time*SCD 
or MM were found for flexibility and positive mental health, however simple effects analyses 
did not indicate and differences between these groups.  
The findings from this study provide evidence that an integrated delivery model of 




functioning, body composition and positive mental health for individuals with a range of CDs 
and MM. Improvements in health-related outcomes as a result of CBER has been well 
documented in SCD cohorts (Gallé et al., 2019; Mendes et al., 2016, 2017; Bethell & Mullee, 
1990; Cramp et al., 2010; Kwan et al., 2016; Marsden et al., 2016; Taylor et al., 2016a; Amin 
et al., 2014; Beauchamp et al., 2013; Godtfredsen et al., 2019; Varas et al., 2018; Foley & 
Hasson, 2016; Foley et al., 2018; Knobf et al., 2014; Leach et al., 2015; Rajotte et al., 2012; 
Santa Mina et al., 2017). Surprisingly, relatively few studies have investigated the effects of 
CBER on habitual levels of PA and SB. The current findings indicate that CBER has the potential 
to positively impact both PA and SB. LIPA improved significantly, however whether the 
improvements are clinically meaningful is worth noting as the mean daily increase in LIPA 
between BL and 12 m was approximately 6 min. Furthermore, the findings provide 
preliminary evidence for the efficacy of a shared delivery model of CBER as a viable strategy 
in the secondary prevention of CD for those with both SCD and MM. Future studies should 
focus on optimising the various components of the MedEx Wellness shared CD model in order 
to inform best practice for CBER.  







Chapter 6  
Study III 
Factors Associated with Inter-Individual Variability in Response to 
Community-Based Exercise in a Diverse Chronic Disease Population 
Introduction  
PA and CRF are major indicators of health status and risk of mortality for healthy 
populations and those with CD (Bossenbroek et al., 2011; Laukkanen et al., 2002; Warburton 
et al., 2006).  Despite the strong evidence for PA and CRF, individuals with CD are reported to 
participate in low levels of PA (Hains-Monfette et al., 2019; Lauret et al., 2014; Lewis et al., 
2016; Pitta et al., 2005; Segura-Jiménez et al., 2015). 
CBER has been shown as an effective approach in increasing PA and CRF among 
individuals with CD (Gallé et al., 2019; Marsden et al., 2016; Pang et al., 2005; Santa Mina et 
al., 2017; Varas et al., 2018).  Results from studies examining the health-related changes in 
CD populations in response to PA interventions are normally presented as average statistics.  
However, there is normally large inter-individual variability in the measured outcomes in 
response to these programs.  In pulmonary rehabilitation research, approximately 25-30% of 
patients may be considered non-responders, where non improvements are observed in terms 
of health status and exercise tolerance (Garrod et al., 2006; Stoilkova-Hartmann et al., 2015). 
To date, there is currently a limited understanding of the factors that may predispose 




The term non-responder can be defined as the lack of a clinically meaningful change 
or the lack of a measurable change (Pickering & Kiely, 2019). Of greatest concern for 
healthcare professionals are adverse responses to exercise rehabilitation.  Adverse training 
responses have been reported during exercise rehabilitation studies.  In a review article of 6 
exercise interventions, Bouchard et al., (2012), found that 31% of participants had at least 
one adverse response, 6.0% had two and 0.8% showed ≥ 3 adverse responses.  In a 14 week 
CBER program for individuals with metabolic syndrome, where mean waist circumference, 
fasting glucose, HDL-C, TG and BP all significantly improved post intervention, the prevalence 
of an adverse cardiometabolic response was between 3.6% - 6.0% (Dalleck et al., 2015).  This 
is considered low, and the general consensus is that severe adverse events are very rare in 
exercise rehabilitation programs that follow evidence-based practice. 
Further research is warranted to identify factors within a CD population associated 
with response to CBER. Understanding both the genetic and non-genetic factors associated 
with inter-individual variability in response to exercise based rehabilitation programs will 
inform potential measure that could be deployed to reduce the number of non-responders. 
Non-genetic factors that could help to explain the inter-individual variability in response to 
exercise based rehabilitation include body weight, BL fitness, training history, training 
program, exercise prescription, nutritional status and mental health (Pickering & Kiely, 2019). 
Mann et al., (2014) undertook a detailed review on the phenomenon of ‘high-responders’ 
and ‘low-responders’ and suggested a better understanding of non-genetic training 
determinants of training responses would allow for the more individually tailored approach  
that would ensure optimal outcomes for all participants. Establishing the non-genetic factors 




implemented into such programs. This would allow for high risk participants of non-response 
to be identified from the onset and allow for strategies to be put in place which could reduce 
the risk of non-response. The current evidence base on the factors associated with non-
response however, remains under developed.   
The minimum clinically meaningful change, refers to changes in health-related 
outcomes as a result of treatment or intervention, which are meaningful to a CD patient or 
have importance in the clinical management for the patient (Cook, 2008; Sedaghat, 2019).  It 
is not uncommon for statistically significant changes to  have little clinical significance for 
patient cohorts (Jaeschke et al., 1989). Minimum clinically meaningful changes provide 
healthcare professionals with a systematic approach to interpreting certain treatment effects.  
A responder is the term used to describe a patient who has achieved a clinically meaningful 
improvement in a given health-related outcome (Copay et al., 2007).  
For patients with CD, the mediating role of PA in optimizing health is also of clinical 
importance. From a functional prospective, regular PA promotes mobility and reduces the 
risk for falls and fractures, which is vital in prevented dependency and institutionalisation in 
old age (Paterson & Warburton, 2010). For individuals with CD, maintaining independent 
living and preserving functional capacity, has direct implications on QoL and psychological 
health (Maresova et al., 2019). In addition, PA can attenuate the risk of developing MM, for 
those with an already established CD (Dhalwani et al., 2016). In terms of a PA intervention for 
CD, results which indicate no change, and therefore maintenance of health status also could 




A recent study found that only 50% of CD patients attending exercise rehabilitation 
achieved clinically meaningful changes in 6MWT distances,  at the end of the program (Barker 
et al., 2018). In addition, this study reported significant improvements in ability to perform 
activities of daily living, however only one third of participants improved to a level established 
as clinically meaningful in this measure. Although a third of participants achieving a clinically 
meaningful improvement as a result of an intervention may be considered an effective 
intervention, there is a need to understand why certain participants attain a beneficial 
response while others do not. The translation of evidence based interventions into clinical 
practice is a major challenge within clinical research. Developing strategies that optimes the 
patient response to interventions will assist in bridging this gap. To date, little information is 
available regarding the inter-individual responses to exercise rehabilitation programs 
involving patients with more than one CD. Although shared exercise rehabilitation offers 
numerous benefits, identifying factors associated with meaningful biological and behavioural 
responses could assist in program design and delivery.   
The primary aim of this study was to identify factors associated with an effective 
response to participation in a CBER, in terms of a measurable improvement, in men and 
women with SCD and MM. A secondary aim was to establish the minimum attendance at 
CBER needed to achieve measurable/clinically meaningful changes in selected indices of 
health. It was hypothesized that inter-individual variability in physical (activity behaviours and 
physical functioning), clinical or psychological health between men and women with SCD and 







The study used a quasi-experimental study.  Detailed methodology is described in 
Chapter 3.  In summary, individuals with one or more established CDs, primarily CVD, 
respiratory disease, metabolic disease, cancer or neuro/MSK disorders, were recruited at 
induction to the MedEx Wellness programme following referral from healthcare 
professionals. Following induction, participants were recommended to attend 2 supervised 
group exercise classes per week.  The classes were 60 min in duration and consisted of a 
combination of aerobic and resistance exercise.  Outcome measures that included PA, SB, 
physical function, blood biomarkers, mental health and psychosocial determinants of PA were 
assessed at BL and 3, 6 and 12 months.  
Health related outcomes that improved significantly in response to participation in a 
CBER program (chapter 5), were selected as dependent variables and used to explore 
predictors of achieving a measurable improvement.  The health related outcomes included 
were LIPA, CRF, lower body strength, upper body strength, waist circumference, hip 
circumference, number and time spent in sedentary bouts 11 to 30 min in duration, total 
number of sedentary bouts, symptoms of depression, self-rated health and satisfaction with 
life (Appendix M). Outcome variables that changed significantly, but unfavourably were not 
explored in further analysis.  These included LDL-C, barriers to self-efficacy for exercise, self-
regulatory self-efficacy for exercise and intentions for exercise showed.  The statistical 
analysis in chapter 5 indicated that there was a significant time main effect for the number of 




number of sedentary bouts. However, as the post hoc analysis did not identify specific time 
points of significant chances, these variables were not included in further analysis.  
In study 2 (chapter 5) a significant association was found between total number of 
classes attended between BL and 12 months and LIPA, MVPA, step count, time spent in 
sedentary bouts < 60 min, weight, BMI, hip circumference, symptoms of depression, self-
rated health, satisfaction with life, positive mental health, barriers to self-efficacy for exercise, 
self-regulatory self-efficacy for exercise and intentions for exercise (appendix N). These 
variables were selected to estimate the approximate number of attendance to MedEx 
Wellness classes requires to achieve a measurable change and a clinically meaningful change 
in each individual outcome measure. Defining a clinically meaningful change in barriers to 
self-efficacy for exercise, self-regulatory self-efficacy for exercise and intentions for exercise 
was deemed inappropriate and these variables were analysed in terms of a measurable 
change only.  
A measurable change was defined as an improvement in a health-related outcome 
of ≥0.01. A clinically meaningful change was defined as an improvement identified to have a 
meaningful impact on a participants health status, functional capacity and/or QoL. A non-
responder referred to participants who did not change from BL or regressed between BL and 
12m.     
Minimum clinically meaningful change  
Evidence based publications were reviewed to establish a threshold which could be 




Physical activity and sedentary behaviour 
Light intensity physical activity  
The volume of LIPA required to elicit health benefits is not yet known, and 
recommendations do not yet exist on the clinically meaningful change in LIPA for healthy 
populations or CD cohorts.  There is however, accumulating evidence to indicate that health-
related benefits of increasing LIPA are possibly independent to the amount of MVPA 
performed.  Khoja et al., (2016) found independent associations between LIPA and a variety 
of cardiometabolic health markers in patients with rheumatoid arthritis.  Each additional min 
of LIPA per day was associated with improvements in BMI, BP, insulin sensitivity, HDL-C and 
disability.  The PA and SB patterns of this cohort (9.8 h/d sedentary, 3.5 h/d in very low 
intensity activity, 2.1 h/d in LIPA and 36 min/d in MVAP) were comparable to the PA and SB 
reported of  the mixed chronic disease cohort of the current study (results chapter 4, study 
1).  Furthermore, each one min increase in LIPA/h during the waking day, was found to 
decrease the risk of mortality in healthy population and those with chronic kidney disease 
(Beddhu et al., 2015).  Based on these findings, an increase in LIPA  of ≥ 16 min/d was used as 
a threshold for a clinically meaningful change in LIPA.  
Moderate to vigorous physical activity 
Strong evidence supports that even small increases in MVPA can confer significant 
health-benefits for individuals with CD (Warburton & Bredin, 2016).  A generalized minimum 
clinically meaningful change has yet to be established for MVPA.  Hur et al., (2019) recently 




meaningful difference for patients with interstitial lung disease. An increase of ≥ 26 min/week 
in MVPA between BL and 12 months was used as a threshold for a clinically meaningful 
change in MVPA.   
Step count 
Estimations of clinically meaningful changes in step count are limited, particularly in 
CD. A study in COPD estimated the minimal clinically important change for COPD to range 
between 600 to 1100 steps/day (Demeyer et al., 2016).  An increase in daily step count of ≥ 
1100 was used as a threshold for a clinically meaningful change in MVPA.  
Time in sedentary bouts > 60 min 
Guidelines recommending changes in SB are yet to be established. A 
recommendation of reducing total SB by 60 min a day has been proposed (Dempsey et al., 
2016). As there are no specific evidence based recommendations applicable to time spent in 
sedentary bouts > 60 mins, only a measurable change in this variable was analysed.    
Physical function 
Six minute timed trial 
Self-paced walk run tests have been established as valid tool for estimating CRF 
(Mayorga-Vega et al., 2016).  The current study used a modified version of the 6 min walk 
test, in which participants where allow to run, walk or a combination of both to complete the 




Numerous studies have established a clinically meaningful change in the 6 min walk 
test across a variety of disease groups.  There estimations range from 34.3 m to 82 m in 
studies including Alzheimer’s disease, geriatric participants, stroke, osteoporosis, Parkinson’s 
disease and pulmonary diseases (Eng et al., 2004; Flansbjer et al., 2005; Kennedy et al., 2005; 
Perera et al., 2006; Rasekaba et al., 2009; Redelmeier et al., 1997; Ries et al., 2007; Steffen & 
Seney, 2008).   More recently, in a systematic review by Bohannon and Crouch (2017) the 
minimal clinical change for 6MWT was estimated as between 14 – 30.5 m across multiple 
patient groups.  
Based on the Bohannon and Crouch’s most recent research, incorporating a mixed 
CD cohort, which is a useful comparison to the current study, an improvement of ≥ 30.5 m 
was used as a threshold for a clinically meaningful change in 6MTT. Caution with the 
interpretation of this analysis is considered as the current estimate is based on the walk only 
test. 
Sit to stand 
The present study used a 10-repatition protocol for the sit to stand test. Based on 
the 5 repetition sit to stand test, minimal clinical different ranges from -1.7 s to 3.1 s (Jones 
et al., 2013b; Vaidya et al., 2017).  A decrease in time of ≥ 3.1 s was used as a threshold for a 
clinically meaningful change in sit to stand.  Similar to the 6MTT, caution with the 
interpretation of this analysis is considered as the current estimate is based on the 5 





Clinically meaningful changes in handgrip strength using a handgrip dynameter have 
been estimated to range from 5.0 kg – 6.2 kg in healthy populations and those with CD 
(Bohannon, 2019; Lang et al., 2008; Nitschke et al., 1999).  A threshold improvement of ≥ 5.0 
kg was used as a threshold for a clinically meaningful change in handgrip. 
Body composition 
Weight  
A 5% reduction in weight from a BL measures has been defined as clinically significant 
and is associated with significant improvements cardiometabolic health (Donnelly et al., 2009; 
Williamson et al., 2015). A threshold of ≥ 5% reduction in weight was as a threshold for a 
clinically meaningful change in weight. 
Note: Changes in BMI between BL and 12 m in the present study will be 
fundamentally the product of changes in weight as BMI is a composite score which includes 
weight as a primary component. BMI was not included in further analysis.   
Waist Circumference 
Verweij et al., (2013) suggest that a clinically meaningful change in waist 
circumference lies within the range of 3.0 cm and 6.8 cm.  Cerhan et al., (2014) found in a 
pooled analysis of 650,000 adults, that for each 5 cm increment in waist circumference the 




BMI.  A decrease in waist circumference of 5 cm was used as a threshold for a clinically 
meaningful change in waist circumference.  
Hip Circumference 
The focus on changes in body composition, with regards to waist and hip 
measurements, have primarily focused on waist circumference and WHR (World Health 
Organization, 2011b).  Hip circumference alone does not effectively represent body 
composition (Mbanya et al., 2015), and was therefore not included in further analysis. 
Psychological health  
8-item Patient Health Questionnaire 
The PHQ8 categorizes individuals by severity of depression ranging from 
none/minimal to severe.  A 5 point decrease indicates an improvement in severity category   
(Kroenke & Spitzer, 2010).  A decrease in score of ≥ 5 was used as a threshold for a clinically 
meaningful change in PHQ8.  
EuroQoL-Visual Analogue Scale 
Zanini et al., (2015) estimated a minimal clinically important change in EQ-VAS 
scores, for patients with COPD as an increase of eight points.  Similarly, Chen et al., (2016a) a 
minimal clinically important different in stroke patients as 8.6 to 10.8 points. An increase in 




Satisfaction with Life Scale 
The satisfaction with life scale is a measurement tool of the life satisfaction 
component of subjective wellbeing.  Total scores are accumulated and results range from 
“extremely satisfied” to “extremely dissatisfied”.  An increase in score ≥ 5 results in an 
improvement in overall life satisfaction (Diener, 2006).  An increase in score of ≥ 5 was used 
as a threshold for a clinically meaningful change in SWLS.   
The Short - Warwick Edinburgh Mental Wellbeing Scale 
The SWEMWBS is a tool used to monitor positive mental health.  The minimal 
detectable change in the SWEMWBS is estimated as a change in score by ≥ 3 points (Warwick 
Medical School, 2019).  An increase in score of ≥ 3 points was used as a threshold for a 
clinically meaningful change in SWEMWBS.   
Statistical analysis 
Health-related outcomes where a significant main effect for time was identified in 
study 2 (chapter 5) were used to classify participants in groups representing response 
category, based on absolute change achieved.  The absolute change between BL and 12 
months for measures of 6MTT, sit to stand, handgrip, waist circumference, PHQ8 and EQ-VAS, 
and between BL and 6 months for measures of LIPA and SWLS was computed on IMB SPSS 
statistics software (version 25). Participants were classified into three groups for descriptive 
analysis: i) non-responder = no change in measure variables or a negative change, ii) 




meaningful change = an improvement equal to or above the identified clinically meaningful 
value in the measured variable.   
Binary logistic regression models were used to assess factors associated with 
achieving a measurable change in health-related outcomes where a significant main effect 
for time was found in study 2 (chapter 5).  Based on the absolute change of each health-
related measure, participants where stratified into 2 groups: 0 = non-responder; 1 = 
measurable change achieved. The dichotomous variables representing non-response or 
measurable change achieved were used as dependent variables in binary logistic regression. 
Age, sex, primary CD diagnosis, SCD or MM, smoking status and BL measures of the specific 
dependent variable were included as independent variables. Contingency table results were 
used to estimate the accuracy of the predictive model, based on the percentage of cases 
correctly classified. The model discrimination was assed using relative operating 
characteristics (ROC) curves. The area under the curve (AUC) was generated using the 
predicted probabilities values (test variable) and non-response or measurable change 
achieved (state variable) (Chan, 2004).  The ROC analysis results were interpreted as follows: 
AUC ≥ 0.60 indicated poor discriminatory ability, AUC = 0.61 – 0.70 fair discriminatory ability 
and AUC > 0.70 = good discriminatory ability (Mandrekar, 2010). P-values reported were not 
adjusted for multiple testing.       
Health-related variables where a significant main effect for attendance was 
identified in study 2 (chapter 5), were investigated to assess if a corresponding attendance 
value could be estimated which is associated with achieving a measurable change and a 




step count, weight, BMI, PHQ8, EQ-VAS, SWLS, WEMWBS, Barriers to Self-Efficacy for Exercise 
Scale, Self-Regulatory Self-Efficacy for exercise and Intentions for Exercise were computed 
using SPSS statistical package v25.  Based on the absolute change of each health-related 
measures and psychosocial determinant of PA, participants where stratified into 2 groups 
representing non-response (0 = non-responder) and achieving a measurable change  (1 = 
measurable change achieved). In addition, based on the absolute change of each health-
related measures, participants were stratified in to 2 groups representing non-response (0 = 
non-responder) and achieving a clinically meaningful change (1 = clinically meaningful change 
achieved).  Dichotomous variables were used in binary logistic regression models as 
dependent variables.  Number of sessions attended between BL and 12 months were used as 
independent variables.  The intercept value for each model was divided by the parameter 
estimate to calculate the point in attendance that corresponds to a change from non-
response to both achieving a measurable change and a clinically meaningful change. Only 
models with a p > 0.05 were interpreted to estimate number of attendance required for 
achieving a measurable change or a clinically meaningful change. P-values reported were not 








A total of 403 participants were recruited for this study with 206 participants 
completing the trial.  Participant characteristics are presented in the results section of chapter 
4 and reasons for drop out are presented in the results section of chapter 5.  In summary, the 
mean age was 62.98 ± 11.00 years and 50.6% were male. The prevalence of achieving a 
positive measurable change in ≥1 health-related variable was 92.2%.  In addition, 86.4% of 
participants achieved a measurable change in ≥ 1 health-related variable while also being 











Predictors of achieving a measurable change 
Light Intensity Physical Activity  
A total of 121 participants had valid BL and 6 months LIPA data, with 38.0% classified 
as non-responders (a decrease in LIPA ≥ 0 hr) and 62.0%  achieving a measurable change (an 
increase in LIPA ≥ 0.01 hr) (figure 6.1). A clinically meaningful improvement in LIPA was 
achieved by 25.6% of participants (an increase in LIPA ≥ 0.26 hr).  
 
Figure 6.1 Inter-individual variability for change in light intensity physical activity between 
baseline and 6 months 
Note: LIPA = light intensity physical activity; hr = hours 
 
The logistic regression was statistically significant X2(11) = 27.51, p=0.004.  The model 
correctly classified 68.7% of cases. The AUC for predicted probabilities was 0.76 (SE 0.05, 
p=0.000, 95% CI 0.67 – 0.85).  A lower BL LIPA increased the likelihood of achieving a 
measurable increases in LIPA (ß=-1.65, OR 0.19, 95% CI 0.06 – 0.60, p=0.005).  In addition, a 
primary CD diagnosis of metabolic disease decreased the likelihood of achieving a measurable 

































6 minute timed trial 
A total of 198 participants completed the 6MTT at BL and 12 months, with 19.2% 
classified as non-responders (a decrease in 6MTT ≥ 0 m) and 80.8%  achieving a measurable 
change (an increase in 6MTT ≥ 0.01 m) (figure 6.2). A clinically meaningful change in 6MTT 
was achieved by 65.7% of participants (an increase in 6MTT  ≥ 30.5 m).  
 
Figure 6.2 Inter-individual variability for change in six minute timed trial between baseline - 
12 months 
Note: 6MTT = 6 minute timed trial; m = metres  
 
The logistic regression was statistically significant X2(11) = 24.97, p=0.009.  The model 
correctly classified 81.8% of cases. The AUC for predicted probabilities was 0.76 (SE 0.05, 
p=0.000, 95% CI 0.68 – 0.84). Increasing age reduced likelihood of achieving a measurable 
change in 6MTT (ß=-0.08, OR 0.93, 95% CI 0.87 – 0.98, p=0.008) and lower 6MTT at BL  
reduced likelihood of achieving a measurable change (ß=0.01, OR 1.01, 95% CI 1.00 – 1.04, 





































Sit to stand 
A total of 201 participants completed sit to stand at BL and 12 months, with 20.9% 
classified as non-responders (an increase in STS ≥ 0 sec) and 79.1%  achieving a measurable 
change (a decrease in STS ≥ 0.01 sec) (figure 6.3). A clinically meaningful change in sit to stand 
was achieved by 54.7% of participants (a decrease in STS ≥ 3.1 sec).  
 
Figure 6.3 Inter-individual variability for change in sit to stand between baseline - 12 months 
Note: STS = sit to stand; sec = seconds  
 
The logistic regression was statistically significant X2(11) = 25.19, p=0.009.  The model 
correctly classified 81.5% of cases. The AUC for predicted probabilities was 0.74 (SE 0.04, 
p=0.000, 95% CI 0.66 – 0.83).  A higher BL sit to stand score, an indication of decreasing lower 
body strength, increased likelihood of achieving a measurable change in sit to stand (ß=0.12, 
OR 1.13, 95% CI 1.04 – 1.23, p=0.006). In additional, a primary CD diagnosis of cancer 
increased the  likelihood of achieving a measurable change in sit to stand (ß=2.10, OR 8.17, 






































A total of 205 participants completed handgrip at BL and 12 months, with 42.9% 
classified as non-responders (a decrease in HG ≥ 0 kg) and 57.1% achieving a measurable 
change (an increase in HG ≥ 0.01 kg) (figure 6.4). A clinically meaningful change in handgrip 
was achieved by 17.6% of participants (an increase in HG ≥ 5 kg). 
 
Figure 6.4 Inter-individual variability for change in handgrip between baseline - 12 months 
Note: HG = handgrip; kg = kilograms  
 
The logistic regression was statistically significant X2(11) = 23.99, p=0.013.   The 
model correctly classified 63.6% of cases. The AUC for predicted probabilities was 0.70 (SE 
0.04, p=0.000, 95% CI 0.62 – 0.77).  Increasing age reduced the likelihood of achieving a 
measurable change in handgrip (ß=-0.05, OR 0.95, 95% CI 0.92 – 0.99, p=0.011) whereas a 
poor handgrip score at BL increased the likelihood of achieving a measurable change (ß=-
0.11, OR 0.90, 95% CI 0.85 – 0.95, p=0.000).  Finally, women were less likely to achieve a 


































A total of 203 participants completed waist measurements at BL and 12 months, with 
23.3% classified as non-responders (an increase in waist circumference ≥ 0 cm) and 76.8%  
achieving a measurable change (a decrease in waist circumference ≥ 0.01 cm) (figure 6.5).  A 
clinically meaningful change in waist circumference was achieved by 42.6% of participants (a 
decrease in waist circumference  ≥ 5 cm).  
 
Figure 6.5 Inter-individual variability for change in waist circumference between baseline - 12 
months 
Note: WC = waist circumference; cm = centimetres  
 
The logistic regression was statistically significant X2(11) = 33.51, p=0.000.  The model 
correctly classified 79.3% of cases. The AUC for predicted probabilities was 0.78 (SE 0.04, 
p=0.000, 95% CI 0.70 – 0.86).  A higher waist circumference at BL increased the likelihood of 
achieving a measurable change in waist circumference (ß=0.04, OR 1.04, 95% CI 1.01 – 1.08, 
p=0.025).  Current or past smokers were less likely to achieve a measurable change in waist 
circumference compared to those who never smoked (ß=-1.09, OR 0.34, 95% CI 0.13 – 0.83, 

































8-item Patient Health Questionnaire 
A total of 139 participants completed PHQ8 at BL and 12 months, with 47.5% 
classified as non-responders (an increase in PHQ8 score > 0) and 52.5%  achieving a 
measurable change (a decrease in PHQ8 score ≤ 0.01) (figure 6.6).  A clinically meaningful 
change in PHQ8 was achieved by 13.7% of participants (a decrease in PHQ8 score ≥ 5). 
  
Figure 6.6 Inter-individual variability for change in 8-item Patient Health Questionnaire 
between baseline - 12 months 
Note: PHQ8 = 8-item Patient Health Questionnaire 
 
The logistic regression was statistically significant X2(11) = 36.71, p=0.000.  The model 
correctly classified 77.6% of cases.  The AUC for predicted probabilities was 0.81 (SE 0.04, 
p=0.000, 95% CI 0.73 – 0.89).  A high PHQ8 score at BL, indicating increased symptoms of 
depression, increased the likelihood of achieving a measurable change in PHQ8 (ß=0.31, OR 






































EuroQoL Visual Analogue Scale 
A total of 149 participants completed EQ-VAS at BL and 12 months, with 44.3% 
classified as non-responders (a decrease in EQ-VAS score ≤ 0) and 57.7% achieving a 
measurable change (an increase in EQ-VAS score ≥ 0.01) (figure 6.7). A clinically meaningful 
change in EQ-VAS was achieved by 39.6% of participants (an increase in EQ-VAS score ≥ 10). 
 
Figure 6.7 Inter-individual variability for change in EuroQoL Visual Analogue Scale between 
baseline - 12 months 
Note: EQ-VAS = EuroQoL Visual Analogue Scale 
 
The logistic regression was statistically significant X2(11) = 49.77, p=0.000.  The model 
correctly classified 74.5% of cases.  The AUC for predicted probabilities was 0.83 (SE 0.04, 
p=0.000, 95% CI 0.66 – 0.90).  Increasing age reduced the likelihood of achieving a measurable 
change in EQ-VAS (ß=-0.06, OR 0.94 95% CI 0.89 – 0.99, p=0.028).  A primary CD diagnosis of 
a respiratory disease reduced the likelihood of achieving a measurable change in EQ-VAS (ß=-










































Satisfaction with Life Scale 
A total of 176 participants completed SWLS at BL and 6 months, with 53.4% classified 
as non-responders (a decrease in SWLS score ≤ 0) and 46.6% achieving a measurable change 
(an increase in SWLS score ≥ 0.01) (figure 6.8).  A clinically meaningful change in SWLS was 
achieved by 17.6% of participants (an increase in SWLS score ≥ 5). 
 
Figure 6.8 Inter-individual variability for change in Satisfaction with Life Scale between 
baseline and 6 months 
Note: SWLS = Satisfaction with Life Scale 
 
The logistic regression was statistically significant X2(11) = 38.27, p=0.000.  The model 
correctly classified 66.5% of cases. The AUC for predicted probabilities was 0.77 (SE 0.04, 
p=0.000, 95% CI 0.70 – 0.84). A lower SWLS at BL, increased the likelihood of achieving a 








































Estimated number of classes attended to achieve measurable/clinically meaningful 
improvements. 
Significant binary logistic regression models (p ≤ 0.05) for LIPA, barriers to self-
efficacy for exercise and, intentions for exercise were identified and used to estimate the 
number of attended classes required to achieve a measurable change in each of the three 
variables.  It was estimated that attending a mean of 13.3 classes was required to achieve a 
measurable change in LIPA, attending a mean of 41.3 classes was required to achieve a 
measurable change in Barriers to Self-Efficacy for Exercise and attending a mean of 51.8 
classes was required to achieve a measurable change in Intentions for Exercise. Results 
displayed in table 6.1      
Significant binary logistic regression models (p ≤ 0.05) for step count and weight 
were found and used to estimate number of attended classes required to achieve a clinically 
meaningful change in each variable.  It was estimated that attending  a mean of 70.5 classes 
was required to achieve a clinically meaningful change in step count and attending a mean of 
146.8 classes was required to achieve a clinically meaningful change in weight. Results 




Table 6.1 Binary logistic regression results used to estimate required number of attendance for achieving a measurable change and clinically 
meaningful change in health related measures and psychosocial determinants of physical activity 
 Measurable change Clinically meaningful change 
Variable β ± SE Intercept No of attendance p β ± SE Intercept No of attendance p 
LIPA .017 ± .008 -.226 13.3 .036 .007 ± .008 -1.354 193.4 .425 
MVPA .004 ± .007 -.028 7.0 .608 .002 ± .008 -.698 349.0 .797 
Step count .012 ± .008 -.172 14.3 .117 .017 ± .008 -1.199 70.5 .029 
Time spent in bouts > 60 min .008 ± .007 -.307 38.4 .283 - 
Weight .011 ± .006 .057 5.2 .065 .015 ± .007 -2.202 146.8 .042 
PHQ8 .006 ± .007 -.089 14.8 .405 .002 ± .010 -1.905 952.5 .842 
EQ-VAS .003 ± .007 .113 37.7 .657 .003 ± .007 -.538 179.3 .679 
SWLS -.004 ± .007 .232 58.0 .534 -.011 ± .010 -1.263 114.8 .250 
SWEMWBS -.005 ± .007 .055 11.0 .491 -.002 ± .007 -.820 410.0 .779 
Barriers to self-efficacy for exercise .029 ± .008 -1.198 41.3 .000 - 
Self-regulatory self-efficacy for exercise .011 ± .007 -.997 90.6 .142 - 
Intentions for exercise .041 ± .009 -2.125 51.8 .000 - 
Numbers in BOLD indicate p ≤ 0.05  
Note: LIPA = light intensity physical activity; MVPA = moderate to vigorous intensity physical activity; PHQ8 = 8-item Patient Health Questionnaire; EQ-VAS = EuroQoL Visual 
Analogue Scale; SWLS = Satisfaction with Life Scale; SWEMWBS = The Short - Warwick Edinburgh Mental Wellbeing Scale 
Note: Within 12 months if participants attended: 2 classes/wk, total available classes = 96; 3 classes/wk, total available classes = 138; 5 classes/wk, total available classes = 







Almost all participants (92.2%) achieved a measurable improvement in at least one 
health related measures after participation in the MedEx Wellness CBER program. For 
measures of LIPA (OR=0.19), lower-body strength (OR=1.04), upper-body strength (OR=0.90), 
waist circumference (OR=1.04), symptoms of depression (OR=1.37) and satisfaction with life 
(OR=0.89), a worse result at BL, increased likelihood of achieving a measurable change. In 
contrast, a better measure at BL of CRF increased likelihood of achieving a measurable change 
in this measures (OR=1.01). Older participants were less likely to improve CRF (OR=0.93), 
handgrip (OR=0.95) and self-rated health (OR=0.94). Women were less likely to improve 
upper-body strength (OR=0.18). Individuals with a primary diagnosis of metabolic disease and 
respiratory diseases were less likely to improve on measures of LIPA (OR=0.07) and self-rated 
health (OR=0.01), respectively. Individuals with cancer were more likely to improve lower-
body strength (OR=8.17).  
It was estimated that attending 13.3 classes, 41.3 classes and 51.8 classes was 
required to achieve a measurable improvement in LIPA, barriers to self-efficacy for exercise 
and intentions for exercise, respectively. In addition it was estimated that attending 70.5 
classes, 146.8 classes and 66.3 classes was required to achieve a clinically meaningful 
improvement in step count, weight and barriers to self-efficacy for exercise, respectively.  
A consistent finding of the present study was the large inter-individual variability in  
response to CBER among a diverse CD population. A lower levels of BL PA, strength, body 
composition and psychological health was associated with an increased likelihood of 




ethnic origin had a minimal effect on the training response, but that pretraining submaximal 
HR and BP were associated with a positive response to exercise. Surprisingly, a lower level of  
BL CRF decreased the likelihood of achieving an improvement in this measure in the current 
study. It is possible that participants with low CRF were  limited in their ability to exercise at 
an intensity required to elicit positive CRF related adaptations. This is supported by Kaminsky 
et al., (2013) who found that low CRF levels may limit participation in MVPA.  There is 
currently a need to expand our understanding of the factors associated with non-response to 
exercise rehabilitation in order to identify non-responders and to tailor programs to minimise 

















Currently, almost half of the world’s adult population suffers from at least one CD, 
with steadily increasing numbers living with MM (Hernández et al., 2019; Kingston et al., 
2018).  The implications of this epidemic are far-reaching (Booth et al., 2011; Suhrcke et al., 
2006). In particular, CD places an overwhelming strain on healthcare resources (Cronin et al., 
2017; Smyth, 2017) and a considerable burden on patients, including limiting ADL and 
impacting QoL (Harris & Wallace, 2012; Moorman et al., 2007).  MM is associated with an 
even higher risk of premature death, hospital admission, reduced functional capacity and QoL 
compared to those with a SCD (Bayliss et al., 2004; Fortin et al., 2005; Smith & O’Dowd, 2007; 
Wallace et al., 2015).   
A series of studies were undertaken to: i) determine the levels of PA and SB in a 
mixed CD cohort and to investigate the associations of PA and SB with selected indices of 
health; ii) evaluate the effects of CBER on PA levels, SB and selected indices of health in a 
mixed CD cohort and iii) investigate factors associated with a favourable response to CBER in 
a mixed CD cohort.   
Limited research to date has investigated levels of PA and SB in a mixed CD cohort 
which also includes individuals with MM. In addition a range of methods have been employed 
to measure PA and SB in specific CD groups, and this has prevented comparison between 




not differ between specific CD cohort or between those with a SCD and MM. This evidence 
suggest a need to move away from segregated interventions for improving PA and SB levels 
within the CD cohort and employing an integrated approach.  
This research provides evidence that an integrated delivery model of CBER is an 
effective approach to increasing PA levels, reducing SB and improving physical functioning, 
body composition and positive mental health for individuals with a range of CDs and MM. The 
evidence supporting this novel approach to CBER delivery has immense implications for 
practical application within the healthcare setting.  
The final study of this thesis highlighted the inter-individual variability to exists in the 
response of individuals with CD to CBER. Notably, specific CD diagnosis or the presence of 
MM has little impact on response to CBER.  BL measures of fitness were identified as primary 
factors determining response to the program. Such findings provide evidence for the ability 
to create a profile of individuals as risk of non-response, identify these individuals at BL and 
implement strategies to reduce the risk of non-response for CD patients attending CBER.  
Study 1  
According to the current WHO guidelines, individuals with CD should accumulate a 
minimum of 150 min of MVPA per week (World Health Organization, 2010) and/or at least 
10,000 steps per day to optimise health status (Tudor-Locke et al., 2011a).  The community-
dwelling CD population in the present study fall short of both PA recommendations, with a 
mean MVPA and daily step count of 126 min per week (18 min.day-1) and 6700 steps per day, 




MVPA has been described as 17 min per day in adults with T2DM (Wang et al., 2017), 7.0 to 
16.5 min per day in patients with COPD (Bernard et al., 2018; Eliason et al., 2011), 8.6 min per 
day among those with heart failure, 11.4 min per day in individuals with angina (Evenson et 
al., 2014), 10 min per day in cancer survivors (Loprinzi et al., 2013), and 3.7 min per day in 
breast cancer survivors (Lynch et al., 2010). Of the participants in this study 36.3% were found 
to meet the PA guidelines for MVPA. This is lower than what has previously been reported in 
healthy adult populations. Recent evidence in the US and Ireland reported that 45% and 48% 
of adults populations meeting the guidelines for MVPA, respectively (Mc Dowell et al., 2020; 
Zenko et al., 2019). For participants that were meeting or above the recommended levels of 
MVPA significantly more favourable measures of aerobic fitness and body composition with 
large effect sizes and self-rated health with a medium effect size were observed.   
Historically, PA guidelines have focused primarily on MVPA.  There is now increasing 
awareness of the importance of LIPA for maintaining and enhancing health. A worrying find 
from the current study is the mean levels of LIPA (1.1 h per day). This is lower than what has 
previously been reported in CD populations.  Mean daily LIPA has been described as 4.5 h per 
day in LIPA in individuals with a history of breast cancer (Lynch et al., 2010), 5.5 h per day in 
individuals with rheumatoid arthritis (Khoja et al., 2016) and 5.8 h per day in patients with 
T2DM (Healy et al., 2007). More comparable findings have been reported individuals with 
intermittent claudication at one h per day of walking and 21 min per day shuffling (Lauret et 
al., 2014).  
There is accumulating evidence that significant health-related benefits are 
associated with LIPA and standing.  Beddhu et al., (2015) found that an increase of 2 min per 




disease. LIPA has also been associated with a reduced risk of hospitalization, waist 
circumference and blood glucose levels in individuals with COPD (Donaire-Gonzalez et al., 
2015; Park & Larson, 2014); cholesterol, waist circumference and risk of visual impairments 
in diabetics (Loprinzi et al., 2014; Loprinzi & Pariser, 2013); and HDL-C and total cholesterol in 
individuals with MM (Li et al., 2019). Recent evidence has demonstrated that reallocating 30 
min of sleep, sedentary time or standing with LIPA is associated with marked improvements 
in BMI, body fat and fat mass in older adults (Powell et al., 2020).  Increasing LIPA may be a 
more attainable goal among individuals with CD who are unable to achieve the daily 
recommended min of MVPA due to a reduced functional capacity. The current study 
promotes that targeting LIPA within CD populations is warranted, as low levels of LIPA within 
this population are established. Moreover, no differences in LIPA were found between 
different CD diagnosis or those with SCD and MM. Emphasising the message that 'some 
activity is better than none' (US Department of Health and Human Services, 2018a) should be 
considered as an target for intervention, with potential to elicit substantial health benefits. 
Research is required to establish feasible and scalable interventions which increase PA 
participation of any intensity within CD populations. 
Daily step count is a useful means of capturing daily PA behaviour as it measures all 
locomotion across the day encompassing both LIPA and MVPA (Tudor-Locke et al., 2011b).  
Furthermore, step count can be easily translated into guidelines and simplifies the exercise 
prescription procedure for both practitioners and patients (Dasgupta et al., 2014).  A 
threshold of 10,000 steps per day is currently recommended for optimal health benefits (Choi 




The total daily step count of the CD population in the present study was 6713 steps 
per day. This is in the typical range for CD cohorts and is categorised as ‘low active’ (Tudor-
Locke et al., 2008).  The currenting findings are in line with the mean daily step count reported 
in previous research. Parkinson’s disease patients were found to have a daily step count 
ranging from 4,765 to 5,423 steps per day (Benka Wallén et al., 2015; Christiansen et al., 2017; 
Lord et al., 2013).  Yates et al., (2014) reported a daily step count of 6,245 steps per day in 
almost 10,000 individual with impaired glucose tolerance while Lauret et al., (2014), reported 
a lower daily step count of 5,212 steps per day among patients with intermittent claudication.  
Among COPD patients, daily step count ranges from 4,782 to 7,232 steps per day, with 
increasing daily step count associated with a reduction in disease severity (Bernard et al., 
2018; Moy et al., 2012).   
An important finding in the present study was the significant association between 
step count and body composition, CRF and self-rated health indicating that a higher step 
count among individuals with a CD may positively impacts functional capacity, body 
composition and perception of health status. Effect sizes for these associations ranged from 
medium to large. Although the current evidence is correlational, research advocates the PA 
is the behaviours that impacts health outcomes (Blair, 2001). Among individuals with 
impaired glucose tolerance, each 2000 steps per day increment was associated with a 10% 
reduction in risk for a cardiovascular event (HR 0.9; 95% CI 0.81 to 1.01) (Yates et al., 2014).  
A increase in daily step count is associated favourable changes in BP, BMI, waist 
circumference and HbA1c in women with T2DM (Manjoo et al., 2012; Manjoo et al., 2010). 




significant reductions in waist circumference (-4.6cm; 95% CI -6.4 to -2.8 cm) and BMI (-1.6 
kg/m2; 95% CI -2.4 to -0.8 kg/m2) and a decline in HbA1c of 0.16% (95% CI 0.35% to 0,04%) 
(Manjoo et al., 2012). A 1000 daily step count increment was associated with a -2.6mmHg 
(95% CI; -4.1 to -1.1 mmHg) and a -1.4 mmHg (95% CI; -2.2 to -0.6 mmHg) change in systolic 
and diastolic BP, respectively (Manjoo et al., 2010). Severity of airflow obstruction and 
markers of systematic inflammation are associated with daily step counts among COPD 
patients (Moy et al., 2014; Saunders et al., 2016).  A recent longitudinal study in 16,741 
women (mean age 72.0 y) revealed that increasing daily step count evoked a steady decline 
in mortality rates, which appeared to reach a plateau at 7,500 steps per day (Lee et al., 2019). 
Per increase in daily step count quartiles from lowest to highest the corresponding HR were 
0.54 (95% CI 0.43 to 0.69), 0.47 (95% CI 0.35 to 0.62) and 0.34 (95% CI 0.24 to 0.48), 
respectively. Notably, the reduce risk of mortality among the women who increased their 
daily step count from 2,700 to 4,400 steps per day was approximately 46%. These findings 
provide strong encouragement for individuals restricted in their ability to achieve 10,000 
steps/day and those in the lowest quartile of daily step count.   
Compared to healthy populations, the CD cohort are markedly less physically active. 
In a population based study, the prevalence of self-reported low PA, classified as “mostly 
sitting down during leisure time”, was highest in COPD (84.2%), followed by rheumatoid 
arthritis (74.4%), diabetes mellitus (72.5%) and finally healthy subjects (60.2%) (Arne et al., 
2009).  Similarly, Brawner et al., (2016) found lower levels of self-reported leisure time PA 
across all CD categories compared to healthy comparisons, with the lowest levels found in 
individuals following a myocardial infarction, diabetes, kidney disease, stroke and COPD.  




matched controls (Pitta et al., 2005).  In the present study , there was no significant difference 
in PA or SB between different primary CD diagnosis or between those with SCD or MM. A 
recent Canadian National Health Survey, also reported no difference in PA or SB between 
individuals with 1, 2 or ≥ 3 CDs (Hains-Monfette et al., 2019).  Efforts to increase PA and 
reduce SB can apply to all individuals with a CD diagnosis, regardless of condition or severity.  
The fact that participants in the current study spent on average 9.5 h of the waking 
day sedentary is alarming considering that SB is associated with increased BMI, waist 
circumference and TG, and decreased HDL-C and VO2peak (Prince et al., 2016). A recent meta-
analysis found a positive dose-response relation between sitting time and CVD, and between 
cancer and all-cause mortality (Zhao et al., 2020).  Not surprisingly, an increased risk of MM 
is associated with SB (Vancampfort et al., 2017).  Zhao et al., (2020) found that the risk of 
mortality associated with SB was amplified in participants with T2DM and hypertension, 
suggesting that SB in combination with CD is more likely to have a damaging impact on health.  
High levels of MVPA can attenuate the negative effects of prolonged SB (Ekelund et al., 2016) 
however, individuals with CD are limited in their ability to achieve the required levels.  A 
definitive threshold of too much SB is yet to be established and current recommendations on 
the daily amount of SB remain vague.  The inverse association between SB and the factor 
representing functional capacity and self-efficacy for exercise is a novel findings and is worthy 
of further investigation. Moreover the effect size of this association was interpreted as large. 
This finding suggest that increasing SB may not only limit an individual’s functional capability 
to be active, but can also reduce their exercise self-efficacy. Hence a vicious cycles onsets. 




meta-analysis reported preliminary evidence that there is a significant inverse association 
between individual’s SB and their self-efficacy to reduce it (Szczuka et al., 2019).  
The pattern in which sedentary time is accumulated is also of clinical relevance.  
Prolonged and less fragmented SB has been associated with less favourable cardiometabolic 
and inflammatory biomarkers, poorer physical function, increased risk of abdominal obesity, 
greater BMI and increased risk of developing CD and depression (Dunstan et al., 2012; Healy 
et al., 2011; Jefferis et al., 2015; Judice et al., 2015; Sardinha et al., 2015).  Among participants 
in the present study, the majority of SB was accumulated in bouts lasting > 30 min, with 
approximately one third of SB accumulated in bouts > 60 min.  Increasing breaks in SB is 
associated with favourable measures of BMI, waist circumference, HDL-C, triglycerides, and 
glucose control, independent of total sedentary time (Bankoski et al., 2011; Dunstan et al., 
2012; Healy et al., 2008a).  Dorhn et al., (2018) recently reported that breaks in SB involving 
LIPA was associated with reduced risk of all-cause and cardiovascular mortality.   
Similar to step count, a specific target for total SB or bout length of sedentary 
behaviour has not yet been identified.  In conjunction with increasing PA levels, current 
guidelines in the US are now promoting the reduction of SB and prolonged bout of SB (US 
Department of Health and Human Services, 2018a).  Other current public health messages 
regarding SB include statements such as “break up long periods of sitting as often as possible” 
(Australian Department of Health, 2019) or “adults and older adults should avoid long periods 
of sitting” (Fuezeki et al., 2017b).  
An unexpected finding was the inverse relation between SB and LDL-C and SB and 




a worsening cholesterol profile. The “active couch potato phenomenon” represents 
individuals who are highly sedentary however also meet the recommended guidelines of 
MVPA (Owen et al., 2010). This pattern of PA and SB among participants could explain result 
in the observed association between SB and LDL-C. However, it is unlikely that this is the case 
given the low levels of PA also reported within the population. A possible explanation for this 
finding may be related to HMG CoA reductase inhibitor (statins) induced muscle myopathy.  
Statins are routinely prescribed to lower cholesterol in patients with CVD (Ziaeian & Fonarow, 
2017).  One of the most common side effects of statin therapy is muscle myopathy that can 
severely limited PA (Parker & Thompson, 2012).  Lee et al., (2014) also reported that older 
men taking statins had significantly more SB than those who were not on the medication.  
Although there was no information provided on medication use, more than one third (37.7%) 
of participants had CVD and were therefore likely to be taking statins as per standard 
guidelines.  
Limitations of Study 1 
Participants were recruited from individuals who were referred to and attended 
induction to a CBER program.  Not all patients referred to the program attended the induction 
session.  It is possible that those who did attend may have been more physically active and 
not representative of the general CD population giving rise to selection bias.  Additionally, 
registering for an exercise rehabilitation program and/or attending induction may motivate 
participants to become more active. As no ActivPAL threshold currently exists for MVPA in a 
chronic disease population, MVPA was classified as ≥ 25 steps per 15 sec epoch, based off 




MVPA in frail and deconditioned participants. Participant use medication was not collected 
which is a significant limitation of this research. Household income was estimated using the 
median household income assigned to the area of each participants address. As this is a proxy 
measure of gross household income it is a limitation when interpreting findings related to 
income. A major limitation of the research design is that exposure and outcomes are 
simultaneously assessed, which prevents the identification of causation or the analysis of 
behaviour over a period of time.  Although, accelerometers, particularly those with an inbuilt 
inclinometer are the most accurate devise currently available to measure PA and SB, they 
have limitations.  Participants may temporarily change their behaviour due to awareness of 
being monitored (Hawthorn effect) (Wickström & Bendix, 2000). In addition, the device has 
to be removed for water-based activities such as swimming or aqua aerobics.   
Finally, as there was a large number of health-related outcome measures that were 
used as dependent variable in analysis, there was an increased risk of a type 1 error (Knudson 
& Lindsey, 2014).  Data was subjected to principal component analysis (PCA) as an approach 
to reducing type 1 error.  However, missing data significantly impacted the sample size 
included within factors.   
Conclusion 
The aim of this study was to describe the levels of PA and SB in a mixed CD population 
and to investigate the association of PA and SB with selected indices of health.  The findings 
suggest that individuals with a CD, regardless of condition, participate in low levels of daily 
PA as measured by daily step count, LIPA and MVPA.  Moreover, a high proportion of the day 




body composition, aerobic fitness and self-rated health, with medium, large and medium 
effect sizes, respectively. More sedentary time was associated with less favourable lower 
body strength, however the effect size of this association was small. In contrast, more SB was 
also associated with more favourable measures of LDL-C and depressive symptoms, both with 
a medium effect size observed.  
Whether individuals with CD become less active as a result of worsening health or 
whether the health of an individual with CD deteriorates as a result of decreased PA levels 
and/or increasing SB is unclear.  Regardless, it is likely that a deleterious cycle exists, where 
sustained physical inactivity induces dysfunction and disease progression, further limiting PA 
engagement and increasing SB (Booth et al., 2017).  There is a need for public health services 
to promote the beneficial effects of both increasing PA, including participation in LIPA, and 
reducing SB.  For the CD population, a simple message of “move more, sit less” very much 
encompasses the action needed to enhance health through PA.  
Study 2  
Exercise rehabilitation programs offer a means of increasing PA engagement for 
individuals with CD.  CBER programs can shift the resource burden from the healthcare system 
and remove many of the accessibility barriers associated with participation in hospital-based 
programmes. MedEx Wellness is a novel CBER program, that takes an integrated approach to 
CD rehabilitation by delivering a shared program across multiple CD.  Study 2 evaluated the 
effect of 12 months of participation in the MedEx Wellness program in men and women with 
a diverse range of both SCD and MM.  There were significant improvements in LIPA and 




higher rate of attendance was associated with improvements in LIPA, MVPA, step count, 
patterns of SB, body composition, psychological health and psychosocial determinants of PA. 
There were largely no differences identified between those with a range of SCD and MM in 
terms of their response to the integrated CBER program.  The results of this study strongly 
advocate the a mixed CBER model can be efficacious.   
The rates of uptake and drop-out to the programme compared favourably to similar 
exercise rehabilitation programs. Uptake, defined as attending at least one exercise class 
following induction, was 92.6%.  In a systematic review of exercise referral schemes in the UK, 
the pooled levels of uptake was 66% (Pavey et al., 2012). Of those individuals who initiated 
the MedEx Wellness program, 41.4% dropped-out within the 12-month period.  Drop-out 
rates of 50% and 58% have been previously been reported for short-term (6 - 8 weeks) cardiac 
rehabilitation (Cannon & O’Gara, 2007; Mikkelsen et al., 2014; Turk-Adawi et al., 2013) and 
pulmonary rehabilitation programs (Royal College of Physicians, 2016). Including individuals 
who never initiated the program, total drop-out was 49%. The highest rate of dropout in the 
current study occurred in the first 3 months, which is a consistent trend in CD exercise 
rehabilitation programs (Carmody et al., 1980; Nam et al., 2012; Yohannes et al., 2007).  The 
findings indicate that if patients can be encouraged to attend a CD program for 3 months, 
there is a much higher likelihood of retention at 12 months.   
The primary reason for dropout was physical limitations due to ill-health or injury. 
Courneya et al., (2014) found a similar trend in cancer patients, where adherence to an 
exercise program was worse in patients with more physical limitations.  A negative perception 
of health is an established barrier to PA among CD patients (Forechi et al., 2018).  A perception 




engagement in this patient cohort. Obesity and/or BMI have also been identified as 
determinants of adherence in cardiac rehabilitation (Forhan et al., 2013) and exercise 
rehabilitation for cancer (Courneya et al., 2014).  Dropouts from MedEx Wellness program 
had significantly less favourable measures of BMI, hip circumference, triglycerides and LDL-C.  
Dropouts had significantly less social support for exercise, which is believed to have 
a direct influence on exercise behaviour (Resnick et al., 2002) and is a primary psychosocial 
determinant of exercise adherence in CD (Hartman et al., 2013).  In patients with CVD, T2DM 
and cancer, social support has been identified as a strong predictor of PA engagement 
(Adeniyi et al., 2012; Aliabad et al., 2014; Ormel et al., 2018; Won & Son, 2017). Individuals 
with CVD were more likely to remain in the MedEx Wellness program compared to other CD 
cohorts.  This may be explained in part by the fact that many of the CVD participants were 
referred directly from a phase III cardiac rehabilitation program and it is possible that 
participating in a CBER program may have provided an opportunity to continue their exercise 
program.  It is also likely that having a significant acute health event, such as a myocardial 
infarction, may intrinsically motivate someone to exercise (Seifert et al., 2012). 
There were significant differences in age and employment status between drop-outs 
and completers. Dropouts were younger and more likely to be unemployed.  Selzler et al., 
(2012) reported age to be the strongest predictor of dropout from pulmonary rehabilitation 
with younger patients at a greater risk of dropping out. Similarly, older adults are more likely 
to uptake and adhere to exercise referral schemes compared to younger adults (Campbell et 
al., 2015;  Pavey et al., 2011).   It is possible that employment is the mediating factor because 
younger participants are on average, below the retirement age.  Unemployment has 




linking unemployment and an increased risk of dropout however, remain unclear (Leung et 
al., 2017).  Developing a profile of dropouts could assist in identifing participants at high risk 
of dropout and guide the support structures required to maintain participation. The current 
study provides evidence that the characteristics of an individual more likely to dropout from 
CBER include younger, unemployed, non-retired or overweight individuals. Whether these 
characteristics occur independently or concurrent has yet to be established, however it is 
likely that exercise adherence is dependent on a range of factors. As drop-out rates remain 
sub-optimal, there is a need for a more proactive approach to prevent the loss of vulnerable 
participants prematurely from CBER programs. For example, the current findings propose 
that individuals who are retired are less likely to drop out, suggesting that time constraints is 
a possible barriers resulting in dropout in the younger, non-retired cohort. This information 
could inform the delivery of CBER services to assist individuals to overcome this barrier. A 
possible offering of shorter classes (45 min rather than one hr) or classes outside of general 
working hours (early morning or evening) could have an impact on drop-out rates. Adherence 
strategies that can be translated into the real-world delivery of CBER requires further 
research. Interestingly, sex was not associated with uptake or adherence to the MedEx 
Wellness program, as previous research has reported that women are more likely to uptake 
exercise referral schemes compared to men, whereas men are more likely to adhere to the 
programs (Gidlow et al., 2005; Pavey et al., 2011).   
Few participants attended the recommended 2 classes per week.  Despite the low 
adherence rate, there were significant improvements in a number of health indices. Previous 
research has shown some efficacy for low exercise dose interventions (Paw et al., 2008; Theou 




benefits. A recent intervention study reported non-significant improvements in HRQoL in  
older adults participating in a low-dose exercise program (2 exercise session/wk), however 
those participating in a high-dose exercise program (three exercise classes/wk) demonstrated 
significant improvements in each HRQoL dimension measured (Kaushal et al., 2019). The 
evidence advocates that although health related benefits can be attained with minimal 
attendance, greater benefits are likely to be achieved when attendance is increased. The role 
of intensity of exercise, in favour of greater intensities, for eliciting positive health-related has 
been widely accepted (Warburton & Bredin, 2017).  However manipulation of total weekly 
exercise time has yet to has not yet been established.   
Home-based exercise programs have shown to be as effective as centre-based in 
cardiac rehabilitation in terms of mortality risk, cardiac events, exercise capacity, a range of 
modifiable risk factors and QoL (Dalal et al., 2010) However, adherence to home-based 
exercise was reported as superior. Home-based rehabilitation provides an opportunity to 
widen access to exercise rehabilitation and thereby may be associated with greater 
adherence.  Hardcastle & Cohen, (2017) suggest that attending centre-based rehabilitation 
programs may require a high level of motivation which can result in reduced adoption of these 
services. Similarly, in cancer survivors, research has reported a preference for home-based 
PA rather than centre-based (Hardcastle et al., 2017). It is possible that the optimal approach 
to exercise rehabilitation delivery is to offer a choice between centre-based or home-based. 
Differing preferences for both home and centre based rehabilitation was explored by 
Wingham et al., (2006) in cardiac patients. Those showing preference for home-based 
rehabilitation believed that their rehabilitation should fit in with their lives rather than their 




rehabilitation placed emphasis on supervision during exercise and the need for the 
camaraderie of a group. Home-based exercise programs do not provide opportunity for peer 
support and role modelling. It is possible that a hybrid model of rehabilitation delivery which 
includes both centre-based and home-based elements may be a suitable alternative to CBER 
to provide wider access and efficacy of the service.   
MVPA and step count did not change significantly in the present study but both were 
positively associated with attendance.  Although MVPA is recommended for optimal health 
benefits, emerging evidence suggests that LIPA improves health.  Participation in the MedEx 
CBER program was associated with a significant improvement in LIPA. The clinical implications 
of the observed improvement are questionable as the average daily increase overserved in 
LIPA between BL and 12 m is approximately 6 min. Conversely, no threshold has yet been 
identified that must be exceeded before beneficial effects onset as a result of increasing PA 
levels.     
It is well established that psychosocial factors, including self-efficacy for exercise, are 
important determining factors for PA participation in individuals with CD (Bauman et al., 
2012; Dutton et al., 2009; Hartman et al., 2013; Plotnikoff et al., 2000; Selzler et al., 2012). A 
regression in barriers to self-efficacy for exercise, self-regulatory self-efficacy for exercise and 
intentions for exercise was observed over the course of this study. This is an unexpected 
outcome as previous research reports that participation in exercise alone can increase 
exercise self-efficacy (Fletcher, 2012). In addition, the incorporation of exercise consultations 
which included a review of participant goals, provided with feedback on progress and 
strategies to overcome barriers was expected to impact exercise self-efficacy.  This finding 




relation between changes in psychosocial determinants for PA and changes in PA were weak, 
which could indicate the absolute change in both variables was minimal and relations could 
not be identified.  
Program attendance was positively associated with improved self-efficacy for PA, 
self-regulatory self-efficacy for PA and intentions to exercise, in addition to MVPA and step 
count. It is probable many of the participants with low attendance did not gain experience or 
develop confidence in their abilities to be independently physically active or overcome 
barriers for physical activity.  It is likely that participants may have had great intentions to 
becoming PA at induction to the program, following initial referral from a healthcare 
professional.  The study findings indicate that these intentions were not maintained after the 
initial stages of joining the program. Several behaviour change techniques such as goal-
setting, self-monitoring, prompts, graded tasks, non-specific rewards and social rewards, 
have been found to enhancing intentions for exercise, self-efficacy and overall PA levels 
(Finne et al, 2018; Samdal et al., 2017). Further research is required to investigate how to 
effectively incorporating evidence based behaviour change techniques feasibly into CBER. 
This knowledge could inform services on how to evoke improvements in exercise self-efficacy 
and further improve engagement with the program and PA outside of the program.    
Increasing the number of interruptions in SB is associated with more favourable 
measures of BMI, waist circumference, HDL-C, TG, blood glucose control and markers of 
chronic inflammation (Bankoski et al., 2011; Dunstan et al., 2012; Healy et al., 2008b; Henson, 
et al., 2013a).  For individuals who fail to meet the recommended levels of PA, reducing time 
spent in prolonged sedentary bouts may be a possible approach to initiating health enhancing 




sectional analysis of study 1 less SB was associated with more favourable lower body strength. 
In study 2, changes in patterns of SB, where SB was accumulated in shorter bouts was 
observed. In addition a range of improvements in physical functioning,  body composition and 
psychological health were found. No changes in MVPA were found, and minimal changes in 
LIPA were demonstrated. The current analysis did not identify the mechanisms which led to 
the positive changes in health outcomes. In line with previous evidence promoting the 
beneficial effects of more fragmented SB, it is possible that this change in SB may have had a 
role to play.  
There is currently no published data evaluating the impact of CBER as an approach 
to reducing SB in CD cohorts. However, available evidence indicates those who are current 
participating in CBER or have previously attended CBER, have lower levels of SB compared to 
those have do not (Hernandes et al., 2013; Simoes et al., 2009). Although there was no 
significant change in total sedentary time, there was a change in the pattern of SB.  An 
increase in the total number of sedentary bouts and more time spent in sedentary bouts of 
11-30 min in duration, may imply there was greater interruption in SB and SB was 
accumulated in less prolonged bouts.  In addition, attendance was inversely associated with 
time spent in sedentary bouts > 60 min.  Although the threshold for a prolonged bout of SB 
has yet to be established, research has found that each additional sedentary bout ≥ 10 min 
was positively associated with waist circumference. Indeed, sedentary bouts of ≥ 60 min are 
associated with a 48% increased risk of abdominal obesity (Judice et al., 2015).   
By participants engaging in the CBER program is was assumed that this would have 




the unintended effect of also increasing SB, resulting the possible offset of the PA related 
health benefits (Siddique et al., 2018). A systematic review and meta-analysis by Prince et al., 
(2014) provides some supporting evidence that small reductions in SB can result from PA 
focused interventions. Interventions that target both PA and SB also resulted in modest 
reductions in daily SB, however SB focused interventions may be the most effective in 
resulting in large and clinically meaningful reductions in daily SB. Incorporating SB targeted  
interventions within the CBER model may have a greater impact on changing SB in this cohort.     
It has been well documented that participation in exercise rehabilitation can improve 
health-related outcomes in individuals with CD, including indices of physical, clinical and 
psychological health (Anderson et al., 2016; Dunlay et al., 2014; Houchen-Wolloff et al., 2018; 
McCarthy et al., 2015; Puhan et al., 2016; Shepherd & While, 2012).  Much of the research 
has focused on exercise in a clinical setting but similar improvements have been reported 
following participation in CBER programs. The effectiveness of CBER in improving health-
related outcomes has been demonstrated in patients with diabetes (Gallé et al., 2019; 
Mendes et al., 2016, 2017), CVD (Bethell & Mullee, 1990; Cramp et al., 2010; Kwan et al., 
2016; Marsden et al., 2016; Taylor et al., 2016a), COPD (Amin et al., 2014; Beauchamp et al., 
2013; Godtfredsen et al., 2019; Varas et al., 2018), cancer (Foley & Hasson, 2016; Foley et al., 
2018; Knobf et al., 2014; Leach et al., 2015; Rajotte et al., 2012; Santa Mina et al., 2017) and 
neurological conditions (Combs et al., 2013; Corcos et al., 2013; Elsworth et al., 2011; 
Poliakoff et al., 2013; Salbach et al., 2014).   
The research to date is limited to specific CD populations and often excludes 
individuals with MM.  A systematic review of CBER across chronic disease populations 




disease (Desveaux et al., 2014a).  The current study adopted a novel approach by integrating 
individuals with diverse CD diagnosis and MM into the same CBER program.  The findings 
indicate that a shared approach to CBER is viable for the management of CD and offers a more 
resource efficient and potentially scalable rehabilitation strategy.   
CRF reflects the integrative functioning of the respiratory, cardiovascular and 
skeletal muscle systems and is an independent predictor of overall health and mortality 
(Church et al., 2001; McAuley et al., 2009; Steell et al., 2019; Sui et al., 2010).  Performance 
in 6MTT, an indicator of CRF improved at each time point in the present study. This is an 
important finding because even small improvements in CRF are associated with  significant 
health consequences.  For example, a one MET increase in CRF is associated with a 13% 
reduction in all-cause mortality (Kodama et al., 2009).  A significant interaction effect between 
time and primary CD diagnosis was identified for 6MTT.  Individuals with a primary diagnosis 
of cancer had a significantly higher CRF across all timepoints, suggesting that on average 
individuals with cancer have greater levels of CRF compared to other disease cohorts. Not 
surprisingly, those with respiratory disease had significantly lower CRF compared to CVD and 
metabolic disease across all timepoints. The specific symptoms of COPD make engagement in 
PA unpleasant as a result of air trapping and increased hyperinflation of the lungs, leading to 
breathlessness (O’Donnell, 2007). Increased breathlessness provokes anxiety towards PA, 
which inevitably leads to exacerbations of COPD. A vicious cycle is likely to develop whereby 
PA is avoided and further deconditioning onsets (Bourbeau, 2007).  
The cancer cohort appear to display a distinct pattern of change in CRF compared to 
all other CD groups (figure 5.5).  There was a large improvement 6MTT performance between 




the only group to receive a fixed 12 week program, as opposed to a continuous service.  They 
were assessed at BL and 3 months, in line with other participants and retested at 6 and 12 
months.  Shorter term programs are common in cancer survivorship rehabilitation 
(Christopher & Morrow, 2004; Foley & Hasson, 2016; Leach et al., 2015).  Once in survivorship, 
there is a greater emphasis for individuals with cancer to return to general public exercise 
services (Dennett et al., 2019; Penttinen et al., 2019).  Similarly, the MedEx Wellness service 
catering for cancer survivors, entitled “Move On”, worked in 12 week cycles with an emphasis 
on patients transferring back to previous gym facilities or exercise routines. In addition, the 
exercise content of the Move On program varied slightly in comparison to the general MedEx 
Wellness classes. Instructors incorporated spinning, circuits, Pilates and TRX training into 
classes on a regular basis within the 12 weeks. It is possible that those within the Move On 
program received a higher intensity exercise prescription during the program, resulting in 
substantial improvements in CRF. However, once out of the service, the findings from the 
present study suggest that  CRF levels may start to decline, whereas other CD cohorts that 
remained in the program continued to improve beyond the 3 month timepoint.   
Musculoskeletal fitness is associated with functional capacity including ability to 
carry out ACL, maintaining independence, risk of fracture, QoL and cognitive function (Kell et 
al., 2001; Pate et al., 2012; Warburton et al., 2001; Warburton & Bredin, 2016) and is 
predictive of premature mortality (Fujita et al., 1995; Katzmarzyk & Craig, 2002). Muscular 
strength improved over the course of the program.  Improvements in musculoskeletal fitness, 
have widespread effects for individuals with CD, particularly improved functional capacity and 
the ability to perform ADL. The current guidelines for resistance training  are 8-10 exercises, 




2 or more days a week (Australian Department of Health, 2019; Chodzko-Zajko et al., 2009; 
Department of Health & Children & Health Service Executive, 2009; Tremblay et al., 2011; US 
Department of Health and Human Services, 2018b). The minimum recommended attendance 
in the MedEx Wellness program of 2 class per week, would ensure participants were meeting 
these guidelines. Improved muscle strength reduces the reliance on family and society for 
personal care, delays in disease progression, reduced obesity, and improves glucose 
metabolism, bone health and psychological health (Hessert et al., 2005; Warburton et al., 
2001).   
Maintaining flexibility is associated with important health implications including QoL 
and independent living (Katzmarzyk & Craig, 2002).  Interestingly, individuals with MM had 
less favourable measures for sit and reach values at BL, but appeared to achieve greater 
improvements across all time points compared to those with SCD.  Compared to individuals 
with SCD those with MM have a significantly greater reduction in functional capacity (Bayliss 
et al., 2004; Smith & O’Dowd, 2007; Wallace et al., 2015) but also achieve substantial 
improvements following participation in a regular physical activity program. (Pate et al., 
1995).  
Favourable changes in body composition were observed over the course of this 
study, with improvements in both waist and hip circumferences.  There was inverse relation 
between attendance with both BMI and weight. Abdominal obesity is strongly and positively 
related to all-cause, CVD and cancer mortality, independent of BMI, with elevated waist 
circumference significantly associated with CVD mortality even among normal weight 
individuals (Zhang et al., 2008). In addition, obesity is a significant contributor to morbidity 




depression (Pi-Sunyer, 2009). Exercise training is effective in counteracting the metabolic 
complications associated with abdominal obesity, both directly through fat loss and through 
favourable effects on insulin sensitivity, plasma lipoprotein profile and improve fibrinolytic 
activity (Buemann & Tremblay, 1996).   
An unexpected finding was the significant increase in LDL-C over the 12 month 
period.  Although information on prescribed medication was not attained from participants, 
it is likely that many participants were prescribed statins to lower cholesterol. Research has 
suggested that 40% of CVD patients reduce adherence to statin therapies within the first year 
of prescription, due primarily to muscle myopathy (Thornley et al., 2012).  There is potential 
that some of the participants, reduced adherence to statin therapies over the course of the 
study leading to an increase in LDL-C levels. It is also a possibility that the dose of PA which 
participants engaged in throughout the study, was not sufficient enough to elicit beneficial 
effects on LDL-C. The fact that levels of MVPA did not change, suggests the potential of this 
theory. Finally, there was no data collected on the dietary habits of participants during the 
study, but it also may be possible that participants changed dietary habits over the 12 m and 
this may have had an impact on measured LDL-C.  
Living with a CD is associated with a significant psychological burden and increased 
levels of depression, anxiety and decreased satisfaction with life are common in many CD 
cohorts (Chapman et al., 2008; Hébert, 1997; Mhaoláin et al., 2012; Rajput et al., 2016; 
Restorick Roberts et al., 2017).  Improvements in psychological health are associated with 
better physical health (Boehm & Kubzansky, 2012; Pressman et al., 2019; Trudel-Fitzgerald et 
al., 2019).  Ideally, treatment strategies for CD should target both the physical and 




There is a substantial body of evidence linking CBER to improved measures of 
psychological health (Amin et al., 2014; Beauchamp et al., 2013; Christopher & Morrow, 2004; 
Elsworth et al., 2011; Foley et al., 2018; Godtfredsen et al., 2019; Haas et al., 2012; Harrington 
et al., 2010; Knobf et al., 2014; Rajotte et al., 2012).  Participation in the MedEx Wellness CBER 
program improved symptoms of depression, self-rated health and satisfaction with life.  The 
largest improvements in psychological health were in participants with the highest 
attendance.  
With the exception of patients with a primary diagnosis of respiratory disease, all 
other CD groups had a significant improvement in symptoms of depression, satisfaction with 
life and positive mental health  throughout the program.  Individuals with respiratory disease 
had evidence of worsening psychological health scores (figures 5.6 – 5.8).  Respiratory disease 
has been strongly associated with a negative psychological health (Hynninen et al., 2005) and 
the rates of both anxiety and depression are more prevalent in COPD sufferers compared to 
other CDs (Solano et al., 2006).  The negative impact of respiratory disease on QoL could not 
be counteracted with CBER, despite significant improvements in other health indices.  This 
may be due in part to the clinical sequelae (fibrosis) and severe functional impairment 
associated with respiratory disease. 
A significant interaction effect was found between time and SCD or MM for positive 
mental health. Simple effects analysis did not indicate and difference between those with SCD 
or MM across timepoints. However, lower measures of psychological health were apparent 
in those with MM at BL compared to individuals with a SCD. Participants with MM achieved 
greater improvements across all time points than SCD (figure 5.10).  MM is associated with a 




et al., 2015) and it is likely that those at poorer initial psychological health had more to gain 
from engagement in the CBER program.    
Although group interaction was relatively low as participants attended a mean of 23 
– 32 sessions in 12 m (all participants and completers, respectively), it is possible that the 
group-based setting of the MedEx Wellness classes had an impact on the improvements 
observed in the various measures of psychological health.  Social isolation is commonly 
observed among individuals with CD (Biordi & Nicholson, 2013) and the group exercise classes 
offered an opportunity for social interaction and engagement. Although no significant 
changes in measures of social support were found in this study, it is worth noting that greater 
attendance was associated with improvements in this measure.  In a qualitative study of CBER 
involving COPD, the psychosocial benefits were believed to mediated in part from the 
interpersonal relationships with the gym instructors and the support received from peers 
within the exercise group (Desveaux et al., 2014b). Participants highlighted the importance of 
the opportunity to integrate into the community and with community members. The 
experience of social connection with regular gym members provided a sense of feeling socially 
included and valued.  
Limitations of Study 2 
The primary limitation of this study is the lack of a usual care control group.  As the 
study setting was within an established program in the community, withholding the service 
to allow for a controlled trial was not considered ethically appropriate.  A clustered controlled 
trial was not feasible due to the challenge of identifying a control group matched to the 




group limits the ability to infer cause and effect.  Similar to study 1, there is a risk of selection 
bias as participants were recruited from those who attended induction to the CBER program 
and no data was collected on those that were not referred or declined to attend.  Additionally, 
study uptake rates were not recorded, although very few patients attending programme 
induction declined to participate. The method used to monitor attendance (scanned entry to 
the gym using individual fobs) could not differentiate between scanner entry for a class or 
scanned entry to the gym for personal use. Although the use of the gym facility outside of 
class times was not regularly availed of by participants, there is possibility that some 
attendance records include personal gym use also. Participant use medication was not 
collected which is a significant limitation of this research. Given the population studied, 
maturation may threaten the validity of the findings, as changes in health status may have 
occurred over the 12-month period.  The MedEx Wellness program closes for three weeks 
during the Summer and three weeks at Christmas, which may have compromised outcome 
results due to a detraining effect and impacted attrition.  Finally the researches were not 
blinded to the outcome measures.   
Conclusion 
PA can have a profound effect on the treatment and management of CD (Warburton 
et al., 2006).  Exercise rehabilitation programs provide an opportunity for individuals with CD 
to increase PA engagement. Delivering such programs in the community can improve 
accessibility, “normalise” or “demedicalise” exercise, and support individuals to incorporate 
PA into their daily or weekly routine.  This study has shown that adopting a common CD model 




however the observed effect size was small. Moreover CBER is effective in enhancing physical 
functioning, body composition and psychological health outcomes. Observed effect sizes 
were small, with the exception of CRF where a large effect size was found. Largely no 
differences were found between different primary CD diagnosis or between those with a SCD 
and MM when participating in CBER, advocating for an integrated model approach.   
Study 3 
The results from Study 2 indicate that participation in the MedEx Wellness CBER 
program is associated with significant improvements in LIPA, SB, physical function and 
psychological health in men and women with a range of CDs.  However, statistically significant 
improvements in health outcomes expressed as mean values often mask large inter-individual 
variability in measurable improvements in the response to lifestyle interventions. The present 
study identified factors associated with a measurable improvement in physical and 
psychological outcomes in men and women with SCD and MM in response to participation in 
a CBER program.  
Although a measurable improvement in at least one health related outcome was 
achieved by 92.2% of participants, the prevalence of non-response (no change or a decrease) 
ranged from 19.2% for CRF to 53.4% for satisfaction with life.  The findings indicate that 
participants attending a CBER program do not achieve positive improvements across all 
health-related measures.  Both genetic and environmental factors and their interaction 
determine the individual response to lifestyle interventions.  It is well established that BL 
measures of fitness and health are important determinants of how individuals respond to 




determine measurable individual responses to exercise training would greatly assist allied 
health professionals in the design and deliver of future services.  Specifically, individuals with 
more favourable BL measures of fitness and health are more likely to have a lower response 
to exercise training than those with less favourable BL measures (Bouchard & Rankinen, 
2001).  This can be explained by the ‘ceiling effect’ where further improvements in indices of 
fitness and health are limited beyond a certain threshold.  
In the present study, a less favourable BL measure of PA levels (LIPA), functional 
capacity (lower- and upper- body strength), body composition (waist circumference), and 
psychological health (symptoms of depression and satisfaction with life) was found to 
increase the likelihood of achieving a measurable improvement.  In contrast, lower BL CRF 
and increasing age reduced the likelihood of achieving a measurable change in the CRF.  The 
6MTT is a commonly used field-based measure of CRF.  Low levels of CRF are associated with 
a small functional reserve and, can therefore severely limit the capacity to undertake 
moderate intensity exercise (Kaminsky et al., 2013).  It is possible that study participants with 
low CRF levels were unable to exercise at an appropriate intensity level required to improve 
oxygen uptake, even when the exercise program was modified to account for their low 
functional capacity.  From a clinical perspective, the identification of an age-adjusted, 
minimum 6MTT performance for entry to CBER would help to identify participants with a 
minimal functional capacity to ensure sufficient engagement with the program. Individuals 
below the minimum 6MTT threshold could be prescribed a remedial one-on-one exercise 
program to increase CRF levels prior to engaging in a group based exercise program.  
For a number of health related outcomes, achieving a measurable change was 




likelihood of improving LIPA.  This has important clinical implications, as low levels of PA are 
commonly associated with the presence of metabolic diseases (Egede & Zheng, 2002; Loprinzi 
et al., 2014; Loprinzi & Pariser, 2013; Nelson et al., 2002) and increasing levels of PA is 
challenging in this sedentary cohort (Cradock et al., 2017). Studies consistently report that 
participation in MVPA is suboptimal in patients with metabolic diseases and based on the 
findings in this study increasing efforts to promote LIPA among this patient cohort are 
warranted.   
 A primary CD diagnosis of cancer was associated with an increased likelihood of 
achieving a measurable improvement in the lower-body strength, which was used to assed 
lower body muscular endurance. Many cancer patients report a substantial decrease in PA 
levels after diagnosis (Irwin et al., 2011). Cancer therapies including chemotherapy, 
radiotherapy and hormonal therapy may result in loss of muscle mass and muscle weakness 
(Daly et al., 2018; Sturgeon et al., 2019) exercise has been shown to reverse the deleterious 
effect of cancer treatment on muscle function.   
A primary diagnosis of respiratory disease was found to reduce the likelihood of 
improving self-rated health.  Psychological health decreased in the respiratory cohort over 
the duration of the 12-month MedEx Wellness program as described in study 2.  An 
individual’s perception of physical exertion during exercise is highly correlated with 
pulmonary ventilation and respiratory rate (Robertson & Noble, 1997).  For individuals with 
COPD, the experience of inspiratory difficulty can be overwhelming (Hanania & O’Donnell, 
2019).  In addition, the increased motor command output and contractile muscle efforts 
associated with exercise induces heavier breathing in both healthy individuals and those with 




considerable negative psychological impact and has been found to be a mediator of anxiety 
(Janssens et al., 2011). Although PA is important for improving patient outcomes in COPD, 
experiences of dyspnea, even in patients with a mild diagnosis of COPD, can significant impact 
health-related QoL (Miravitlles & Ribera, 2017).  
A secondary aim of study 3 was to identify the minimum CBER attendance required 
to achieve measurable/clinically meaningful changes in selected health indices. However, due 
the fact that statistical model did not control for extraneous variables and the low attendance 
to the program, the estimations of required number of classes attended to achieve 
improvements are likely to be imprecise.  Notwithstanding these limitation, it was found that 
almost 5 months attendance (two classes a week) was associated with achieving a measurable 
change for any of the psychosocial determinants.  Indeed, research has consistently 
demonstrated the link between psychosocial factors and PA participation (Bauman et al., 
2012; Dutton et al., 2009; Hartman et al., 2013; Plotnikoff et al., 2000; Selzler et al., 2012), 
suggesting that one cannot change without the other (i.e. to induce changes in PA, 
psychosocial factors must also be addressed).  The considerable duration of attendance 
required to achieve improvements in psychosocial determinants of PA, could help to explain 
the small changes in PA levels over the course of the program.   
Maintaining optimal clinical, psychological and physical health and preventing 
disease progression are outcomes of exercise rehabilitation (Agency for Clinical Innovation, 
2017; World Health Organization, 2019a).  In this study, individuals who had no change in the 
selected indices of health or a regression, were classified as non-responders.  However, for 
some of the participants maintaining health status or slowing the rate of disease progression 




Genotype variations are significant determinants of training response phenotypes.  
In recent years, a greater number of specific gene variations associated with such responses 
have been identified.  It is well established that approximately 50% of the variance in VO2max 
response to training is explained by 21 single nucleotide polymorphisms (Bouchard et al., 
2011).  A significant genetic role has also been identified in the response of muscle 
performance and body composition to resistance training (Clarkson et al., 2005; Harmon et 
al., 2010; Van Deveire et al., 2012; Walsh et al., 2012; Walsh et al., 2009).  However our 
understanding of genomic predictions particular, in relation to gene-environmental 
interactions is only in its infancy and, is currently of little real value in maximizing participants 
response to CBER.   
The current research investigated inter-individual responses to CBER in terms of 
phenotypic traits including measures of physical function, CD diagnosis and sex.  Identifying 
phenotypic predictors of responders and non-response has practical application in the CBER 
setting.  There is a still lack of understanding of the individual characteristics associated with 
non-response to CBER.  When limiting the number of measures assessed to determine 
response, it is likely that many positive response mechanisms are missed. (Pickering & Kiely, 
2019).  Exercise has wide varying implications that it is almost impossible to capture all within 
the one study.  Furthermore, in addition to the established physiological benefits, the 
psychological and community benefits should also be appreciated.  
The findings from this study indicates that individuals with CD attending CBER do not 
achieve positive improvements across all health-related outcomes. However, there is a 
predominate pattern whereby those with less favourable BL measures of LIPA, strength, body 




cluster exist, where the same individual has less favourable BL measures across all health-
outcomes. What is notably from this research is that those initiating the CBER program at the 
lower end of the spectrum in terms of health related measures, are found to be the most 
likely to benefit. This further advocates for the role of CBER in the secondary prevention of 
CD, as it essentially may primarily benefit those who need it most. Moreover, primary CD 
diagnosis or the presence of MM largely was not associated with response to the program.  
Limitations of study 3 
The thresholds used to classify clinically meaningful changes require caution with 
interpretation. For many of the health-related measures, evidence-based clinically 
meaningful changes do not exist or they are based on a single disease group and may not be 
generalizable across the range of disease included in this study.  Secondly, the analysis used 
did not differentiate between participants who had healthy measured of certain outcomes at 
BL and those who did not. For instance, individuals with healthy measured of weight and waist 
circumference, ideally would remain unchanged, however in this analysis such individuals 
were considered non-responders. Thirdly, grouping all participants who achieved a 
measurable change or more may not effectively represent those who achieved a positive 
change to the program, as large variation exists within this category. For example, there 
would be substantial difference in an individual who increased their LIPA by ≥ 0.01 min/day 
and those who increased it by > 30 min or more. Currently both types of individuals are 
represented within the one group for analysis. Furthermore, training responses can be 
detected in a myriad of outcome measures and interpreting inter-individual training response 




outcomes identified.  For instance, increasing age was a predictor of non-response to 
improving handgrip.  Although the current evidence suggests that older individuals are less 
likely to improve handgrip strength, it cannot necessarily be assumed that older individuals 
will not respond positively in other outcome measures.  Moreover, the selected indices of 
health used to investigate inter-individual responses, do not account for all putative 
components, which could be impacted by participating in a CBER program. In addition, 
participant use medication was not collected which is a significant limitation of this research. 
Finally, the analysis on estimated attendance required to achieve measurable and clinically 
meaningful improvements is not robust, and specific values revealed from required 
attendance must be interpreted with caution.  Inter-individual variability exists in the 
required attendance to achieve a measurable change, and the current analysis technique did 
not account for this variability.   
Conclusion  
This study found that inter-individual variability exists among participants attending 
a CBER program.  These findings suggest that individuals with lower PA levels, strength and 
psychological health are more likely to response positively to the program.  In contrast, a 
lower level of CRF is an indicator of non-response.  Future research could provide the 
evidence-base used to predict responders to exercise rehabilitation by identifying the factors 
or cluster of factors which predispose participants to a greater risk of non-response.  
Assessing the effectiveness of strategies, such as an introductory individualised program for 
those identified as at risk of non-response, would enhance the delivery of CBER and maximise 




Strengths of this research 
The clinical conditions which fall under the umbrella term of CD, although diverse in 
many ways, are associated with a similar impact on functional capacity and QoL.  The mixed 
CD population which included individuals with both a SCD and MM is a key strength of this 
research. Research studies which focus on individual disease cohorts limits the 
generalizability of findings beyond that of the specific condition in question.   
  Study 1 (chapter 4) demonstrated that, regardless of disease, PA levels are low and 
excessive levels of SB exist within Cd population. Integrating a range of CDs within one study, 
including those with SCD and MM is current a novel approach in this field of research.  The 
findings advocate that increasing PA levels and reducing SB within this cohort, has the 
potential to significantly impact disease progression, physical function and QoL.  
The research was undertaken in the MedEx Wellness program, a CBER program that 
has been operating since 2007.  A major finding of study 2 was that participation in the MedEx 
Wellness CBER program resulted in  significant improvements in LIPA, patterns of SB, physical 
function and psychological health. Levels of MVPA were not found to significantly change, 
however a significant improvement in CRF was observed, with a large effect size. This finding 
suggest that although frequency of MVPA may not have changed, it is possible the intensity 
of MVPA bouts did while participating in MedEx Wellness classes. This change in MVPA 
participation was possibly enough to onset improvements in CRF. CRF is a vital predictor of 
health status (Warburton & Bredin, 2016; Blair et al., 2001; Myers et al., 2004; Williams, 
2001). Hence, the effectiveness of the CBER program in eliciting changes in CRF, further 




been clearly demonstrated through its growth as a company, currently operating in a number 
locations in Ireland.  The current research findings provide empirical evidence regarding the 
effectiveness of the service.   
The study sample size would be considered relatively large.  There are a limited 
number of interventional exercise studies involving individuals with CD, meeting the sample 
size of the current research.  The inclusion of a number assessments throughout the study 
allowed for analysis of temporal changes.  
An additional strength to this research is the incorporation of a wide variety of 
outcome measures, which were related to levels of PA, SB, physical function, clinical health, 
psychological health and psychosocial determinants of PA.  This large data collection series 
provides a holistic insight into the potential benefits achieved through participation in the 
MedEx Wellness program.  CD, in many cases, is a lifelong condition, and the management of 
the condition should ideally focus well beyond the immediate disease manifestations. This 
research highlights the potential of CBER as a comprehensive rehabilitation service which can 
simultaneously positively impact a number of CDs disease, while also enhancing additional 
components of health and wellbeing.  
Impact of this research 
It is likely that a futile cycle is prevalent among individuals with CD, whereby 
decreased PA participation and increased SB is associated with decreased functional capacity, 
QoL and accelerated disease progression (figure 7.1).  The current  findings advocate for an 









Figure 7.1 Cycle of physical inactivity associated with chronic disease   
Note: QoL = quality of life; MM = multimorbidity, ADL = activities of daily living 
The current shift in distribution of population age and increased life expectancy 
make it more likely that the prevalence of CD will continue to remain a substantial burden to 
society.  PA/exercise is well established an adjunctive therapy in the secondary prevention of 
CD.  
Exercise rehabilitation remains an under-utilized therapy within in the treatment of 
CD. The major findings from the current research are twofold. Firstly, the research provides 
Physical inactivity & increased 
sedentary behaviour 
Deconditioning
→ Decreased aerobic capacity
→ Decreased strength
→ Decreased balance 




→ Development of MM
Reduced functional capacity
→ Reduced exercise capacity





evidence for the efficacy of CBER as a secondary preventative therapy.  Secondly, the research 
advocates for the novel integrated approach to CBER delivery for those with SCD and MM. 
CBER programs have enormous potential to widen access for CD populations to supervised 
exercise and reduce reliance on overwhelmed clinically based services.  Not only does the 
CBER model remove some of the burden of rehabilitation from the hospitals where resources 
are sparse, it also has the potential to reduce future hospital admission and use of clinical 
healthcare systems. Future research is recommended to further enhance CBER design and 
delivery. For example, the optimal exercise dose remains unknown (optimal frequency of 
classes, duration and intensity). Although gaps still remain, referral to CBER should become 
part of standard care for the growing CD cohort.  
The current global COVID-19 pandemic has further heightened interest in the 
delivery of non-essential health services in the community.  In response to COVID-19,  
hospital-based exercise rehabilitation services have ceased, and staff reassigned to intensive 
care.   
National recommendations of social-distancing and cocooning have created an 
environment less conducive to PA and more likely to promote SB  (Pinto et al., 2020).  The 
MedEx Wellness CBER program facilitated continuation of their services through a home-
based online delivery platform, demonstrating the adaptability of CBER programs over more 
traditional hospital-based programs.  It is likely that CBER programs will evolve to a blended 
centre and online model of delivery.  Commercial devices are now available to monitor the 
electrical activity of the heart, respiratory rate and oxygen saturation during exercise (Fourth 
Frontier, 2020; Gilgen-Ammann et al., 2019).  The adoption of these technologies has the 




CBER program.  This will facilitate the continued access for high risk patients to hospital-based 
program that will be running at a much lower capacity.   
Although it was recommended that participants in the current study attend two 
classes per week, the MedEx Wellness model of delivery encouraged a flexible approach to 
attendance. For certain outcome variables, for example 6MTT, continuous significant 
improvements were observed at each time point, indicating that greater improvements were 
gained with longer engagement, and suggest that up to 12 months there is no significant 
plateau effect.  
Creating a profile to identify individuals at risk of non-response to CBER has 
substantial implications for the future of CBER delivery. Inter-individual variability in response 
to CBER is inevitable, especially in a highly heterogeneous cohort. Notably, the current study 
found minimal differences in the response to CBER across different CD and between those 
with SCD or MM. Response was primarily based on BL levels of measurable health outcomes. 
Although the current consensus supports the theory that those with lower levels of PA, fitness 
and health at BL are generally the most susceptible to exercise rehabilitation, the current 
study provides evidence that low levels of CRF may contradict this. Low levels of CRF appear 
to prevent individuals for effectively responding to the MedEx Wellness program. Establishing 
a profile of those at risk of non-response, could inform strategies to reduce this risk from the 




Recommendations for future research 
 Research establishing a threshold for “too much sitting” in terms of the total 
accumulated amount of sitting per day and the length of a single uninterrupted 
sedentary bout are paramount in the development of the public health guidelines for 
this behaviour. 
 Future studies should expand on various components of the MedEx Wellness shared 
CD model that could inform best practice for CBER. Areas in which research is 
particularly warranted include the following:  
i) Factors associated with uptake and adherence to CBER, which currently 
remain sub-optimal  
ii) Optimal exercise prescription in terms exercise intensity and total exercise 
dose 
iii) Compliance of participants to the recommended exercise intensity within 
the group based setting 
iv) Randomised controlled trials investigating the impact of different models of 
delivery that provide greater or less flexibility in relation to attendance to determine 
most effective prescription approach to CBER 
v) Optimal program design to cater for low, moderate and high risk CD patients 
in order to ensure the most efficient use of resources in both the clinical setting and 
in the community   
vi) Effect of behaviour change techniques to enhance the impact of CBER on 
habitual PA and SB. Research should investigate feasible behaviour change techniques 




increasing habitual PA participation outside of class times/days. Specifically, 
increasing LIPA outside of the classes is recommended.    
vii) Strategies to overcome the risk of non-response in order to maximise 
engagement with CBER for all referred participants 
 Research establishing the factors and mechanisms that contribute to response to 
CBER is warranted. Defining the  range of biopsychosocial factors associated with non-
response could be used to create a profile of those at risk of non-response. Identifying 
individuals at BL who are at risk of non-response and implementing strategies to 
overcome the risk would inform the overall effectiveness of the service in practical 
application.   
 An integrated clinical and community healthcare delivery model has significant 
potential for enhancing the management of patients with CD. Healthcare delivery 
systems are beginning to move away from segregated management of SCD to a 
multidisciplinary approach. Future research should focus on developing an evidence-
base to support the new model of delivery  
 An economic impact analysis of the CBER shared model is integral to inform future 
policy development.   
Recommendations for future practice 
MedEx Wellness, which has been recently renamed ExWell Medical, is a growing 
company and service.  Since its debut in 2006, the program has expanded and is now 
operating in 3 community-based locations in Dublin and varies additional locations in Ireland, 




institute of Technology, and a University of Pittsburgh Medical Centre supported branch in 
Kilkenny. All centres have adopted the integrated model to CBER. The evidence provided by 
this thesis supports commencement of a national roll out of this service. The current research 
has highlight aspects of the program design and delivery that could be altered to further 
enhance the service. Attendance was suboptimal, with few participants attaining the 
recommended levels of twice a week or more. More emphasis on attendance from the 
medical director during induction to the program could improve this component. 
Incorporating behaviour change techniques focused on reducing SB and improving habitual 
PA outside of classes could enhance the holistic impact of this program. Finally, offering a 
beginners/lower intensity program or one to one service for individuals with very low CRF at 
baseline may enhance the ability of such participants to engage in the standard group exercise 
effectively.  
There is an imperative need to embed PA into healthcare for the secondary 
prevention of CD. The current evidence supports an integrated CBER service for those with 
SCD and MM as an effective health intervention. Government collaboration is recommended 
to support the provision of CBER nationwide. Resources in terms of trained personnel and 
support for suitable centres could be incorporated in the government healthcare agenda.  In 
addition, standard procedures for exercise referral should be put in place to promote exercise 
referral among primary care healthcare professionals. A National Exercise Referral 
Framework (NERF) for Ireland was published in 2016 (Woods, et al., 2016). The development 
of NERF was commissioned by the HSE. The framework recommends exercise referral to CBER 
for those with CD to. The design of the NERF community centres was based off a MedEx 




provides the evidence base to advocate for the implementation of the NERF in Ireland. 
Developing a national registry of appropriate facilities with qualified personnel to deliver 
CBER and establishing links between local healthcare practitioners and CBER services is the 
steps the need to be taken to allow for nationwide implementation of CBER.     
Ireland’s National Centre for Exercise is Medicine® (EIM) was launched in February 
2020. Increasing PA assessment, prescription and referral to NERF centres by physicians and 
allied health professionals has been stated as a primary aim within the current EIM initiative 
in Ireland (EIM Ireland, 2020). The implementation of an integrated pathway that 
standardizes the referral of CD patients to evidence based, safe and effective CBER services is 
recommended.  
Conclusion 
Despite the beneficial effects of PA in the secondary prevention of CD, only a small 
proportion of CD patients in this study meet the current PA recommendations.  Furthermore, 
time spent in SB was excessive, potentially accelerating the rate of disease progression.  
Recent PA guidelines for the general population and those with CD, recommend that 
individuals who engage in little or no PA, should replace SB with LIPA, as there is no threshold 
to be exceeded before health benefits are observed (US Department of Healt and Human 
Services, 2018b).  The current thesis findings support these recommendations.  A shared CBER 
model across CD populations was found to be an effective approach to increasing PA 
engagement and habitual levels of LIPA in this cohort.  The model of delivery improved 




associated health care costs, there is an urgent need to identify effective approaches to 
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Appendix A. Plain language statement 
Plain Language Statement 
DUBLIN CITY UNIVERSITY 
 
An evaluation of the effects of the MedEx programme on physical, clinical and psychosocial 
outcomes and an examination of determinants of adherence to MedEx 
 
School of Health and Human Performance, DCU 
  
Dr. Catherine Woods (catherine.woods@dcu.ie), Dr. Noel McCaffrey (noel.mccaffrey@dcu.ie) and Ms Fiona Skelly 
(fiona.skelly2@mail.dcu.ie) 
  
Details of what involvement in the Research Study will require 
Participation in this study will involve you attending DCU for 2 days of testing, before you start the MedEx 
programme.  Each visit will last approximately 90 minutes and be separated by at least 1 week.  On day 1 you will be 
asked to complete a questionnaire and perform some physical tests, including a simple strength test, and flexibility test. 
You will also have your height, weight, waist and hip circumference, measured. On this day you will also be asked to 
give a blood sample. Before you leave on day 1, a device will be given to you to wear for 1 week. This device is an 
ActivPal Accelerometer and will measure your activity levels throughout the week. A second questionnaire will also be 
given to fill out at home.   
On testing day 2 you will be perform a simple walk test. Along with this you will perform two brain function tasks. One 
measuring memory and the second measuring attention. As part of the induction process, on day 2, a group exercise 
consultation will be conducted. This will be repeated at 4 weeks and then at 3 month intervals going forward.  
A second questionnaire is also give out to fill out at home. Before you leave on day 2 you will be given a 24 hour blood 




During your first class participants with claudication will conduct a treadmill walking test, participants with lung 
conditions will be assess on lung function and also participants identified as at risk of falls will perform a simple balance 
test.   
Every 3 months you will be asked to repeat the induction measures in order to monitor your progress.  
Potential risks to participants from involvement in the Research Study (if greater than that encountered in everyday life) 
Exercise and exercise testing carries with it a very small risk of abnormal heart rhythms, heart attack or death in less 
than one in 30,000 people. There may also be a risk of anginal symptoms such as an increased blood pressure or 
arrhythmias. With all exercise sessions, there is a risk of delayed onset of muscle soreness. Participants will be advised 
that they may experience muscle soreness. All individuals will be advised and given training to exercise at their own 
level of intensity and to increase progressively to help minimize any discomfort. Participants may also experience some 
discomfort due to the effects of exercise, such as increased respiration and sweating. Drawing blood may cause a slight 
pain where the needle is inserted and can leave a bruise.  A person trained to take blood will be used to decrease these 
risks. The amount of blood drawn is not harmful. 
Benefits (direct or indirect) to participants from involvement in the Research Study 
Besides the benefits associated with regular exercise which participants will be receiving as part of the MedEx service, 
benefit to participants will include increased knowledge regarding recommended levels of physical activity for people 
living with chronic conditions and methods of achieving these recommendations  Participants will also benefit from 
meeting other people in similar situations to themselves and will be provided with a supportive and safe environment 
in which they can exercise in a supportive safe environment. 
Advice as to arrangements to be made to protect confidentiality of data, including that confidentiality of information 
provided is subject to legal limitations  
Confidentiality is an important issue during data collection. Participant’s identity, or other personal information, will not 
be revealed or published. All raw data will only be available to the DCU research team who shall not have any means of 
accessing the identity of any participants. All responses are anonymous and will be dealt with on a strictly confidential 
basis. The investigators alone will have access to the data. In accordance with DCU policy all data will be kept on-site in 
DCU in a locked secure area. 
Advice as to whether or not data is to be destroyed after a minimum period 
After a 5 year period, if participants do not wish to have their data returned, or do not contact the investigators, all data 
will be destroyed in accordance with DCU policy.  
Statement that involvement in the Research Study is voluntary 
If at any point during your participation in the study you feel as if you wish to leave, this is not a problem. You are under 
no obligation to stay involved if you do not wish too. 
If you are willing to do so please contact the investigators if you are unable or unwilling to continue in the project so as 
we can address an issues within the project. 
If participants have concerns about this study and wish to contact an independent person, please contact: 
The Secretary, Dublin City University Research Ethics Committee, c/o Research and Innovation Support, Dublin City 





Appendix B. Informed Consent 
Informed Consent 
DUBLIN CITY UNIVERSITY 
An evaluation of the effects of the MedEx programme on physical, clinical and psychosocial 
outcomes and an examination of determinants of adherence to MedEx 
Principal Investigator: Dr. Catherine Woods, School of Health and Human Performance, Dr Noel McCaffrey School of 
Health and Human Performance 
Other Investigators: Ms. Fiona Skelly School of Health and Human Performance 
The purpose of this study is to evaluate the MedEx programme on participant physical and psychological health, as well as 
investigating the factors associated with uptake, adherence, relapse, and dropout of a community based chronic illness 
rehabilitation programme.  
This study requires you to participate in physical fitness testing (walk test, lower body strength test, grip strength test, 
flexibility test, and body composition measure) at induction and at  3 month intervals, and completion of questionnaires at 
induction,  also at 3 month intervals. Finally participants will be asked to give a blood sample at baseline and at 3 month 
intervals.  
As part of the induction process a group exercise consultation will be conducted. This will be repeated at 4 weeks and then 
at 3 month intervals going forward.  
Finally, you are asked to wear two devices. The first is an ActivPal Accelerometer. This is a small device attached to the right 
leg and worn for one week. The second is a 24-hour blood pressure monitor. This consists of a blood pressure cuff around 







Participant – please complete the following (Circle Yes or No for each question) 
I have read the Plain Language Statement (or had it read to me)   Yes/No 
I understand the information provided   Yes/No 
I have had an opportunity to ask questions and discuss this study   Yes/No 
      I have received satisfactory answers to all my questions                          Yes/No 
If at any point during your participation in the study, you feel as if you wish to leave this is not a problem. You are under no 
obligation to stay involved if you do not wish to. Please make sure to contact the investigators if you are unable or unwilling 
to continue in the project so as we can address any issues within the project. 
Dublin City University will protect all the information about me, and my part in this study. I will be assigned a unique ID 
number under which all my personal information will be stored securely and saved in a password protected file in a computer 
at DCU. My identity or personal information will not be revealed or published. All records associated with my participation 
in the study will be subject to the usual confidentiality standards applicable to medical records. All contact information will 
be securely stored in Dublin City University and will not be revealed to any third party. In addition, the study findings may be 
presented at scientific meetings and published in a scientific journal but my identity will not be divulged and only presented 
as part of a group. I am aware that the confidentiality of information provided can only be protected within the limitations 
of the law. It is possible for data to be subject to subpoena, freedom of information claim or mandated reporting by some 
professions. 
If I have questions about the research project, I am free to call Dr. Catherine Woods at 01-7008008 or Brona Furlong at 01 
7006442 
I have read and understood the information in this form.  My questions and concerns have been answered by the 
researchers, and I have a copy of this consent form.  Therefore, I consent to take part in this research project: 
Participants Signature:           
Name in Block Capitals:          
Witness:           


















































































































Appendix G. Summary of main effects for participant demographics on health-related measures  
Health-related outcomes Age Sex Income Educational Status Marital Status Working status Smoking Status 
 df F sig df F sig df F sig df F sig df F sig df F sig df F sig 
Physical functioning                      
6MTT (1, 163) 9.6 .002 (1, 163) 0.7 .395 (3, 163) 0.5 .663 (4, 163) 1.1 .367 (2, 163) 0.4 .663 (2, 163) 1.5 .221 (1, 163) 1.3 .256 
Sit to stand (1, 163) 2.8 .096 (1, 163) 0.6 .449 (3, 163) 1.9 .140 (4, 163) 1.7 .147 (2, 163) 0.2 .791 (2, 163) 3.7 .027 (1, 163) 1.2 .270 
Handgrip  (1, 165) 3.8 .054 (1, 165) 76.4 .000 (3, 165) 0.2 .927 (4, 165) 0.1 .990 (2, 165) 1.9 .147 (2, 165) 2.3 .106 (1, 165) 0.1 .720 
Sit and reach (1, 162) 10.8 .001 (1, 162) 6.1 .015 (3, 162) 1.4 .250 (4, 162) 0.9 .480 (2, 162) 3.5 .033 (2, 162) 1.1 .340 (1, 162) 0.0 .919 
Body composition                      
BMI (1, 165) 0.0 .978 (1, 165) 2.3 .133 (3, 165) 0.6 .618 (4, 165) 1.9 .120 (2, 165) 0.8 .430 (2, 165) 3.6 .029 (1, 165) 2.3 .133 
Waist to hip ratio  (1, 165) 3.4 .068 (1, 165) 47.9 .000 (3, 165) 0.4 .777 (4, 165) 0.6 .697 (2, 165) 0.5 .635 (2, 165) 1.6 .209 (1, 165) 4.8 .030 
Blood biomarkers                      
Fasting glucose (1, 116) 0.0 .976 (1, 116) 3.0 .086 (3, 116) 0.5 .711 (4, 116) 1.5 .212 (2, 116) 0.4 .679 (2, 116) 0.3 .754 (1, 116) 0.0 .915 
Triglycerides (1, 132) 1.4 .247 (1, 132) 3.6 .061 (3, 132) 0.1 .941 (4, 132) 1.2 .300 (2, 132) 0.3 .731 (2, 132) 1.7 .183 (1, 132) 0.9 .347 
LDL cholesterol (1, 131) 0.0 .899 (1, 131) 1.8 .188 (3, 131) 2.1 .102 (4, 131) 1.0 .396 (2, 131) 1.1 .347 (2, 131) 1.0 .375 (1, 131) 3.4 .068 
HDL cholesterol (1, 131) 1.7 .195 (1, 131) 7.4 .007 (3, 131) 0.6 .590 (4, 131) 2.2 .072 (2, 131) 0.9 .400 (2, 131) 1.4 .249 (1, 131) 0.0 .926 
hsCRP (1, 101) 0.0 .967 (1, 101) 2.9 .090 (3, 101) 0.5 .673 (4, 101) 1.3 .266 (2, 101) 2.0 .145 (2, 101) 2.7 .073 (1, 101) 1.4 .232 
Psychological health                      
PHQ8 (1, 109) 2.2 .144 (1, 109) 0.8 .376 (3, 109) 4.0 .009 (4, 109) 0.6 .644 (2, 109) 1.2 .303 (2, 109) 0.6 .527 (1, 109) 3.3 .070 
EQ-VAS (1, 109) 1.0 .320 (1, 109) 0.2 .676 (3, 109) 0.7 .567 (4, 109) 3.4 .059 (2, 109) 0.4 .697 (2, 109) 0.9 .418 (1, 109) 5.3 .023 
SWLS (1, 109) 7.8 .006 (1, 109) 0.1 .914 (3, 109) 3.9 .010 (4, 109) 1.6 .182 (2, 109) 0.9 .407 (2, 109) 0.3 .706 (1, 109) 0.5 .482 
Psychosocial det                      
Self-efficacy (1, 109) 1.4 .223 (1, 109) 0.2 .626 (3, 109) 0.7 .583 (4, 109) 0.2 .919 (2, 109) 0.2 .842 (2. 109) 0.1 .930 (1, 109) 1.9 .176 
Note: 6MTT = 6 minute time trial; BMI = body mass index;  PHQ8 = 8-item Patient Health Questionnaire; EQ-VAS = EuroQol Visual Analogue Scale; SWLS = Satisfaction with 
Life Scale; LDL = low density lipoprotein; HDL = high density lipoprotein; hsCRP = high sensitivity C-reactive protein; Psychosocial det = psychosocial determinants of physical 
activity.  




Appendix H. Summary of post hoc analysis on primary outcome variables with a 
significant main effect for time 
Outcome Timepoint p 
Standard 
error df C.I Cohen’s D 
LIPA BL – 3 m .249 0.04 139.34 (-0.19, 0.03) 0.03 
BL – 6 m .014 0.05 135.92 (-0.30, -0.02) 0.06 
BL – 12 m 1.00 0.06 144.83 (-0.22, 0.09) 0.02 
3 m – 6 m .794 0.05 118.18 (-0.21, 0.06) 0.03 
3 m – 12 m .1.00 0.06 127.53 (-0.14, 0.18) 0.01 





BL – 3 m .069 0.29 160.15 (-1.52, 0.03) 0.11 
BL – 6 m .173 0.33 137.46 (-1.62, 0.16) 0.11 
BL – 12 m .396 0.42 131.72 (-1.91, 0.35) 0.10 
3 m – 6 m 1.00 0.31 107.17 (-0.83, 0.85) 0.00 
3 m – 12 m 1.00 0.43 117.91 (-1.18, 1.10) 0.00 





BL – 3 m .066 5.18 164.45 (-27.17, 0.51) 0.46 
BL – 6 m .109 5.85 135.14 (-29.65, 1.68) 0.50 
BL – 12 m .531 7.76 131.64 (-34.09, 7.47) 0.42 
3 m – 6 m 1.00 5.44 105.32 (-15.28, 13.97) 0.03 
3 m – 12 m 1.00 7.73 115.57 (-20.74, 20.77) 0.00 




BL – 3 m .296 1.29 142.22 (-6.01, 0.89) 0.19 
BL – 6 m .087 1.41 133.81 (-7.26, 0.28) 0.25 
BL – 12 m .211 1.54 137.24 (-7.40, 0.85) 0.22 
3 m – 6 m 1.00 1.48 121.94 (-4.90, 3.04) 0.07 
3 m – 12 m 1.00 1.78 147.93 (-5.48, 4.04) 0.04 
6 m – 12 m 1.00 1.59 109.91 (-4.06, 4.48) 0.02 
Numbers in BOLD indicate p < 0.05. 




Appendix I. Summary of simple effects analysis on time*primary CD interaction effect for the 6MTT  
 Baseline 3 months 6 months 12 months 
Primary CD MD SE sig 95% CI MD SE sig 95% CI MD SE sig 95% CI MD SE sig 95% CI 
Cancer 
CVD 87.5 18.0 .000 (34.3, 140.7) 142.6 21.1 .000 (80.4, 204.9) 116.9 23.1 .000 (28.8, 185.0) 97.6 24.6 .001 (24.7, 170.5) 
Respiratory 152.9 20.7 .000 (91.7, 214.0) 236.2 25.0 .000 (162.2, 310.1) 210.6 27.6 .000 (129.0, 292.3) 183.8 29.4 .000 (96.9, 270.8) 
Metabolic 91.4 24.0 .002 (20.4, 162.3) 141.0 29.1 .000 (55.0, 226.9) 101.3 32.0 .025 (6.7, 195.8)     
Neuro/MSK 116.9 29.7 .001 (29.1, 204.7) 173.5 35.6 .000 (68.3, 278.7) 171.3 38.6 .001 (39.2,  303.3)     
Unspecified 138.1 33.1 .001 (40.1, 236.0) 177.1 40.8 .000 (56.5, 297.7) 159.4 44.7 .002 (45.2, 273.6)     
Respiratory 
CVD -65.4 19.0 .001 (-121.6, -9.2) -93.5 22.8 .001 (-161.0, -26.0) -93.7 25.0 .003 (-167.7, -19.8) -86.2 26.2 .017 (-163.8, -8.7) 
Metabolic     -95.2 30.0 .024 (-183.8, -6.6) -210.6 27.6 .015 (-292.3, -129.0) -111.8 29.4 .000 (-213.5, -10.0) 
Note: CD = chronic disease; MD = mean difference; SE = standard error; 95% CI = 95 % confidence interval; CVD = cardiovascular disease; Neuro/MSK = neurological/musculoskeletal  
 
Appendix J. Summary of simple effects analysis on time*primary CD interaction effect for the PHQ8 
 Baseline 3 months 6 months 12 months 
Primary CD MD SE sig 95% CI MD SE sig 95% CI MD SE sig 95% CI MD SE sig 95% CI 
Respiratory 
CVD         2.7 0.8 .022 (0.2, 5.2) 4.0 0.9 .000 (1.4 to 6.6) 
Metabolic         3.6 1.1 .025 (0.2, 6.9) 3.9 1.2 .015 (0.4 to 7.4) 
Cancer     2.8 0.9 .043 (-0.4, 4.6)     4.6 1.0 .000 (1.6 to 7.5) 






Appendix K. Summary of simple effects analysis on time*primary CD interaction effect for the SWLS 
 Baseline 3 months 6 months 12 months 
Primary CD MD SE sig 95% CI MD SE sig 95% CI MD SE sig 95% CI MD SE sig 95% CI 
Respiratory 
CVD             -3.9 1.3 .049 (-7.7, -0.01) 
Cancer -3.6 1.2 .046 (-7.2, -0.03)     -3.7 1.2 .040 (-7.3, -0.1) -6.8 1.5 .000 (-11.2, -2.4) 
Note: CD = chronic disease; MD = mean difference; SE = standard error; 95% CI = 95 % confidence interval; CVD = cardiovascular disease; Neuro/MSK = neurological/musculoskeletal  
 
Appendix L. Summary of simple effects analysis on time*primary CD interaction effect for the WEMWBS 
 Baseline 3 months 6 months 12 months 
Primary CD MD SE sig 95% CI MD SE sig 95% CI MD SE sig 95% CI MD SE sig 95% CI 
Respiratory 
CVD             -3.9 1.3 .049 (-7.7, -0.01) 
Cancer -3.6 1.2 .046 (-7.2, -0.03)     -3.7 1.2 .040 (-7.3, -0.1) -6.8 1.5 .000 (-11.2, -2.4) 







Appendix M. Outcome measure were there was a significant main effect for time in study 
2 (chapter 5) 
Outcome measures 3 months 6 months 12 months 
Physical activity and sedentary behaviour     
Sedentary time     
Standing time     
LIPA  ↑ BL  
MVPA    
Step count     
Number of  sedentary bouts <10 min    
Time sedentary bouts <10 min (min)    
Number of sedentary bouts  11-30 mina    
Time sedentary bouts 11-30 min (min)a    
Number of  sedentary bouts 31-60 min    
Time sedentary bouts 31-60 min (min)    
Number of sedentary bouts > 60 min    
Time sedentary bouts > 60 min (min)    
Total number of sedentary boutsa    
Physical function     
6MTT ↑ BL ↑ BL ↑ BL, ↑ 3 m 
Sit to stand ↑ BL ↑ BL ↑ BL 
Handgrip    ↑ BL 
Sit and reach     
Body composition     
Weight    
BMI    
Waist circumference ↑ BL ↑ BL ↑ BL 
Hip circumference ↑ BL ↑ BL ↑ BL, ↑ 3 m, ↑ 6 m 
Waist to hip ratio    
Blood biomarkers    
Fasting glucose    
Triglycerides    
HDL-C    
LDL-Cb     
hsCRP    
Psychological health    
PHQ8 ↑ BL ↑ BL ↑ BL 
EQ-VAS ↑ BL ↑ BL ↑ BL 
SWLS  ↑ BL  
SWEMWBS    
Psychosocial determinants of physical activity    
Barriers self-efficacyb    
Self-regulatory self-efficacyb   
Intentions for Exerciseb  
Family support    
Friend support    
↑ BL = Significant improvement between baseline and indicated timepoint 
↑ 3 m = Significant improvement between 3 months and indicated timepoint 
↑ 6 m =Significant improvement between 6 months and 12 months 
a Significant main effect for time with insignificant post hoc and no identified timepoint of change  
b Significant main effect for time with a negative outcome 
Note: LIPA = light intensity physical activity; MVPA = moderate intensity physical activity; 6MTT = 6 minute timed 
trial; BMI = body mass index; HDL-C = high density lipoprotein cholesterol; LDL-C = low density lipoprotein 
cholesterol; hsCRP = high sensitivity C-reactive protein; PHQ8 = 8-item Patient Health Questionnaire; EQ-VAS = 
EuroQoL Visual Analogue Scale; SWLS = Satisfaction with Life Scale; SWEMWBS = The Short Warwick Edinburgh 




Appendix N. Outcome measures were there was a significant main effect for attendance 
in study 2 (chapter 5) 
Outcome measures Main effect for attendance  
Physical activity and sedentary behaviour   
Sedentary time   
Standing time   
LIPA X 
MVPA X 
Step count  X 
Number of  sedentary bouts <10 min  
Time sedentary bouts <10 min (min)  
Number of sedentary bouts  11-30 min  
Time sedentary bouts 11-30 min (min)  
Number of  sedentary bouts 31-60 min  
Time sedentary bouts 31-60 min (min)  
Number of sedentary bouts > 60 min  
Time sedentary bouts > 60 min (min) X 
Total number of sedentary bouts  
Physical function   
6MTT  
Sit to stand  
Handgrip   
Sit and reach   
Body composition   
Weight X 
BMI X 
Waist circumference  
Hip Circumference X 
Waist to hip ratio  
Blood biomarkers  
Fasting glucose  
Triglycerides  
HDL-C  
LDL-C   
hsCRP  





Psychosocial determinants of PA  
 Barriers self-efficacy X 
Self-regulatory self-efficacy X 
Intentions for Exercise X 
Family support  
Friend support  
X indicates variables where a significant association with attendance was identified in study 2 (chapter 5) 
Note: LIPA = light intensity physical activity; MVPA = moderate intensity physical activity; 6MTT = 6 minute timed 
trial; BMI = body mass index; HDL-C = high density lipoprotein cholesterol; LDL-C = low density lipoprotein 
cholesterol; hsCRP = high sensitivity C-reactive protein; PHQ8 = 8-item Patient Health Questionnaire; EQ-VAS = 
EuroQoL Visual Analogue Scale; SWLS = Satisfaction with Life Scale; SWEMWBS = The Short - Warwick Edinburgh 
Mental Wellbeing Scale 
 
